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A (C, G, T)   Adenine- (cytosine-, guanine- and thymine-) derivatives 
AMA    Ammonia/Methylamine 
br    broad 
n-BuLi   n-Buthyllithium 
c    concentration  
χ    mole fraction  
CD    Circular Dichroism 
d    doublet  
δ    chemical shift 
DFT    Density Function Theory 
DMAP   4-Dimethylaminopyridine 
DMSO-d6   Deuterated dimethylsulphoxide 
DMTr    4,4´-Dimethoxytrityl 
DNA    2´-Deoxyribonucleic acid 
ε    extinction coefficient /elipticity 
ESI-MS   Electo Spray Ionisation Mass Spectrometry 
h    hours 
HPLC    High-Pressure(Performance)-Liquid Chromatography 
IUPAC   International Union of Pure and Applied Chemistry 
LDA    Lithium diisopropylamine 
m (NMR)   multiplet  
MeDP    Methyldeazapurine or 1-deaza-9-methylpurine 
MHz    Mega Hertz 
1-mimi   1-methylimidazole 
m    mass 
M    Molar mass 
MALDI-TOF Matrix-Assisted Laser Desorption/Ionisation Time-Of-
Flight 
min    minutes 
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Mn+    M = metal and n =charge of the metal 
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NMR    Nuclear Magnetic Resonance 
NOESY   Nuclear Ovehauser Enhancement Spectroscopy 
ppm    parts per million 
q    quartet  
RNA    Ribonucleic acid 
r.t.    room temperature 
s    singulet  
TEEA    Triethylammonium acetate 
TLC    Thin Layer Chromatography 
TMS    Tetramethylsilane 
TSP    Sodium-3-(trimethylsilyl)-propanesulfonate 
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T    Temperature 
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A Introduction  
 
1 DNA 
 
The DNA (2´-deoxyribonucleic acid) exists of two complementary strands1-3 that 
bind together through π-stacking and H-bonding as the two stabilising forces. These 
two strands are not linear, but are twisted into a helix. A single strand consists of 
chains of five-membered-ring sugars linked by phosphate groups, the so called sugar 
phosphate backbone. The anomeric carbon of each sugar is connected to a N of a 
nucleobase by a β-glycosidic linkage. The backbone on the outside is wrapped 
around the nucleobases in the inside.4-7  
 
 
 
Figure 1: Example of a DNA structure; blue and red represent nucleobases, grey the 
sugar phosphate backbone.7 
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There are only four bases in DNA: adenine (A), cytosine (C), guanine (G) and 
thymine (T). A and G are substituted purines and C and T are substituted 
pyrimidines and they are linked to the sugar over N9 and N1, respectively. It should 
be mentioned that RNA (ribonucleic acid) differs from DNA by one additional OH-
group at the 2´-position of the sugar and RNA has uracil as base instead of thymine. 
Uracil does not possess a CH3-group at the 5-position in comparison to thymine.  
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Figure 2: Schematic diagram of an oligonucleotide strand with the four natural 
nucleobases found inside DNA. 
 
The Watson-Crick base pairs1 are shown in Figure 3. It can be seen that A-T forms 
two and C-G three hydrogen bonds. The base pairs are planar. It should be noticed 
that the H-bonds that hold the base pairs together are all of a length of about 2.9(1)Å.  
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Figure 3: Watson-Crick base pairing of the four natural nucleobases. 
 
There are additional stacking interactions that are stronger between two purines than 
two pyrimidines. Important for this, again, is the planarity of the base pairs. 
Although these are very weak interactions, when added together they have a large 
contribution to the stability. There are also other sides, where the base pairing on the 
nucleobases can take place, such as the Hoogsteen side8,9 shown in Figure 4 for an A-
T base pair.4-7 
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Figure 4: Hoogsteen base pairing of two natural nucleobases. 
 
Each strand has a direction, for example, 5´ to 3´ or 3´ to 5´. Always A-T and C-G 
base pairs are formed, but the direction of the single strands in a double helix can be 
parallel (5´-3´and 5´-3´) or anti parallel (5´-3´and 3´-5´), as usually found in natural 
DNA. There are also two kinds of grooves because of the backbone twisting around 
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the nucleobases in the inside. They are called major and minor groove. These grooves 
are used by enzymes, proteins, metals and many more as docking station to get to 
the inside of the DNA or only to stabilise the backbone.  
There are some common types of naturally occurring DNA: A-DNA, B-DNA and Z-
DNA. Next to those other helical forms exist. The A- and B-DNA are right-handed 
helices, the Z-DNA is left-handed. The B-DNA is the most common form in living 
organisms and in aqueous solution. For A-DNA nonpolar solvents and for Z-DNA 
regions with a high content of G-C base pairs are necessary. A-T base pairs have a 
highly destabilising effect for the formation of Z-DNA. The Z-DNA is longer and 
thinner than the B-DNA, which itself is longer and slightly thinner than A-DNA. 
Helices in general can be looked at by the amount of bases per 360° turn, which is 
also a measure for the π-stacking interactions, and the diameter of the double helix, 
which gives rise to the thickness of the helix and the space present for an H-bonding 
pair. 
 
A-DNA B-DNA Z-DNA 
right handed right handed left handed 
26Å diameter 20Å diameter 18Å diameter 
2.9Å helix rise 3.4Å helix rise 3.7Å helix rise 
11 bases/turn 10 bases/turn 12 bases/turn 
 
Table 1: Common helical forms and their structural properties.7 
 
Next to the double helices, higher order structures such as triple and quadruple 
helices are also found in nature.  The resolution of DNA structures in general is done 
via NMR and X-ray diffraction methods, though this is not always trivial and does 
not always lead to the wanted accurate results. Another important fact is that DNA, a 
polynucleotide, is also a polyanion, due to the negative charges on the phosphates. 
This negative charge can be compensated by polyamines or through metal ions by 
the counter-ion condensation.7 Water molecules are also present through the spin of 
hydration in the minor groove and can surround positions at the nucleobases and the 
phosphate groups. For the formation of Z-DNA metal ions, such as Mg2+, are also of 
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great importance, since they stabilise the structure greatly. In general, soft metals 
tend to coordinate to the nucleobases (N-positions), whereas hard metals usually 
bind to the backbone (O-positions). 
The organism’s complete genetic information is stored and the growth and the 
division of the cell are controlled by DNA. Its highly specific self association is one 
interesting aspect for scientists. DNA has a potential as template for preparations of 
newly functionalised molecular architecture and bioinorganic and organic nano 
building blocks. Nowadays sciences find more uses for DNA, one example are the 
DNAzymes.10   
 
Historical background:4-6 
 
The DNA was first isolated in 1869 from the nuclei of white blood cells and because 
it was found to be acidic, it was called nucleic acid. Around 1900 it was possible to 
define nucleic acids as containing four different nucleotides. These could each get 
divided into phosphate, sugar and heterocyclic base. Although it was found a few 
years later that all nuclei of cells contained DNA, it took until 1944 to conclude that 
the DNA was a carrier of genetic information. At that time it was also found by 
Chargaff that the amount of a certain nucleobase present was dependent on another 
nucleobase being present; A = T and C = G. This was a first indication of 
complementarities. Also Pauling published his DNA model in 1953 before Watson 
and Crick1, the latter came the nowadays excepted model very close. The proposed 
structures were underlined by crystallography findings by Wilkins2 and Franklin3. It 
shall be mentioned that while Watson had his PhD already for two years, Crick was a 
graduate student while he worked at the prior work that brought Watson, Wilkins 
and him the Nobel Prize in 1962. Then the scientific interest became greater and in 
1957 the triple helix and in 1962 the quadruple helix were postulated. Hoogsteen8,9 
suggested in 1959 additionally to the Watson-Crick base pairing a different way of 
base pairing, named after him. In 1999 the first pentaplex was published, though it 
was synthesised and not found in nature.7 
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2 Modifications of DNA 
 
Due to the fascinating properties of DNA scientists are not only interested in 
understanding more about DNA, but also to copy the properties for their own 
purposes. Therefore many scientists have been working on modifying DNA to obtain 
more interesting and useful properties, but also to further understanding of its 
behaviour. As already mentioned, a nucleotide contains a phosphate, a sugar and a 
nucleobase unit. These are the first three categories of DNA modifications:  
 
I Modifications on the phosphate backbone: 
 
The phosphate backbone can be modified by substitution of an O atom with a CH3 
group or an S atom. Both free O atoms can also be substituted by S atoms. 
Modifications can alter the negative charge at the backbone of an oligonucleotide. 
Having a CH3 group present instead of an O atom, deletes the negative charge on the 
backbone. This oligonucleotide is no longer a polyanion. Also S is a softer atom than 
an O atom and might bind different metals or avoid the binding to metals, which 
would have been bound by the O atom. 
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Figure 5: Modifications at the phosphate backbone: a) Substitution of an O atom by a 
CH3 group, b) an O atom by a S atom, c) two O atoms by two S atoms (R = a base). 
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II Modifications on the sugar: 
 
The five-membered-ring sugar can be modified by adding groups at the free 2´- or 4´-
positions,11 substituting the O atom in the ring by an S atom or by a NH2 functional 
group12 or by replacing the 3´-OH or 5´-OH groups by thiol, amine or alkylthiol 
functional groups.13,14 Adding a SeCH3 group, for example, at the 2´-position can be 
used for improved X-ray crystallography measurements.15  
Next to the simple changes in atoms there are some interesting changes in bonds and 
other structural features that can be used for modifications. The TNA, threofuranosyl 
nucleic acid by Eschenmoser,16,17 that is a simple nucleic acid derived from a tetrose 
sugar has been shown to support Watson-Crick base pairing, to form antiparallel 
duplexes and to crosspair with DNA and RNA. Simplification of the sugar phospha-
te backbone to improve the synthetic accessibility of artificial duplexes while contain-
ing the properties is the aim. The introduction of a C3-backbone instead of the sugar 
ring was found to be of great stability.18-20 It is called GNA, glycol nucleic acid, and 
the thoughts that a duplex needs a sugar ring for helix formation are proved wrong. 
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Figure 6: Modifications on the sugar unit of a) DNA (RNA): b) TNA and c) (S)-GNA 
(R = a base), numbering in analog to a) and b).18 
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One interesting substitution of the complete sugar phosphate backbone is done in so 
called PNA, peptide nucleic acid. As can be seen in Figure 7, the sugar phosphate 
backbone is replaced by a peptide, an amino acid chain. The two chains are held 
together by C-G base pairs and by four histidines coordinating a metal ion.21 With 
Zn2+ a melting point and double strand formation were observed. For Cu2+, however, 
only bonding to two histidines of one strand and therefore no double strand 
formation could be observed. By now, many examples of PNA, with and without 
metal ions coordinating, are known.22-25 
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Figure 7: Idealised representation of two strands based on a peptide backbone 
connected via four C-G base pairs and four histidines binding one metal ion.21 
 
There are other examples of complete substitution of the backbone using chains of 
mostly aromatic organic molecules to bring the base pairs in the right position for 
binding. H-bonding base pairs are formed, but the backbone is not necessarily 
twisted around the nucleobases.26-29 
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III Modifications on the nucleobase:  
 
The third modification region are the nucleobases that can be divided in three 
categories of modifications on the nucleobases.30-32 The first category is the simple 
modification of the four natural nucleobases by adding or substracting functional 
groups. The actual H-bonding and the π-stacking interactions, as stabilising forces, 
are not changed.  
One example of this modification is the extension of natural nucleobases by fusion 
with a benzo ring and therefore the increase in size of the formed double helix.33-36 
Due to the increase in size of the nucleobases and the raised strain in the backbone, 
the oligonucleotides turned out to be less stable than unmodified oligonucleotides 
with the same sequence of natural nucleobases, if the base pairing partner is another 
nucleobase with increased size. The opposite is the case, if the base pairing partner is 
a natural nucleobase. 
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Figure 8: Introduction of a methylene group between the sugar ring and the base.37 
 
Another example is the extension of the glycosidic bond between the sugar ring and 
the nucleobase by a methylene group, as can be seen in Figure 8.37 This imposes an 
extra degree of conformational flexibility in comparison to the normal glycosidic 
bond being present. 
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Exchanging the N atom at the 3-position in an adenine with a C atom and adding a 
NO2-group at that 3-position lead to other interesting properties of modified natural 
nucleobases.38 The melting behaviour and the stability of an oligonucleotide 
containing such a modified adenine nucleobase differ only marginal from an 
oligonucleotide containing adenine itself. Though, the NO2 group was shown to 
allow photo induced strand cleavage. 
Many other modifications on the functional groups of natural nucleobases can be 
found in the literature.39-42  
 
The second modification of nucleobases is the replacement of important functional 
groups (NH2 or CO) of natural nucleobases by the substitution of those functional 
groups or by the introduction of artificial nucleobases.43,44  
Taking for example an indole nucleoside and introducing it into a self complemen-
tary oligonucleotide the formation of a stable duplex was observed. The introduction 
of a fluorinated hydrocarbon gave an even more stable double helix. This shows that 
not only H-bonding is important for double helix formation and stability. Also π-
stacking interactions, although a weak stabilising force, can have a high contribution 
to the stability, when many of them are present without interruption.  
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Figure 9: An example of artificial nucleobases that can be introduced into DNA; in 
the benzo ring fluorinated indole nucleoside and indole nucleoside (on the left and 
the right, respectively).43,44 
 
Many other examples of this modification type can be found in the literature.20,45-49 
These are mainly artificial nucleosides with large aromatic systems. A high amount 
of π-stacking ability is present in those systems and therefore these systems have 
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been used as opposites for abasic sites. Although there is no possibility of H-bonding, 
the large aromatic systems can contribute with their large amount of π-stacking inter-
actions to the stabilisation forces that are responsible for the formation of a double 
helix of two oligonucleotides.50 These aromatic systems can be larger than a natural 
nucleobase, when present opposite an abasic site, since more space is available. 
 
The third modification of nucleobases is reached through the introduction of a third 
stabilising interaction, the metal ion ligand interaction, hence the formation of metal-
mediated base pairs. By designing completely new nucleobases, by extending natural 
nucleobases by functional groups or by using natural nucleobases, metals can be 
brought into the inside of oligonucleotides, forming double helices.30,31 A possible 
[1+1]-, [2+2]- and [3+1]-coordination of the metal ion has been found to be successful. 
In Figure 10 an example of a [3+1]-coordination is shown.51 Introduction of pyridine-
2,6-dicarboxamide and pyridine as artificial nucleobases in opposite positions in two 
complementary oligonucleotide strands and addition of Cu2+ as metal ion showed an 
increase in stabilisation of the double helix structure. The melting temperature was 
even higher by introducing four artificial nucleobases in a row into two 
complementary strands. 
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Figure 10: The tridentate pyridine-2,6-dicarboxamide and the monodentate pyridine 
nucleobase build a metal-mediated base pair in the presence of Cu2+.51 
 
Another example of metal-mediated base pairing is shown in Figure 11.52 By 
exchanging the NH2 group of an adenine with a pyridine, a 6-(2´-pyridyl)-purine 
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metallo base pair could be formed with Ni2+ selectively inside a double helix. A 
stabilisation of the double helix structure by an increase in melting temperature of 
6°C was observed. This is an example of changing a functional group of the adenine 
nucleobase for the purpose of introducing a Mn+ inside two complementary 
oligonucleotides forming an helix. 
 
N
N
sugar
N
N
N
sugar
N
N
N N
N
= metal ion  
 
Figure 11: The two bidentate 6-(2´-pyridyl)-purine nucleobases form a metallo base 
pair with Ni2+.52 
 
The use of a metal-mediated base pair in a double helix to form a catalyst that is used 
for many organic reactions can be seen in the example in Figure 12.53  
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Figure 12: Formation of a metal-salen base pair.53 
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The artificial nucleobases can only build a metal-salen base pair upon the addition of 
two components, the ethylene diamine and Cu2+ or Mn2+. A Schiff-base is formed 
and the reaction is reversible in water. Through the formation of this metal-mediated 
base pair the double helix of the two complementary oligonucleotides is highly 
stabilised. 
Many other examples of artificial nucleobases that have been brought forward as 
possible candidates for the introduction into an oligonucleotide or that have already 
been built into oligonucleotides are listed in Figure 13.54-65 The number of possible 
artificial nucleobases for metal-mediated base pairing increases steadily. 
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Figure 13: Examples of possible artificial nucleobases for metal-mediated base 
pairing from the last six years only. Except one (bottom left) all have been introduced 
into oligonucleotides.54-65 
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There are some rules that have to be considered when designing new artificial 
nucleobases for metal-mediated base pairing:30  
• The artificial nucleobases or modified natural nucleobases need to be of 
comparable size and form with the natural nucleobases. 
• The nucleobases should build planar complexes with the metal ions.  
• The artificial nucleobases as chelating donors should have a higher metal 
affinity to metal ions than natural nucleobases.  
• The preparation of the oligonucleotides should be possible with a 
standardised and automatic method.  
These rules are actually more or less important guidelines. For example, the base 
pairs formed in nature by H-bonding are not always completely planar. Some kind of 
flexibility is present in the base pairs. This flexibility exists for metal-mediated base 
pairs, too.  
 
Through the introduction of artificial nucleobases into oligonucleotides that can act 
as chelating donors and bind metal ions a third stabilising interaction has been 
found, next to the H-bonding and π-stacking interactions. A third stabilising effect 
opens up many more possibilities of modifying oligonucleotides and perhaps later 
DNA, too. The fascinating properties of DNA itself, such as the self association, made 
scientists become interested in this topic. Through the increasing number of 
modification possibilities present, one now has to look at the potential uses of 
artificial nucleobases binding metal ions inside the double helices.  
Next to the general interest in gaining a better understanding of interactions inside 
DNA, the aim is also to use the third stabilising effect to change the properties of 
oligonucleotides, where it is wanted, without losing existing properties. The 
possibility of using metal ions to stabilise artificial base pairs means that next to the 
four naturally occurring nucleobases as building blocks, new building blocks can be 
introduced. This can result in an enlargement of the genetic alphabet.  
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The construction of new oligonucleotide structures and functions can lead to 
interesting magnetic properties.66,67 In this example, the metal ions show spin-spin 
interactions, which shows that the metal ions are close to each other (3.7 ± 0.1Å). 
Figure 14 shows the most metal ions bonded inside a double helix and stacked in a 
row that has been published by now.  
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Figure 14: Schematic representation of Cu2+-mediated base pairs inside an anti-
parallel double helix.66,67 
 
It has to be mentioned that not many examples of metal ions aligned in a linear 
fashion can be found in solution, unlike in the solid state, where there are many 
examples. Five Cu2+ sit above each other, which is not only giving rise to novel 
magnetic properties, but also to possible electrical properties of such a double helix. 
If it is possible to align many metal ions above each other and close enough to each 
other there should be a possibility of observing electrons moving through the inside 
of a double helix.32 So it has been shown that M-DNA, metal ion containing DNA, 
can have fast electron transfer in comparison to DNA. The first evidence of 
metalliclike conduction was observed by Rakitin et. al.68 The introduction of Zn2+ 
into A-T and C-G base pairs is shown in Figure 15. 
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Figure 15: Schematic representation of postulated base pairs in M-DNA formed by 
the natural nucleobases.68 
 
A one dimensional chain of metal ions inside a double helix that is bound through 
artificial nucleobases that self associate with the help of metal ions and the sugar 
phosphate backbone as structural template outside gives a strong indication of a 
possible use as DNA nanowire and as self-assembling electronic circuit.69,70 
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B Aim 
 
The aim of this work is the synthesis of oligonucleotides containing new artificial 
nucleobases that are able to build artificial planar metal-mediated base pairs without 
disturbing the geometry of the backbone and therefore partially or fully exchange H-
bonding and π-stacking interaction through covalent metal ligand interactions. 
Through the synthesis of these new systems further information about the structure 
and the bonding behaviour shall be studied.  
 
1 4´-Methyl-2,2´:6´,2´´-terpyridine (Chapter I) 
 
Different ways of introducing metal ions into the inside of a double helix using 
artificial base pairs have been developed. Next to the [1+1]- and the [2+2]-
coordination, the [3+1]-coordination has been found successful. The tridentate 
heterocyclic ligand, 4´-methyl-2,2´:6´,2´´-terpyridine, is known to have a high metal 
affinity and additionally the ability of participating in π-stacking interactions. Using 
either imidazole or tetrazole, two monodentate ligands, as base pairing partners, the 
possibility of having stabilising interactions and a planarity in these possible artificial 
base pairs shall be looked at. This can be done with model structures containing a 
2,2´:6´,2´´-terpyridine, a metal ion and either 1-methylimidazole or 1-methyltetrazole. 
The synthesis of a 4´-methyl-2,2´:6´,2´´-terpyridine nucleoside can also help 
characterising and gaining information about the behaviour of this ligand inside an 
oligonucleotide. This can be done, for example, by obtaining a crystal structure or by 
measuring the pKa value to exclude the possibility of a concurrent protonation 
reaction to the wanted metallation. The 4´-methyl-2,2´:6´,2´´-terpyridine is meant to 
be connected via the 4´-methyl group to the sugar ring, which gives rise to a 
methylene group that links the artificial nucleoside with the sugar ring. As explained 
in the Modifications of DNA (I) section this methylene bridge shall introduce an 
extra degree of conformational flexibilitx to the system. For simplification reasons the 
nucleoside will be named 4´-methyl-2,2´:6´,2´´-terpyridine nucleoside. 
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Imidazole or tetrazole as the two monodentate ligands shall be looked at, since there 
could also be a possibility of 4´-methyl-2,2´:6´,2´´-terpyridine being not only able to 
build artificial base pairs selectively with one other monodentate ligand, but with 
two or three different monodentate ligands (one at a time), depending on the 
strength of the metal ligand interaction. For example, the imidazole could be 
exchanged by the tetrazole, since this might give a stronger complex with the 
terpyridine ligand and a metal ion and vice versa. This could be an advantage to the 
natural nucleobases, because they only have one binding partner. The adenine binds 
with thymine and cytosine with guanine. Another advantage could be the variety of 
different metal ions that can be bound strongly by 4´-methyl-2,2´:6´,2´´-terpyridine 
and that therefore different metal-mediated base pairs could be found. Metal ions 
could be prevented to bind at other positions within the oligonucleotide, such as the 
backbone or natural nucleobases, due to the high metal affinity of 4´-methyl-
2,2´:6´,2´´-terpyridine.  
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Figure 16: Possible [3+1]-coordination of a 4´-methyl-2,2´:6´,2´´-terpyridine 
nucleoside with an imidazole or tetrazole nucleoside. 
 
Primarily model structures with 2,2´:6´,2´´-terpyridine, a metal ion and the either of 
the two different monodentate ligands, 1-methylimidazole or 1-methyltetrazole, shall 
be synthesised and characterised. 
Secondarily, the 4´-methyl-2,2´:6´,2´´-terpyridine nucleoside shall be synthesised to 
start gaining further information about the possible systems, as mentioned above. 
For the synthesis of this artificial nucleoside a C-glycosidic bond formation is 
necessary. 
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2 1-Deazapurine and 1-Deazaadenine (Chapter II) 
 
Whereas the potential artificial nucleoside in chapter I would contain of a C-
glycosidic bond, in chapter II of the thesis potential artificial nucleosides with a N-
glycosidic bond shall be looked at. Also another strategy in the actual binding 
possibilities of a possible artificial nucleobase with metal ions shall be explored. 
Instead of taking new ligand systems and employing them into oligonucleotides, the 
natural nucleobases can be altered by adding or subtracting binding sites. At the 
natural nucleobase adenine an N atom could be substituted by a CH group and the 
NH2 group could be abstracted to give a 1-deazapurine, which would only have one 
potential binding site for H-bonding left. The N7 atom left could bind to a thymine 
using H-bonding. This is overall expected to be destabilising for this artificial base 
pair.  
At the natural nucleobase adenine one could also only substitute one N atom by a 
CH group to give 1-deazaadenine, so that Watson-Crick base pairing, again, is 
hindered and any possible binding sites are at the Hoogsteen side. 
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Figure 17: The possible binding of 1-deazaadenine, a), and 1-deazapurine, b), with 
thymine over the Hoogsteen side without metal ions being present. 
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This would mean that the then resulting 1-deazaadenine would build out two and 
the 1-deazapurine one H-bond to the natural base pairing partner thymine. But upon 
the addition of a metal ion, metal-mediated base pairing could be induced.  
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Figure 18: Possible metal-mediated base pairs between thymine and 1-deazaadenine, 
a), and thymine and 1-deazapurine, b). 
 
So the destabilising effect of minimising the H-bonding in this system could 
eventually be overcome by additional metal ligand interactions that normally are 
stronger than H-bonds. Although alterations on the adenine change the possibility of 
H-bonding, the π-stacking interactions should not be affected largely. [1+1]-
coordination on a metal ion, one additional H-bond and π-stacking interactions 
would give a system with the two traditional and natural interactions and the metal 
ligand interaction as third stabilisation effect inside an oligonucleotide. However, 
properties, such as the self assembling, might be influenced greatly. To find out 
about this and other possible changes in properties of oligonucleotides containing 
these artificial nucleobases, one has to examine these systems more closely. One can 
study them by synthesising possible model structures, the artificial nucleosides, 
themselves, and by introducing them into oligonucleotides. Comparison between 
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these systems, for example, could give information about the strength of the extra H-
bond present in 1-deazaadenine compared to 1-deazapurine. 
 
Primarily, model structures of the 1-deazapurine nucleoside (sugar unit replaced by 
a methyl group, for example, as in 1-deaza-9-methylpurine) in addition to the actual 
1-deazapurine and 1-deazaadenine nucleosides shall be synthesised to start gaining 
information about the coordination systems, such as the probability of protonation 
reactions that can be in concurrence to metal binding. The stoichiometry and the 
strength of metal binding in comparable model structures shall be measured. 
Secondarily, the artificial nucleoside shall be introduced in oligonucleotide strands 
and the synthesis standardised. 
Thirdly, the oligonucleotide strand shall be subjected to thermal melting with 
different metal ions and base pair partners to prove the possibility of metal-mediated 
base pairing with these systems and to gather further information about these 
systems. 
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C Results and Discussion 
Chapter I 
1 4´-Methyl-2,2´:6´,2´´-terpyridine 
1.1 Introduction 
 
Aryl C-nucleosides are analogues of natural nucleosides where the bases have been 
replaced with aromatic moieties. The use of 4´-methyl-2,2´:6´,2´´-terpyridine as an 
artificial nucleobase inside an oligonucleotide is thought to induce a high metal 
affinity. As the opposite monodentate artificial base imidazole and tetrazole are 
possibilities. Though, these should not give rise to steric hindrance. The planarity of 
those systems that is essential for the introduction into double helices, as already 
mentioned in the introduction, can be visualised with the help of model structures 
between 1-methylimidazole and 1-methyltetrazole with 2,2´:6´,2´´-terpyridine 
coordinated by metal ions such as Pd2+ and Pt2+. These metal ions should build 
strong complexes that can be used for crystallisation. Also DFT calculations can give 
a rough idea about the amount of energy needed to bring these [3+1]-coordination 
systems into a planar form. Additionally to the covalent M-L bonds the heterocyclic 
systems could induce π-stacking in a great amount, since it has three pyridine rings 
being able to stack, which is another advantage compared to other [3+1]-
coordination systems, known by now. 
Next to the preparation of those model structures and the following interpretation, 
the synthesis of the 4´-methyl-2,2´:6´,2´´-terpyridine nucleoside is a great challenge 
and needs discussion.  The methyl group is meant to function as linker between the 
4´-methyl-2,2´:6´,2´´-terpyridine and the sugar, giving the system some kind of 
flexibility and freedom. The synthesis of C-glycosidic bonds is described in the 
literature, but under still changing reaction conditions and routes, depending on the 
artificial nucleobase used. The different approaches to reach this goal will be 
discussed and analysed. New ways of synthesising the nucleoside are put forward.  
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1.2 Model Structures 
 
For the model structures 1-methylimidazole (1-mimi) (1) and 1-methyltetrazole (1-
mtet) (2) are needed. 1 was commercially available and 2 had to be synthesised. After 
the reaction route by Koren et al.71 did not produce product 2, another route was 
chosen72 and successful. Deprotonation of tetrazole using NaH followed by 
methylation with MeI and finally a distillation over a ball-tube (“Kugelrohr”) 
distillation gave the wanted product 2 and as side product 2-methyltetrazole (2-mtet) 
(3). The product ratio was 2:1 and the yields were low and did not compete with the 
literature values. 
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Figure 19: Schematic diagram of 1-methylimidazole (1-mimi) (1), 1-methyltetrazole 
(1-mtet) (2) and 2-methyltetrazole (2-mtet) (3). 
 
Next, [(trpy)PdCl]Cl· 2H2O (4) was prepared analogous to the synthesis of 
[(trpy)PtCl]Cl· 2H2O (5) that was prepared similar to the synthesis by Annibale et 
al,73 starting of from the 1,5-cyclooctadiene precursors74. The difference in reaction of 
4 was the lower reaction temperature (r.t.) and the excellent yield. The yield for 5 is 
lower than described in the literature. 
For the synthesis of the [(trpy)Pd(1-mtet)](ClO4)2 (6) the [(trpy)PdCl]Cl· 2H2O (4) is 
stirred with two equivalents of AgNO3 and 5 equivalents of 1-methyltetrazole (2) for 
one day, whereby one Cl- is displaced by NO3- and the other by 2. The produced 
AgCl is taken off, the pH raised to 9 and the NO3- is displaced by ClO4-. The resulting 
Pd2+ complex (6), however, could not be crystallised. As shown later with the help of 
NMR spectroscopy, complex 6 probably is [(trpy)2Pd2(1-mtetate)](ClO4)3.75 
The synthesis of the [(trpy)Pt(1-mtetate)](ClO4) (7) complex is analogous to 6, but due 
to the PtII being more inert in comparison longer reaction times and higher reaction 
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temperatures are necessary. Both syntheses were done analogous to the synthesis by 
B. Lippert et al.76  
Since the obtained side product 2-methyltetrazole (3) could also show a binding 
behaviour that one could compare with the other structures, it was tried to synthesise 
[(trpy)Pd(2-mtet)](ClO4)2 (8) and [(trpy)Pt(2-mtet)](ClO4)2 (9) using the same 
procedures as for 6 or 7. But only the starting compound was found after the 
reaction, showing that this was not easily synthesised. This is a first indication that it 
is not possible to use 3 as opposite artificial nucleoside inside DNA. This could be 
due to steric reasons of the methyl group of 3 or due to electronic reasons. Different 
reaction conditions, however, might allow binding. 
Using the same procedures as for 6 or 776 with 1 as ligand, two complexes can be 
obtained, the [(trpy)Pd(1-mimi)](ClO4)2 (10) and [(trpy)Pt(1-mimi)](ClO4)2 (11).  
Having synthesised all four complexes (6, 7, 10 and 11) it is important to realise, that 
the monodentate ligand can bind over different atoms in the heterocyclic ring. The 
possible coordination sites of 1-methyltetrazole inside 6 and 7 are shown in Figure 
20. 
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Figure 20: Schematic diagram of possible structures of the cations of 6 and 7. 
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For the 1-methyltetrazole (2) four possible coordination sides can be found for each 
metal ion. On the one hand it can coordinate at the three different N atoms; on the 
other hand it could bind over the C atom, if it is deprotonated. For the Pt2+ complex 
(7) a crystal structure was obtained, but at first the complex was analysed using 
NMR and elemental analysis. Looking at the 1H-NMR spectrum one could not find a 
signal for the H5 proton, which could be due to the deprotonation of this proton and 
binding over the C5 atom. Though, it could not be surely said that it is not hidden 
underneath the heteroaromatic proton signals of the 2,2´:6´,2´´-terpyridine. Additio-
nally in the 1H, 1H-NOESY spectrum a cross-peak between the H6 and H6´´ protons 
with the methyl group of the 1-methyltetrazole (2) was observed. This shows that the 
methyl group lies close to the H6 and H6´´ protons. A coordination of 2 over N3 or 
N4 can therefore be excluded. Now, looking at the elemental analysis one can 
differentiate between the N2 and C5 linked complexes formed, since the number of 
counter ions (ClO4-) differs by one. The elemental analysis showed that there is only 
one ClO4- in the structure ruling out the coordination over the N2 position. Another 
observation that has been made in the NMR spectra is the movement of H6 and H6´´ 
to higher field. This could be the case, if 7 has its hetero aromatic ring of the 1-
methyltetrazole perpendicular to the plane of the 2,2´:6´,2´´-terpyridine. The ring cur-
rent effect of the 1-mtet would act on the two protons and move them to higher field. 
 
 
 
Figure 21: Crystal structure of the cation of [(trpy)Pt(1-mtetate)](ClO4) (7). 
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Indeed, all the interpretations on the complex were correct, as can be seen in Figure 
21. The 1-methyltetrazolate (1-mtetate) binds over the deprotonated C5 atom, 
probably because a fast deprotonation-equilibrium is present. The 1-methyl-
tetrazolate (1-mtetate) is not planar, but on the way of being perpendicular to the 
metal ion terpyridine plane. The measured angle between the Pt-N3C plane and the 
1-mtetate coordination plane is 67.0(2)°. It should be mentioned that the Pt-N and Pt-
C distances are all between 1.98 and 2.03Å. Looking at the bond lengths inside the 
tetrazole ring in 7, only one short bond length and four nearly equal bond lengths 
were observed. This shows that there is a double bond between N2 and N3 in the 
tetrazole ring, but the second double bond, as shown in Figure 20, cannot be located. 
One could think that the charge might be delocalised or that N4 has a negative 
charge, however this could not be proven. Though, looking at other tetrazole 
containing complexes this phenomenon of only one short bond was often found. 
 
 
 
Table 2: Selected distances and angles of the crystal structure of 
[(trpy)Pt(1-mtetate)](ClO4) (7). 
 
In Figure 22 it can be seen nicely that the plane of tetrazole ring is close to being 
perpendicular to the metal ion terpyridine plane. Only one ClO4- has been found 
since the deprotonated C5 is negatively charged, and therefore balancing one 
positive charge of the metal ion. 
 
Distances (Å) and 
angles (°) 
7 
M-C5 2.006(5) 
M-N1 2.034(4) 
M-N1´ 1.981(4) 
M-N1´´ 2.023(4) 
MN3C-L 67.0(2) 
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Figure 22: Crystal structure of [(trpy)Pt(1-mtetate)](ClO4) (7). 
 
In expectation of the tetrazole ring to bind over the N3 position DFT-caculations77 
were performed. The calculations show that in the comparable Pd2+ complex (6) that 
binds 1-mtet over N3 the energy difference between the calculated structure with a 
relaxed geometry (MN4-L = 27.9°) and the geometry optimised planar structure 
(MN4-L = 0.1°) lies at 0.8kJ/mol. This is a very low energy barrier and gives rise to 
the possibility of having a planar [3+1]-coordination system. However, it should be 
tried now, to coordinate the 1-methyltetrazole (2) over the N3-position by avoiding 
the deprotonation of C5. Bonding through the N3-position could stabilise the 
planarity of that system by having additionally to the metal ion coordination H-
bonds via C6-H6···N4 and C6´´-H6´´···N2.  
The Pd2+ complex (6) was also synthesised, but it could not be crystallised. Analysis 
of the structure using 1H-NMR showed two sets of signals (1:1) of the 2,2´:6´,2´´-
terpyridine ligand in the aromatic region. Now, this could give rise to equal amounts 
of two different products, having the tetrazole ring coordinated over two different 
coordination sites to two Pd2+. Another explanation would be an asymmetrical 
2,2´:6´,2´´-terpyridine bound to two different Pd2+. Both, however, do not fit to the 
integration value of the methyl group of the 1-methyltetrazole ligand. The methyl 
group has three protons, but then, the aromatic protons count up to 22 and one 
2,2´:6´,2´´-terpyridine only has 11 protons. This is a ratio of one methyl group to two 
2,2´:6´,2´´-terpyridines. This data put forward the idea of the 1-methyltetrazole ring 
acting as a bridge between two Pd2+ each bound to a 2,2´:6´,2´´-terpyridine. The 
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question arising from this idea is then, over which atoms the 1-methyltetrazole ring 
binds to each of the two Pd2+. 
These are not easily identified using NMR spectroscopy. Crystallisation attempts 
have been made, but by now no suitable single crystal could be obtained. A crystal 
structure could identify, of course, the whole structure with all its bond lengths and 
angles.  
For the 1-methylimidazole complexes (10 (M = Pd2+) and 11 (M = Pt2+)) a 
deprotonation of a C atom is much less likely (different pKa value) and it is expected 
that the 1-methylimidazole coordinates over the N3 position.  
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Figure 23: Schematic diagram of the possible structures of the cations of 10 (M = Pd2+) 
and 11 (M = Pt2+). 
 
Indeed, it has been found through the use of NMR spectroscopy and elemental 
analysis that the 1-methylimidazole binds over the N3 position in both complexes. In 
the 1H-NMR spectra for both complexes a ring current effect on the H6 and H6´´ of 
the 2,2´:6´,2´´-terpyridine could again be observed giving rise to a perpendicular 
position of the 1-methylimidazole ligand. Additionally, crystals were obtained that 
were suitable for X-ray crystallography.  
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Figure 24: Crystal structure of the cation of [(trpy)Pd(1-mimi)](ClO4)2 (10). 
 
It can be seen that the imidazole ring is out of the Pt-N4 plane and nearly 
perpendicular with 73.9(3)°. The 1-methylimidazole is connected via N3 and the 
bond distances to the metal ions are between 1.94 and 2.02Å. There is a great 
similarity to the Pt2+ complex (11), since nearly all distances and angles are identical. 
 
 
 
Figure 25: Crystal structure of the cation of [(trpy)Pt(1-mimi)](ClO4)2 (11). 
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One reason for the non planar structure is the fact that the H2 and H4 protons of the 
1-methylimidazole and the H6 and H6´´ protons of the 2,2´:6´,2´´-terpyridine would 
be very close to each other and interference between them hinders the planarity. In 
the [(trpy)Pt(1-mtetate)](ClO4) (7) the angle between the planes is smaller, which 
could be due to the N4 atom of the 1-methyltetrazolate wanting to build an H-bond 
with H6 or H6´´ of the 2,2´:6´,2´´-terpyridine and therefore pushing the aromatic ring 
further to planarity. But, the methyl group of the 1-methyltetrazolate hinders this 
greatly for obvious steric reasons. In 10 and 11 there is no driving force to planarity. 
Both, H2 and H4 of 1-methylimidazole, are looking for the sterically least strained 
position. 
 
  
Distances (Å) and 
angles (°) 
10 (M = Pd2+) 11 (M = Pt2+) 
M-N3 2.023(5) 2.029(5) 
M-N1 2.019(6) 2.032(5) 
M-N1´ 1.940(5) 1.943(4) 
M-N1´´ 2.006(5) 2.026(5) 
MN4-L 73.9(3) 74.0(2) 
 
Figure 26 and Table 3: Pictures and selected distances and angles of the crystal 
structures of 10 (M = Pd2+) and 11 (M = Pt2+). 
 
It has been shown in DFT calculations77 for [(4´-methyl-2,2´:6´,2´´-terpyridine)Pd(1-
methylimidazole)]2+ that there is a great energy difference between the relaxed 
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geometry and an optimised planar geometry of around 81kJ/mol. The distances in 
the relaxed geometry of the Pd-N bonds are similar to the distances obtained in the 
crystal structure, thus, having an angle of 89.9° between the plane of the PdN4 and 
the imidazole ring. In the planar structure the Pd-N distances are all increased by 
around 0.05-0.2Å. Whereas the H2 and H4 of 1-methylimidazole are far away from 
the H6 and H6´´ of the 2,2´:6´,2´´-terpyridine in the crystal structure and the relaxed 
geometry in the calculation, in the planar geometry the distances would be small 
giving rise to the sterical strain. From this the large amount of energy needed to force 
1-methylimidazole into planarity can be explained. It can therefore be said, that the 
probably most successful system for the introduction into oligonucleotides, since it 
easily goes to planarity, is the system with the 1-methyltetrazole bound to Pd2+ or 
Pt2+ over N3. The N2- and N4-positions of the 1-methyltetrazole give the possibility 
of H-bonding via C6-H6···N4 and C6´´-H6´´···N2 and therefore a stabilising force for 
the planarity. Complete planarity, however, is not necessary for the formation of H-
bonds. The methyl group does not hinder the formation of planarity, since it is then 
far enough away from the 2,2´:6´,2´´-terpyridine. It should also be recognised that 
planarity is essential for the formation of such a metal-mediated base pair inside an 
oligonucleotide, but that also in nature the base pairs are found to be twisted or tilted 
slightly.5,7 Therefore the angle between the Pt-N4 plane and the tetrazole ring should 
be close to zero. 
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1.3 Nucleoside 
 
Starting with the esterification of 3-methylpentanedioic acid (12) to give dimethyl 3-
methylpentanedioate (13) and following this with a substitution reaction that results 
in 1,5-bis(2-pyridyl)-3-methylpentane-1,5-dione (14), yellow 4´-methyl-2,2´:6´,2´´-
terpyridine (15) was obtained after a ring closure reaction, as can be seen in Figure 
27.78 
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Figure 27: Schematic diagram of the synthesis of 4´-methyl-2,2´:6´,2´´-terpyridine 
(15).78 
 
It needs mentioning that primarily a different route was taken with a 4´-thiomethyl-
2,2´:6´,2´´-terpyridine intermediate.79 But this route left us with the problem of 
having to separate 4´-methyl-2,2´:6´,2´´-terpyridine (15) and 4´-thiomethyl-2,2´:6´,2´´-
terpyridine, which was neither described in the literature, nor was an easy way 
found to do this separation. 
For the first synthesis step higher yields were obtained than described in the 
literature.78 Difficulties were experienced with the substitution reaction of dimethyl 
3-methylpentanedioate (13) with 2-bromopyridine using n-BuLi to give 1,5-bis(2-
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pyridyl)-3-methylpentane-1,5-dione (14). The purification turned out to be more 
challenging than described in the literature.78 Especially the purification by flash 
chromatography seemed to be responsible for the low yields obtained.  
The chromatographic purification is effected by the so called diffusion. The 
longitudinal diffusion effects the movement for the same molecules on the stationary 
phase. The same molecules will have different retention times.  
Therefore the length of the silica gel column was shortened and the amount of 
substance added to the column increased. This gave an improvement of the yield of 
14. However, the yield described in the literature could not be obtained. 
Finally, the 4´-methyl-2,2´:6´,2´´-terpyridine (15) was synthesised using ammonium 
acetate and very good yields could be obtained, even better than described in the 
literature.78 Since the product found after the purification steps described in the 
literature was not pure, attempts were undertaken to find a way of purification, such 
as flash chromatography and crystallisation. The first did not show an improvement 
and even more a loss in product. The crystallisation was found to be more successful. 
The extraction step with CH2Cl2, the drying over Na2SO4 and the evaporation to 
dryness, as described in the literature, were followed by re-crystallisation from n-
heptane. The residue was dissolved in n-heptane and left in the ultrasonic apparatus 
for 10min at 40°C. Then the emulsion was put in the refrigerator (-18°C) for 10min. 
The yellow n-heptane (containing only the 4´-methyl-2,2´:6´,2´´-terpyridine) was 
decanted (leaving the side products in the round bottom flask) and evaporated. The 
work up procedure was repeated until no more 4´-methyl-2,2´:6´,2´´-terpyridine was 
found. Standard crystallisation with n-hexane or n-heptane was not of any 
satisfactory value. 
Now, the synthesised 4´-methyl-2,2´:6´,2´´-terpyridine (15) was tried to link to a silyl-
protected sugar as shown in Figure 28.80-82 The disiloxane-protected 2-deoxy-
ribonolactone (16) was synthesised in high purity. Then, attempts were undertaken 
using n-BuLi and LDA as to get the aryllithium reagent that could react with the 
disiloxane-protected 2-deoxyribonolactone (16).  
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Figure 28: Schematic diagram of a possible way for the synthesis of 4´-methyl-
2,2´:6´,2´´-terpyridine nucleoside. 
 
The 4´-methyl-2,2´:6´,2´´-terpyridine nucleoside could not be synthesised after many 
unsuccessful attempts, with altering reaction conditions. The observation of 
unreacted 16 after the attempted reactions led to the idea that the terpyridyllithium 
reagent was not reactive enough, maybe due to sterical hindrance, or more likely, has 
not been formed. Therefore, at first, the reaction is repeated with acetone instead of 
the disiloxane-protected 2-deoxyribonolactone (16). Acetone is smaller than 16 and is 
expected to find the reactive terpyridyl species more easily. But the observation in 
the 1H NMR spectrum after the reaction showed no chemical shift change of the CH3 
group protons of 4´-methyl-2,2´:6´,2´´-terpyridine upon the possible formation of a 
methylene group. Also no change in intensity upon integration (3H to 2H) was found 
in the spectrum. Therefore the sterical hindrance and the lack of reactivity as reasons 
could be excluded. To find out, whether the terpyridyllithium species was actually 
built, the reaction was repeated with D2O. But as before the 1H NMR spectrum after 
the reaction showed no chemical shift change of the CH3-group protons of 4´-methyl-
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2,2´:6´,2´´-terpyridine, no change in intensity upon integration (3H to 2H) and no 
change in complexity of the singlet that would be expected, due to a formation of a 
CH2D group. Therefore one can conclude that the terpyridyllithium species has not 
been formed. This could be due to the lack of reactivity of the the CH3-group of 4´-
methyl-2,2´:6´,2´´-terpyridine. 
Therefore a new strategy had to be found to synthesise the 4´-methyl-2,2´:6´,2´´-
terpyridine nucleoside. To increase the reactivity of the 4´-methyl-2,2´:6´,2´´-
terpyridine  (15) a Br should be introduced at the 4´-methyl group. 
For that 15 needs at first to be oxidised to 4´-carboxyaldehyde-2,2´:6´,2´´-terpyridine 
(17).79 Reduction of 17 gives the 4´-hydroxymethyl-2,2´:6´,2´´-terpyridine (18).83 Then 
the Br can be introduced at the C4´ position of 18 to obtain the target molecule 4´-
bromomethyl-2,2´:6´,2´´-terpyridine (19)83 as show in Figure 29. 
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Figure 29: Schematic diagram of the synthesis of 4´-bromomethyl-2,2´:6´,2´´-
terpyridine (19). 
 
The oxidation reaction was done with SeO2, as described in the literature,79 but the 
produced Se metal could not be filtered off completely after the reaction, so that 
chelating resin was used to clear the solution. Yet again, the final crystallisation with 
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n-hexane did not have any success on purifying the product. A mixture of the wan-
ted product 4´-carboxyaldehyde-2,2´:6´,2´´-terpyridine (17) and the starting material 
4´-methyl-2,2´:6´,2´´-terpyridine (15) was obtained. Another synthesis route by J.-P. 
Collin et al.84 did not lead to any product formation at all. Since neither another way 
of synthesising 17, nor of separating 15 from 17 was found, the further reaction steps 
had to be done with a mixture of both. Thus, an starting material/product ratio from 
4:1 clearly shows that the oxidation reaction was not very efficient. 
Using NaBH4 the 4´-carboxyaldehyde-2,2´:6´,2´´-terpyridine (17) can be reduced to 
the 4´-hydroxymethyl-2,2´:6´,2´´-terpyridine (18).83 More importantly, one was able to 
recover most of the unreacted 4´-methyl-2,2´:6´,2´´-terpyridine (15). For this the 
purification of the product (18) had to be done differently. To the residue n-heptane 
was added and it was placed in the ultrasonic apparatus for 10min at 40°C. Then the 
suspension was left in the refrigerator for 10min. The slightly yellow n-heptane was 
decanted and evaporated to give 15. To the residual solid CH2Cl2 was added and the 
suspension centrifuged. The solution was decanted and the solid again extracted 
with CH2Cl2. The CH2Cl2 phases were combined and evaporated. The extraction with 
n-heptane, as described above, was done four times, whereby the last two times the 
n-heptane was not decanted, but filtered off. Although this way 18 could be purified 
and 15 recovered, the actual yield is low. 
The last step for the synthesis of 4´-bromomethyl-2,2´:6´,2´´-terpyridine (19) was done 
as stated in the literature with CBr4.83 Again the purification had to be optimised, 
since the described way gave a loss of product on the silica gel column. So we 
shortened the silica gel column and used different solvents to obtain 19 in a yield 
comparable to the literature. 
Now the 4´-bromomethyl-2,2´:6´,2´´-terpyridine (19) can be connected with a DMTr-
(S)-glycidol (20) to get a sugar mimic using a Grignard. The C3-backbone sugar 
mimic was chosen, since it is nowadays accepted as useful artificial backbone18-20 and 
the epoxide should be more reactive, since it has a strained three membered ring, 
than the carboxy group of the disiloxane-protected 2-deoxyribonolactone (16).80-82 It 
is synthesised by reacting (R)-glycidol with DMTr-Cl.85 Another advantage is the 
already integrated DMTr protecting group, since one further protection step would 
give the building block for an oligonucleotide. 
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Figure 30: Schematic diagram of a possible way for the synthesis of 4´-methyl-
2,2´:6´,2´´-terpyridine-DMTr-C3-backbone. 
 
This way of synthesis was not successful. One reason could be that the used CuI has 
not reacted, since it has been complexed by the terpyridine ring of 4´-bromomethyl-
2,2´:6´,2´´-terpyridine (19). The Cu ion is needed for the formation of a Gilmour 
reagent during the reaction.  
Other strategies therefore have to be developed. One suggestion is to connect a 
pyridine ring first to the sugar moiety, since the pyridine does not have such a high 
metal affinity as a terpyridine ring and would not be expected to bind Cu ions 
during the reaction. A 2,4,6-halogenated pyridine ring could be linked to a sugar 
moiety via the C4 position at the ring leaving the C2 and C6 positions to connect the 
other two pyridine rings by using a Negishi or Stille-type cross-coupling reaction.86-90 
These reactions have already been used to synthesise bipyridines and terpyridines. 
However, it has to be shown that under these conditions the sugar moiety does not 
undergo a reaction, too. The 2,4,6-halogenated pyridine could be synthesised from a 
2,6-chloro-4-aminopyridine that is available for purchase.91 
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1.4 Summary and Discussion  
 
The model structures with 2,2´:6´,2´´-terpyridine as possible tridentate ligand and the 
1-methylimidazole (1-mimi) (1) and 1-methyltetrazole (1-mtet) (2) as monodentate 
ligands have been synthesised and analysed. Whereas the [(trpy)Pd(1-mimi)](ClO4)2 
(10) and [(trpy)Pt(1-mimi)](ClO4)2 (11) showed no tendency for planarity due to steric 
hindrance of certain protons, one can argue that the Pd2+ complex (6) and [(trpy)Pt(1-
mtetate)](ClO4) (7) could give rise to planarity, if 1-methyltetrazole is bound over the 
N3 atom to the metal ion. The possibility of H-bonds in addition to the metal ion 
coordination could drive the tetrazole ring close to planarity, as it has been shown by 
DFT calculations. Even bound about C5 to the Pt2+, which means that planarity is 
sterically hindered due to the methyl group being close to the terpyridine rings, 1-
methyltetrazolate had an angle between the planes (PtN3C-L) that was smaller than 
for 1-methylimidazole in 10 and 11, which is possibly because of the N4 wanting to 
form an H-bond with a proton from the terpyridine ring. Though, to finally prove the 
formation of H-bonds and herewith the resulting planarity, the two complexes with 
the 1-methyltetrazole bound over N3 should be synthesised. A decrease in pH 
during the reaction should leave the C5 of the tetrazole ring protonated. This means 
that it could bind over N3. Also for the Pd2+ complex (6) a change in pH could 
influence the outcome, so that only one Pd ion is bound, instead of possible two. 
In attempts to synthesise the 4´-methyl-2,2´:6´,2´´-terpyridine nucleoside, it has been 
tried to connect not just the 4´-methyl-2,2´:6´,2´´-terpyridine (15), but also the more 
reactive 4´-bromomethyl-2,2´:6´,2´´-terpyridine (19) to the different sugar moieties 16 
and 20, as shown in Figure 28 and 30. It was neither possible to deprotonate the 4´-
methyl group of 15 with the reagents available in the laboratory, nor to use metal 
ions (i.e CuI) in the reactions possibly due to the terpyridine immediately 
complexing them.  
The idea of introducing two new artificial nucleobases, having the ability of planar 
[3+1]-coordination with metal ions, into oligonucleotides has been strengthened by 
the results of the model structures and DFT calculations. Therefore there is a great 
necessity of finding a possible way of synthesising a 4´-methyl-2,2´:6´,2´´-terpyridine 
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building block for the automated DNA synthesiser, so that it can be introduced into 
an oligonucleotide. A route of synthesis, building the three terpyridine rings after 
having connected part of it to a sugar moiety, has been suggested and now needs to 
be tested for functionality. The tetrazole nucleoside has already been synthesised.92  
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Chapter II  
 
1 Introduction 
 
By systematic subtraction of functional groups or through the exchange of N atoms 
with C atoms the binding possibilities of adenine become limited. As mentioned 
before (Aim section), adenine builds a Watson-Crick base pair with thymine (T), but 
without the N1 atom, a possible binding over this side is hindered, as is shown in 
Figure 31 for 1-deazaadenine (Z). Without the N1 atom and the NH2 group binding 
over this side is even excluded, as for 1-deazapurine (Y).  
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Figure 31: Binding possibilities over the Watson-Crick side for the base pairs T-Z, a) 
and T-Y, b). 
 
The exchange of the N1 atom by a C atom, hence, the formation of 1-deazaadenine, 
hinders one of the H-bonds to form. The rotation of the 1-deazaadenine over the N-
glycosidic bond can lead to the formation of a Hoogsteen or a reverse Hoogsteen 
base pair with thymine. Under certain conditions it is also possible for adenine to 
build Hoogsteen base pairs, but 1-deazaadenine is more or less forced to do so, since 
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the possibility of formation of Watson-Crick base pairs is limited. In size the adenine 
and the 1-deazaadenine are quite similar. This is an important fact for the recognition 
process during the self association process. An oligonucleotide containing 1-
deazaadenine has already been published to show melting behaviour with a thymine 
containing complementary strand, but the actual melting temperature, Tm, is only 
15°C.93 The measured oligonucleotide was a 20mer and this shows that the strand 
should not be any shorter, since otherwise no melting behaviour will be observed. 
The authors state that this double helix is of parallel orientation. 
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Figure 32: Binding possibilities over the Hoogsteen side for the base pairs T-Z, a) and 
T-Y, b). 
 
The idea is to introduce metal ions that can linearly coordinate at the N3 atom of 
thymine and at the N7 atom of 1-deazaadenine. This should raise the Tm, since an 
additional stabilising force is present. A self assembling double helix with three 
stabilising forces, H-bonding, π-stacking interaction and covalent metal-ligand 
bonds, and binding over the Hoogsteen side would be built. There are reports of 
Hoogsteen base pairs blocking the information flow from Watson-Crick duplex DNA 
to mRNA by simply building out a triple helix.93 The possibility of Hoogsteen base 
pairs opens up many other binding possibilities. 
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Subtracting the NH2 group from the 1-deazaadenine will hinder the H-bonding over 
the Watson-Crick side completely, as can be seen in Figure 31. Over the Hoogsteen 
side one H-bond could be built. This could prevent self association, but upon the 
addition of metal ions there is still a possibility of forming a stable double helix. A 
comparison of the Tm and melting behaviour of a strand with 1-deazapurine and a 
strand with 1-deazaadenine, each binding to a thymine strand, could give 
information about the strength of H-bonding. One would also be able to gain 
knowledge about the co-operativity of H-bonding and Mn+-binding. 
The 1-deazapurine could also be able to act as monodentate ligand in a [1+1]-
coordination system. Either with itself or with natural nucleobases as base pairing 
partner, 1-deazapurine could build a metal-mediated base pair. It has been used in 
first attempts of expanding the genetic alphabet,94 and it has been suggested that it 
might be formed in vivo.95 
The size of 1-deazapurine, although having lost the NH2 group, is still suitable for 
binding. But only building out one H-bond, it is probably not strong enough for self 
association. Introduction in a strand with only natural nucleobases around will show 
the destabilising effect of a single mispairing or non pairing 1-deazapurine. The 
stabilising effect with linearly coordinating metal ions could then give information 
about the strength of a single metal-mediated base pair in such a system. 
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2 Nomenclature 
 
Unlike the compounds in chapter I, the compounds in chapter II have many possible 
and often used names. Therefore it is essential for the understanding of this work 
and for comparison reasons with other work to explain the nomenclature that is used 
throughout this thesis. 
In Figure 33 a purine is shown. All related derivatives of purine are named using this 
purine nomenclature. 
 
N
N N
NH1
2
3
4
5
6 7
8
9  
 
Figure 33: Numbering of purine. 
 
One exception is the 1-deaza-6-aminopurine that will be named 1-deazaadenine and 
another exception is the 1-deaza-6-aminopurine-N9-β-2´-deoxyribonucleoside that 
will be named 1-deazaadenine-N9-β-2´-deoxyribonucleoside or 1-deazaadenine 
nucleoside for simplification and for comparison reasons with adenine, shown in 
Figure 34. This is also no problem, since the numbering of the two is identical. 
Nucleoside will always be used as shortage for 2´-deoxyribonucleoside, since in this 
thesis non of the sugar moieties has an OH group and it is exclusively written about 
DNA. 
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Figure 34: Nomenclature for adenine. 
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If a sugar ring is present the molecules will be named in order of the sugar 
numbering. The example in Figure 35 will be explained. 
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Figure 35: 1-deaza-(6-methoxyacetylamino)-purine-N9-β-[2´-deoxy-3´-O-(2-
cyanoethyl)-N,N-diisopropylphosphoramidite-5´-O-(4,4´-dimethoxytrityl)-
ribonucleoside] as example for the numbering and the nomenclature in this thesis. 
 
One starts of at the C1´ position of the sugar with the 1-deaza-(6-methoxy-
acetylamino)-purine. The purine is linked to the C1´ position via N9 and it is the 
beta-anomer. The C2´ position is named 2´-deoxy, since it has no OH group present. 
At the C3´ position a protecting group is linked at the O atom and therefore this bit is 
named 3´-O-(2-cyanoethyl)-N,N-diisopropylphosphoramidite. No extra functional 
group is found at the 4´-position; hence, no further name is required. At the C5´ 
position on the O atom another protecting group is found and it is named 5´-O-(4,4´-
dimethoxytrityl). Finally the sugar is named: ribonucleoside. 
One names this molecule therefore: 1-deaza-(6-methoxyacetylamino)-purine-N9-β-
[2´-deoxy-3´-O-(2-cyanoethyl)-N,N-diisopropylphosphoramidite-5´-O-(4,4´-
dimethoxytrityl)-ribonucleoside]. 
Throughout the thesis the positions, where reactions or other changes take place, will 
be numbered again for clarity. 
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3 1-Deazapurine  
3.1 Model Structures  
 
As a suitable model for a 1-deazapurine nucleobase interacting with a metal ion in an 
oligonucleotide N9-methyl-1-deazapurine has been taken as the monodentate 
ligand.96 The sugar ring has been substituted through a methyl group to avoid 
binding of the free OH groups with metal ions. As metal ion Hg2+ was taken, because 
mainly, although it can adopt many other coordination geometries, it prefers linear 
coordination with nucleobases.97,98 This linear coordination is, as mentioned before, 
also from great necessity for the coordination inside the oligonucleotide.30 There are 
only three examples of Hg2+ binding two nucleobase derivatives, although the 
coordination behaviour with nucleic acids of the Hg2+ has been studied over a period 
of time;97,99,100 a bis(methylthyminato-N3) complex,101 a bis(9-methyladeninium-N7) 
complex102 and a bis(8-azahypoxanthinato-N9) complex,103 that is not actually useful 
for the introduction into DNA, since in DNA the metal can not coordinate over N9. 
There are several other examples of methylmercury99,104 and HgCl2 adducts105 to 
nucleobases. 
First of all, synthesis of 1-deazapurine (21) was done in good yield as described in the 
literature,106 starting from purchased 2,3-diaminopyridine, but although using a 
liquid-liquid extractor over night, instead off extracting by hand, the yield could not 
be raised any further. However, the use of the liquid-liquid extractor was essential 
for getting these good yields. Other descriptions of this synthesis did not raise the 
expectations of getting higher yields.107,108 
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Figure 36: Schematic diagram of the synthesis of 1-deazapurine (21) from 2,3-
diaminopyridine. 
Results and Discussion        Chapter II 
 
46 
The methylation of 1-deazapurine (21) using methyl iodide gave the 1-deaza-9-
methylpurine (22) and the isomeric 1-deaza-7-methylpurine (23) as side product, 
which could be separated by flash chromatography.96 The synthesis used is 
analogous to the synthesis of methylpurines.109 In the literature other routes of 
obtaining the two methyl-1-deazapurines or derivatives of them are described using 
different starting materials and reactions conditions.110-112 1-Deaza-9-methylpurine 
(22) and the isomeric 1-deaza-7-methylpurine (23) could be distinguished with the 
help of 1H,1H NOESY experiments, which gave rise to two cross-peaks involving the 
methyl group in the second case (close contacts to H6 and H8) and one cross-peak 
only in the first case (close contact to H8). The relative amount of 22 and 23 is 
probably influenced by the reaction solvent, as has been reported for the methylation 
of purine, where the N9-isomer was favoured in DMSO and equal amounts of N7- 
and N9-isomer were found in H2O. This is thought to be due to the H2O building H-
bonds with the N7-anomer and therefore stabilising it.109,113 
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Figure 37: Schematic diagram of the synthesis of 1-deaza-9-methylpurine (22) and the 
1-deaza-7-methylpurine (23) from 1-deazapurine (21). 
 
For the reaction with Hg2+ any possible competition between protonation and 
metalation of the ligand had to be ruled out beforehand. Therefore the pKa values 
had to be evaluated in order to verify pKa values determined spectrophotometrically 
more than 40 years ago.112 pD-dependent 1H chemical shifts of the aromatic protons 
have been measured and gave a pKa value (corrected for H2O) of 3.67(5) for 1-deaza-
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9-methylpurine (22). The isomeric 1-deaza-7-methylpurine (23) was found to be 
slightly less acidic; its pKa amounts to 3.83(5). A good correlation with the 
photometrically determined values112 (3.93 and 4.10, respectively) was found. 
Therefore no competing effect of protonation should be expected when performing 
the metalation reaction at pH values higher than 5. 
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Figure 38: Schematic picture of the cation of [Hg(9-MeDP)2](NO3)2 · H2O (24). 
 
To a solution of 1-deaza-9-methylpurine (22) and half an equivalent of Hg2+, NaNO3 
was added to give colourless crystals of [Hg(9-MeDP)2](NO3)2 · H2O (24). The 
crystals turned out to be suitable for X-ray crystallography and the crystal structure 
is shown in Figure 39. With Ag+, as another linear coordinating metal ion, no clean 
reaction was observed and the product seemed to have a low solubility. From that it 
was not possible to obtain crystals. 
 
 
 
Figure 39: Crystal structure of [Hg(9-MeDP)2](NO3)2 · H2O (24). 
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The Hg2+ is bound to the N7 positions of two 1-deaza-9-methylpurine (22) ligands 
that are arranged approximately trans to each other (173.1(1)°) and are orientated 
nearly perpendicular at a dihedral angle of 82.98(7)°. Due to the lack of coordination 
sites on the Watson-Crick side, the N7 position on the Hoogsteen side is the available 
free binding position for metal-mediated base pairing. This is also the case in a triple 
helix.114 
The Hg–N distances of 2.073(3) and 2.075(3)Å are in the range of those typically 
found in complexes between ligands coordinated via trans orientated endocyclic 
nitrogen atoms and Hg2+. Examples for these typically found bond lengths of around 
2.07Å are complexes with 1-methylthymine (2.04Å), 9-methylguanine (2.06(1)Å, 
2.08(1)Å) or ,thirdly, 1-methylcytosine (2.07(1)Å, 2.08(1)Å).101,102,105,115,116 However, 
the intermetallic distance between two neighbouring mercuric ions of 5.402(1)Å is 
too long to account for a metal-metal interaction. In an oligonucleotide the backbone 
could, however, bring the metal ions bound in different base pairs closer to each 
other. This could lead to interactions between these metal ions and then possibly to 
interesting magnetic and electrical properties. But for the use inside an 
oligonucleotide there is a necessity of planarity for the base pairs. In Figure 40 it can 
clearly be seen that this is not the case for the model structure.  
 
 
 
Figure 40: Crystal structure of [Hg(9-MeDP)2](NO3)2 · H2O (24) looking along the 
N7a-Hg-N7b axis. 
 
But next to the important features of the crystal in comparison with 1-deaza-9-
methylpurine (22) as a potential artificial nucleobase in an oligonucleotide, the 
Results and Discussion        Chapter II 
 
49 
crystal has further interesting aspects.96 In Table 4 selected interatomic distances and 
angles are listed. 
 
Hg–N7a 2.075(3) N7a–Hg–N7b 173.1(1) 
Hg–N7b 2.073(3) N10–O11–Hg 92.5(3) 
Hg–O11 2.985(4) N10–O13–Hg 104.1(3) 
Hg–O13 2.747(3) N20–O21–Hg 98.2(2) 
Hg–O21 2.716(3) N20–O22–Hg 96.1(3) 
Hg–O22 2.774(3) N20a–O21a–Hg 99.0(2) 
Hg–O21a 2.758(2) N20a–O23a–Hg 94.8(3) 
Hg–O23a 2.856(3) Hg···Hga 5.402(1) 
Hg···O1w 6.065(5)   
 
Table 4: Selected interatomic distances (Å) and angles (°) 
 
It is known that mercuric complexes can contain distant bonded atoms in addition to 
the close bonded atoms98. This can be seen for [Hg(9-MeDP)2](NO3)2 · H2O (24), too. 
Using a van der Waals radius of 1.70Å for mercury, which is the lower limit of the 
values suggested in the literature117 and 1.40Å for oxygen, the Hg–O contacts 
between the metal ion and nitrate oxygen atoms in the title compound (Hg–O: 
2.716(3) – 2.985(4)Å) can surely be considered as bonding interactions.  
In addition, bonds exist to two symmetry-generated nitrate oxygen atoms from a 
neighbouring unit cell (Hg–O: 2.758(2)Å, 2.856(3)Å). The HgII coordination sphere is 
completed by six longer contacts to three nitrate ions oriented more or less 
perpendicular to the N–Hg–N plane (65.2(2)°, 72.8(3)° and 72.8(3)°). All nitrate 
moieties in [Hg(9-MeDP)2](NO3)2 · H2O (24) can be considered symmetrically 
bidentate, when applying certain criteria.118 Around the metal ion a distorted 
hexagonal bipyramidal geometry is present. The sum of inner angles within the 
distorted hexagonal plane should deviate only slightly from that of an ideal hexagon 
(720°). The sum amounts to 696° and is very close to the wanted 720°. This kind of 
arrangement of nitrate ions has previously only been observed for cadmium and tin 
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complexes.119-121 It has to be said, though, that that strictly seen the nitrate ions in the 
cadmium complex are asymmetrically bidentate. 
 
 
 
Figure 41: Honeycomb-like chain structure of [Hg(9-MeDP)2](NO3)2 · H2O (24). 
 
As the nitrate ion comprising N20, O21, O22 and O23 is bridging two neighbouring 
mercuric ions, an unprecedented honeycomb-like chain structure of nitrate moieties 
is generated that is held together by HgII ions positioned inside the combs. Usual 
bond lengths are observed for the nitrate N–O bonds (1.229(4)–1.258(4)Å). The water 
of crystallisation bridges neighbouring nitrate ions that are present in a nitrate chain 
via O1w–H···O12 hydrogen bonds (O1w···O12: 2.964(6)Å, O1w···O12a: 2.928(6)Å). 
There is no contact of the water of crystallisation with the mercuric complex 
(Hg···O1w: 6.065(5)Å). 
 
Results and Discussion        Chapter II 
 
51 
3.2 Synthesis of the Nucleoside 
 
For the synthesis of the 1-deazapurine-N9-β-2´-deoxyribonucleoside the 1-deaza-
purine (21) was deprotonated with NaH and Hoffer´s chlorosugar (25)122-124 was 
added to get 1-deazapurine-N9-β(α)-[2´-deoxy-3´,5´-di-O-(p-toluoyl)-ribonucleoside] 
(26b and 26a), as product and 1-deazapurine-N7-β(α)-[2´-deoxy-3´,5´-di-O-(p-
toluoyl)-ribo-nucleoside] (27b and 27a), as side product.  
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Figure 42: Schematic diagram of the synthesis of 1-deazapurine-N9-β(α)-[2´-deoxy-
3´,5´-di-O-(p-toluoyl)-ribonucleoside] (26b and 26a) and 1-deazapurine-N7-β(α)-[2´-
deoxy-3´,5´-di-O-(p-toluoyl)-ribonucleoside] (27b and 27a). 
 
The appearance of both, the N9 (26) and N7 (27) product (no N3 coordination) is 
thought to be due to the possible tautomeric structure of the 1-deazapurine (21) as 
described by T. Wenzel and F. Seela.113 The ratio of N9 (26) to N7 (27) product can be 
influenced by the reaction temperature and the reaction solvent;109 the lower the 
temperature (down to 0°C), the more N9 product (26) was found; the higher the 
temperature (up to 60°C), the more N7 product (27) was found. At a reaction 
temperature of 0°C the ratio of 2:1 (N9:N7) and the yields are comparable to those 
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from T. Wenzel and F. Seela,113 though they synthesised the two products using five 
equivalents of powdered KOH and TDA-1 as catalyst, instead of NaH, and got 
additionally mono protected products. Other reaction routes have been suggested for 
the synthesis of the nucleoside or its derivatives, though, they did not appear more 
successful than the chosen one.125,126 However, not many observed the formation of 
alpha- and beta-anomers (26a and 26b, 27a and 27b), especially not in the latter 
publications. While in the literature the formation of the alpha-anomer has not been 
reported for the formation of N-glycosidic bonds, all our reactions still gave both 
anomers. This could be due to the fact, that Hoffer´s chlorosugar (25) rapidly turned 
from the alpha-anomer, from which the beta nucleoside is formed, to the beta-
anomer in solution. The synthesis was not always successful; the yields were low in 
comparison with the literature and changing permanently. Nevertheless Hoffer´s 
chlorosugar (25) could be stored under vacuum for up to two weeks without 
showing any sign of decomposition or anomerisation. Indeed, it has been reported, 
that the alpha-anomer is stable in the solid state, but that it undergoes a 
decomposition-anomerisation reaction in solution.122-124 Therefore it is more likely, 
that Hoffer´s chlorosugar (25) turned into its beta-anomer very rapidly upon the ad-
dition to the deprotonated 1-deazapurine (21). The N9 and N7 species (26 and 27) can 
be separated by flash chromatography. At first, only the N9 linked 1-deazapurine as 
nucleobase (26) was aimed at and regarded as useful. Due to the high amounts of N7 
linked 1-deazapurine (27) that were synthesised, as so called side product,  and due 
to the possibility of having a [2+2]-coordination system next to the [1+1]-coordina-
tion system of 1-deazapurine-N9-β-nucleoside (28), the 1-deazapurine-N7-β-nucleo-
side (29) (both shown in Figure 44) became interesting and was synthesised, too.  
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Figure 43: Example of a possible metal-mediated base pair with over N7-coordinated 
1-deazapurine (X) nucleoside (29) binding to a metal ion over N3 and N9. 
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The N9 and N7 species (26 and 27) were deprotected using saturated NH3/CH3OH 
solution to give 28 and 29, respectively. The reactions were monitored using TLC and 
the reaction times were much longer than described by T. Wenzel and F. Seela,113 still 
the yields were comparable. 
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Figure 44: Schematic diagram of the syntheses of 1-deazapurine-N9-β(α)-nucleosides 
(28b and 28a) and 1-deazapurine-N7-β(α)-nucleosides (29b and 29a). 
 
The different anomers of the N9 product (28b and 28a) and the N7 product (29b and 
29a) can also be separated by flash chromatography and distinguished by 1H, 1H 
NOESY and by the characteristic coupling constants of the H1´ sugar proton in N-
glycosides. When the two anomers are still protected (26b, 26a, 27b and 27a), there is 
a very valuable observation, for distinguishing between the two anomers. The 
protecting group of the beta-anomer only shows chemical shifts in two regions of the 
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aromatic region (2 multiplets), in the alpha-anomer a third signal in-between the 
other two is observed. This is due to two protons on the protecting group on the O3´, 
which observe a high field shift, probably, because these protons experience the ring 
current of the heterocyclic aromatic ring of 1-deazapurine in the alpha-anomer (26a 
and 27a). 
For the 1-deazapurine-N9-β-2´-deoxyribonucleoside (28b) the coupling constants 
H1´/ H2´ and H1´/ H2´´ are almost identical (6.4 and 7.4Hz), which often gives rise 
to a pseudo-triplet in the 1H NMR spectrum, whereas for the alpha-anomer the 
coupling constants are quite different (2.8 and 7.8Hz), leading more likely to a 
doublet of doublets. Using 1H, 1H NOESY experiments both anomers can easily be 
distinguished. The H1´ proton of 1-deazapurine-N9-β-2´-deoxyribonucleoside (28b) 
displays a strong cross-peak to H2´´, but only a week to the H2´. This is the opposite 
trend for the alpha-anomer. The stereospecific assignment of H2´ and H2´´ can be 
facilitated by comparing the intensities of their cross-peaks to the H3´ (strong and 
weak, respectively). Similarly the 1-deazapurine-N7-β-2´-deoxyribonucleoside (29b) 
can be distinguished from its alpha-anomer using 1H, 1H NOESY experiments. 
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3.3 Characterisation 
 
Having synthesised the two nucleosides (28b and 29b), one can characterise them 
and from the obtained data relate to their behaviour in oligonucleotides and possible 
double helix formation upon the addition of metal ions. 
One was able to crystallise the 1-deazapurine-N9-β-2´-deoxyribonucleoside (28b) and 
the 1-deazapurine-N7-β-2´-deoxyribonucleoside (29b). Additionally, crystals of the 
1,3-deazapurine-β-2´-deoxyribonucleoside (30) that has been synthesised in our 
research group127 as another potential artificial nucleobase for metal-mediated base 
pairing, were obtained and all three turned out to be suitable for X-ray 
crystallography.  
 
To describe the structures exactly and comparable to other nucleosides one has to 
define certain torsion angles. Here, the definition from the IUPAC of the year 1998 
was used.128 The five sugar torsion angles ν0-4 are defined as follows: 
ν0 for C4´-O4´-C1´-C2´, 
ν1 for O4´-C1´-C2´-C3´,  
ν2 for C1´-C2´-C3´-C4´,  
ν3 for C2´-C3´-C4´-O4´,  
ν4 for C3´-C4´-O4´-C1´. 
 
Figure 45: A nucleoside (B = base) showing ν0-4. 
 
Using two equations,  
νm = ν2/cosP and tanP = [(ν4+ ν1) – (ν3+ ν0)]/2ν2(sin36°+sin72°), 
a value for the angle of pseudorotation (P) and for the puckering amplitude (νm) can 
be calculated. Important to notice: If the value of ν2 is negative, one has to correct the 
value of P by +180°. Also a negative ν2 gives an N-type conformation of C1´-C2´-C3´-
C4´, a positive value an S-type conformation, as shown in Figure 46. 
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Figure 46: N-sugar (3´-endo and 2´-exo) and S-sugar (2´-endo and 3´-exo) 
conformations, twisted forms (T). 
 
Knowing the value for P and using the pseudorotation cycle of the furanose ring, one 
can now exactly find out, whether only one atom is out of the sugar plane (envelope 
or E) or two atoms (twisted or T). From the value it can also be described, which 
atom or atoms come out of the plane (C1´, C2´, C3´, C4´or O4´), and in which 
direction (above the sugar plane = endo or underneath the sugar plane = exo). For 
example in Figure 46 both the C2´ and the C3´ are out of the sugar plane, but in 
Figure 45 only the C4´ is out of the plane and it would be named C4´-endo or 4E. The 
pseudorotation cycle of the furanose ring can be found in the literature, as well as the 
conformational region cycle for torsion angles.128  
There are further two important torsion angles that are described by this 
conformational region cycle for torsion angles, γ (O5´-C5´-C4´-C3´) (+/- synclinal (sc) 
or gauche), which describes the position of the C5´-O5´ compared to the sugar ring, 
and χ (O4´-C1´-N(base)-C4/for purine bases) (syn or anti), which describes the 
orientation of the nucleobase around the glycosidic bond.  
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Figure 47: Picture of the two torsion angles in a nucleoside, γ (O5´-C5´-C4´-C3´) and χ 
(O4´-C1´-N(base)-C4/for purine bases). 
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Now, for the 1-deazapurine-N7-β-2´-deoxyribonucleoside (29b) the structure 
obtained was disordered at the C2´and C3´ of the sugar ring. Therefore, two different 
conformations can be observed. The first (29b I) is in the 2´-exo envelope N-type or 
2E (N) conformation, as shown in Figure 48, which is not usually found for 2´-deoxy-
ribonucleosides. The often observed conformations are of the C1´-exo (S) and C3´-exo 
(S) and C2´-endo (S) and C3´-endo (N) type. The second (29b II) (not shown) is in the 
3´-exo envelope S-type or 3E (S) conformation. The C5´-O5´ of both are in the 
+gauche or +synclinal conformation compared to the sugar ring and both have the 
base in syn position, since this is not influenced by the disorder at C2´ and C3´.  
 
 
 
Figure 48: Crystal structure of 1-deazapurine-N7-β-2´-deoxyribonucleoside (29b I) in 
the 2E (N) or 2´-exo envelope (N) conformation with the base in syn position and the 
C5´-O5´ in +gauche or +sc. 
 
The 1-deazapurines stack on top of each other having the N3 nearly on top of the N7 
and vice versa and the N9 nearly on top of the other N9. The O5´-H5´ builds an H-
bond with the N3 that lies on top of the 1-deazapurine unit that belongs to this 
molecule and vice versa. The length of the H-bond is 2.838(6)Å with an angle of 
160.9(3)°. In one direction the 1-deazapurines stack having the sugar units lying 
alternating on opposite sides. The different channels of the 1-deazapurine stacking 
are linked by the sugar units with an H-bond over the O3´-H3´ to that of another 
sugar unit. However, through the disorder in the C2´, C3´and O3´ positions it is dif-
ficult to exactly find these H-bonds. The atoms do lie close enough together (≈2.8Å). 
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The 1-deazapurine-N9-β-2´-deoxyribonucleoside (28b) is present twice in one unit 
cell and the two nucleosides differ. Both C5´-O5´ are in the +gauche or +sc 
conformation. For the first (28b I) the sugar is in the 3´-endo envelope N-type or 3E 
(N) conformation that is, as has been mentioned already, a typical conformation for 
2´-deoxy-ribonucleosides. However, the second (28b II) has a C4´-exo envelope N-
type or 4E (N) conformation, as can be clearly seen in Figure 49. The C4´ can be found 
underneath the plane of the four other atoms in the sugar ring. Whereas the 
glycosidic bond angle for 28b I can be described as syn with -82.3(5)°, the angle for 
28b II is right at the borderline between syn and anti with a value of -91.1(4)°. This 
could be due to the unusual conformation of 28b II, since the sugar conformation has 
an influence on the glycosidic bond angle. 
 
 
 
Figure 49: Crystal structure of 1-deazapurine-N9-β-2´-deoxyribonucleoside (28b II) in 
the 4E (N) conformation with the base in syn/anti position and the C5´-O5´ in 
+gauche or +sc. 
 
The deazapurine rings stack with the N3 positions over the C6 position in alternating 
fashion, as it was found for the 1-deaza-N3-oxidepurine (35). The sugar rings of two 
neighbouring molecules always point in opposite directions. Rows of stacking 
dezapurine rings can be found, where the six membered rings are completely on top 
of each other and the five membered rings are tilted slightly to one side in an 
alternating manner. Next to this, there are also channels of sugars. An H-bond 
between the O5´-H5´ of each sugar and an N7 of a neighbouring deazapurine is 
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present. The O5´-H5´···N7 bond has a length of 2.775(4)Å and an angle of 160(3)°. 
The interconnection of the different chains and channels, which are stabilised by 
stacking 1-deazapurine and an H-bond, is done by further two H-bonds. 28b I 
always builds out an H-bond over its O3´-H3´ to the N3 of a 28b II (2.800(4)Å and 
170(4)°). On the other side the 28b II builds out an H-bond over its O3´-H3´ to the 
O5´ of a 28b I (2.800(5)Å and 174(4)°). Since alternating 28b I and 28b II are present 
that bind differently, one finds a tight connection between the different channels of 
sugar and 1-deazapurine stacking. 
The crystal structure of the 1,3-deazapurine nucleoside (30) shows the base in the syn 
conformation with a glycosidic bond angle of -63.8(3)°. Again, it can nicely be seen 
that the C2´ atom comes of the plane of the other four atoms giving rise of a 2´-endo 
envelope S-type or 2E (S) conformation. The C5´-O5´ points away from the ring, 
which shows that a –gauche or –sc conformation is present. 
 
 
 
Figure 50: Crystal structure of 1,3-deazapurine-N9-β-2´-deoxyribonucleoside (30) in 
the 2E (S) conformation with the base in the syn position and the C5´-O5´ in -gauche 
or -sc. 
 
It has been found that there are H-bonds between O5´-H5´ and N7 from a 
neighbouring molecule and O3´-H3´of another neighbouring molecule to the O5´. 
The distances between O5´-H5´···N7 and O3´-H3´···O5´ are 2.765(3) and 2.725(2) with 
angles of 168(2)° and 174(2)°, respectively. These are typical values for strong H-
bonds. There are one dimensional chains horizontally and vertically connected by the 
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H-bond O5´-H5´···N7. The one dimensional chains are like steps, but no stacking 
between the bases is observed. Additionally the O3´-H3´···O5´ H-bonds connect the 
vertical one dimensional chains with the horizontal chains and vice versa. 
To be able to compare all results of the conformations of the nucleosides, the values 
are summarised in Table 5. Important to notice are the envelope conformation for all 
nucleosides, as well as the glycosidic bond angles that are all, except of one that is on 
the borderline, in the syn conformation. The values for the puckering amplitudes do 
differ slightly; however, they are all in the normal range for these values.  
 
 29b I 29b II 28b I 28b II 30 
ν0 +20(1)° - 2.9(5)° +2.1(4)° - 17.0(4)° - 31.7(2)° 
ν1 - 40(1)° +26(1)° - 19.5(4)° - 2.3(5)° +40.8(2)° 
ν2 +40(2)° - 35(1)° +28.3(4)° +19.1(4)° - 34.0(2)° 
ν3 - 29(2)° +35(1)° - 27.4(4)° - 29.1 (4)° +16.5(2)° 
ν4 +8(1)° - 19(1)° +16.3(4)° +29.0(4)° +9.2(2)° 
P - 11° +194° +14° +51° +148° 
 2E (N) 3E (S) 3E (N) 4E (N) 2E (S) 
νm 41° 36° 29° 30° 40° 
γ +44(1)° +72(1)° +56.4(5)° +50.7(5)° - 63.4(3)° 
 +sc, +gauche +sc, +gauche +sc, +gauche +sc, +gauche -sc, -gauche 
χ - 74.5(6)° - 74.5(6)° - 82.3(5)° - 91.1(4)° -63.8(3)° 
 syn syn syn syn/anti syn 
 
Table 5: The endocyclic torsion angles (ν0-4) in the sugar ring to calculate the phase 
angle of pseudorotation (P) and the puckering amplitude (νm), the torsion angle (γ) 
for the conformation of the C5´-O5´ compared to the sugar ring and the glycosidic 
bond angle (χ) are listed (in the order as discussed). 
 
As done before with the ligand, 1-deaza-9-methylpurine (22), of the model structure, 
[Hg(9-MeDP)2](NO3)2 · H2O (24), it is important to look first at the protonation 
reaction of the nucleosides, to rule out an interference of this reaction with the 
wanted metalation. Therefore the pKa values for the nucleosides needed to be 
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determined. pD-dependent 1H chemical shifts of the aromatic protons of the 
nucleosides have been measured, as shown in Graph 1. 
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Graph 1: Chemical shift (δ) of the aromatic protons against pD-value for 1-deaza-
purine-N9-β-2´-deoxyribonucleoside (28b). 
 
For 28b a pKa value (corrected for H2O) of 2.84(2) was calculated from the data 
obtained, for 29b the pKa value is 3.26(2). Hence, at pH values higher than 5 no 
competition of protonation and metalation should be expected. 
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Graph 2: Chemical shift (δH/ppm) of the H8 protons of the β- and α-anomer against 
the pD-value for 1-deazapurine-N7-β(α)-2´-deoxyribonucleoside (29b and 29a) 
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The 29b and 29a are slightly less acidic than 28b and 28a. This trend was also 
observed for the 1-deaza-7-methylpurine (23) and the 1-deaza-9-methylpurine (22) 
and for the alpha-anomers of the nucleosides in comparison with the beta-anomers. 
For simplification, Table 6 shows all pKa values of the synthesised nucleosides and 
others for comparison. 
 
Nucleoside β-Anomer α-Anomer Methyl derivative 
1,3-Deazapurine (30) 4.21 ± 0.03127 4.45 ± 0.03127 5.67 ± 0.02129 
1-Deazapurine-N9  (28) 2.84 ± 0.02 3.15 ± 0.02 3.67 ± 0.05 
1-Deazapurine-N7 (29) 3.26 ± 0.02 3.45 ± 0.02 3.83 ± 0.05 
Imidazole 6.01 ± 0.0592 6.42 ± 0.0592 7.20 ± 0.02130 
Triazole 1.32 ± 0.0592 1.53 ± 0.0592 2.31 ± 0.03131 
Tetrazole ‹ -3 ‹ -3 - 3.00132 
 
Table 6: pKa values of the synthesized nucleosides and others for comparison; the 
values of -3 for the tetrazoles are estimates based on the pKa value of the 
corresponding 1-methyl derivative. 
 
The methyl derivatives have in each case a less acidic pKa value than the 
nucleosides133, as is customary for nucleosides. The alpha-anomer of the nucleosides 
always has a less acidic pKa value than the beta-anomer. The sugar ring of the 
nucleosides has a more stabilising effect on the non-protonated form than a methyl 
group, but the fact, that the alpha-anomer is less acidic has to be investigated further. 
The same trends are found for the imidazole, triazole and tetrazole nucleosides or 
methyl derivatives, but also an additional observation could be made. An increase of 
N atoms in the five membered ring gives an increase in acidity. And comparing 
imidazole and the 1-deazapurine-N9 or -N7 nucleosides (28 and 29), it can be said, 
that introducing a pyridine ring onto the five membered imidazole ring, which ever 
way around, gives also an increase in acidity. This increase is larger than through the 
addition of a benzene ring, as in 1,3-deazapurine (30). Substitution of a C atom with 
an N atom in the six membered ring shows the same trend as found in the five 
membered rings, but the effect is found to be much smaller.  
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Knowing, that no competition between protonation and metalation is thought to 
occur, it is possible to characterise the nucleosides further, especially their behaviour 
towards metal ions.  
The ability of forming a complex with a metal ion, as well as a rough idea of the 
strength of such a complex and the stoichiometry can be observed with the means of 
a Job-Plot. The method of continuous variation was used for the Job-Plot.134-137 The 
change in chemical shift (Δδppm) is observed with the help of 1H NMR at different 
mole fractions (χ) of ligand (nucleoside) and Mn+. A Job-Plot for 1-deazapurine-N9-β-
2´-deoxyribonucleoside (28b) with Hg2+ is shown in Graph 3. The change in chemical 
shift (Δδ) of the aromatic protons multiplied with the mole fraction (χ) of 28b is 
applied at the y-axis and the different mole fractions (χ) of 28b at the x-axis. 
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Graph 3: Job-Plot of 1-deazapurine-N9-β-2´-deoxyribonucleoside (28b) with Hg2+ at 
pD 5. 
 
Graph 3 shows a maximum higher than 0.6 mole fraction (χ) of the 1-deazapurine-
N9-β-2´-deoxyribonucleoside (28b). It can be concluded that a complex has been 
formed and that this result gives rise to a 2:1 complex. Two 1-deazapurine-N9-β-2´-
deoxyribonucleosides (28b) bind to one Hg2+. This correlates nicely with the model 
structure [Hg(9-methyl-1-deazapurine)2](NO3)2 · H2O (24), which is also a 2:1 
complex. The stability of the complex formed in the Job-Plot experiment could not be 
quantified exactly at this point, but it could be gathered that it is reasonably stable. 
Results and Discussion        Chapter II 
 
64 
The sharper the change of slope the more stable the complex is found to be, the less 
sharp the change of slope the less stable the complex.137 Now, in Graph 4 we can see 
the Job-Plot for the 1-deazapurine-N7-β-2´-deoxyribo-nucleosides (29b) with Hg2+ 
(1H NMR used). It can clearly be seen that the maximum is found at 0.5 mole 
fractions, leading to a 1:1 complex. Further Job-Plots with Cu2+ and Fe3+ were 
measured with the help of UV spectroscopy (at 280nm) giving rise to a 1:1 and a 2:1 
complex, respectively. It should be mentioned that those Job-Plots had a minimum 
and not a maximum, which is dependent on an increase or a decrease in absorbance. 
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Graph 4: Job-Plot of 1-deazapurine-N7-β-2´-deoxyribonucleoside (29b) with Hg2+. 
 
To gather more information about the stoichiometry and the stability of the com-
plexes, titrations with metal ions were done. The changes in chemical shift (Δδppm) or 
in absorbance (range of wavelength: 190-350nm) of the nucleosides are observed up-
on the addition of different equivalents Mn+ to a fixed amount of ligand (nucleoside).  
For the 1-deazapurine-N9-β-2´-deoxyribonucleoside (28b) the titration was first done 
at pD 7 as shown in Graph 5. The binding of Hg2+ to the ligand takes place in the fast 
exchange limit (NMR scale). Therefore no individual signals of starting compound 
and product can be observed, but only the average chemical shifts. It was found that 
not only one, but more complexes seemed to have been built, when more Hg2+ was 
added. A 2:1 complex, a 2:3 complex and a 2:5 complex were thought to be present. A 
possible explanation is the formation of complexes where the Hg2+ binds to O atoms 
from the surrounding H2O molecules. 
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Graph 5: Titration of 1-deazapurine-N9 nucleoside (28b) with Hg2+ at pD 7. 
 
To check the possibility of the H2O molecules being involved in binding of Hg2+, the 
pD was lowered down to 5. Graph 6 shows, in the first view, only the presence of a 
2:1 complex. So a lower pD value cancels out the possibility of oxo bridged species 
being formed.  
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Graph 6: Titration of 1-deazapurine-N9 nucleoside (28b) with Hg2+ at pD 5. 
 
On the second view, there is a further small change in chemical shift at 0.5 equi-
valents to 1.0 equivalent of Hg2+. This increase is best seen at the H8 proton and the 
chemical shift lowers down again upon the addition of more equivalents. The reason 
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for this is thought to be the presence of a 1:1 complex in addition to the 2:1 complex. 
Both would have a similar chemical shift. At 0.5 equivalents of Hg2+ both the 2:1 and 
the 1:1 complex are present and upon the excess of equivalents of Hg2+, slowly the 
equilibrium turns fully to the 1:1 complex side. 
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Figure 51: Schematic diagram of a possible 2:1 complex of 1-deazapurine-N9 
nucleoside (28b) with Hg2+, where R = sugar ring. 
 
The stability of the complex formed can not be quantified exactly through a look at 
the titration with Hg2+, but it could be gathered that it is reasonable stable, because a 
relatively abrupt change at 0.5 equivalents has been found, and not a broad change 
over a few equivalents, which would indicate a weak stability of the complex. 
From the data of the titrations, the data necessary for calculating the stability 
constants were obtained and the stability constants were calculated using EQNMR.138 
 
Nucleoside log β1 log β2 
1-Deazapurine-N9 (28b) 2.39 ± 0.03 5.22 ± 0.04 
Imidazole › 592,136 › 1092,136 
Triazole 1.56 ± 0.0492 ---92 
Tetrazole ---92 ---92 
 
Table 7: Calculated stability constants of the 1-deazapurine-N9 nucleoside 28b for a 
1:1 (log β1) and 2:1 (log β2) complex with Hg2+ and for other nucleosides for 
comparison. 
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The stability constants are calculated for the 1:1 and the 2:1 complex and it should be 
noticed that the individual stability constant log K2 (log β2 – log β1 ≈ 2.8) is larger 
than log K1 (log β1 ≈ 2.4) for 28b, which is also the case for the [Ag(NH3)2]Cl, for 
example. But examples for this are rare in the literature and the reasons for the larger 
value are not known. The value for the 1-deazapurine-N9-β-2´-deoxyribonucleoside 
(28b) is lower than the value for the imidazole nucleoside, though the addition of a 
pyridine ring to an imidazole destabilises the complex building. This can be 
compared with the pKa values, where upon the addition of a pyridine ring the value 
also dropped. This is the same for a substitution of a C atom by an N atom. But the 
stability constant is higher than for triazole that only builds a 1:1 complex and 
tetrazole that does not build complexes with Hg2+. The trend is comparable with the 
tendency of the individual nucleosides and their pKa values. 
Although the stability constants for the 1-deazapurine-N7 nucleoside (29b) were not 
calculated, titrations with different metal ions were done using UV-spectroscopy. 
Whereas for Ni2+, Hg2+ and Cu2+ no change in absorption maxima upon addition of 
metal ions was observed, but only a small change in absorbance, for Fe3+ a change in 
both was seen. Studies by Lenarcik et al.139 showed that there are many possible 
metal ions with the ability of binding 1-deazapurine (21) and found high stability 
constants for 1-dezapurine metal complexes. As described in the literature139,140 and 
found in the UV-spectra there seems to be some kind of binding taking place, but it is 
difficult to quantify this.  
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3.4 Synthesis of Oligonucleotides 
 
For the automated DNA-synthesizer protecting groups have to be introduced at the 
O5´-position and the O3´-position of the 1-deazapurine nucleosides (28b and 29b). 
This was done following standard procedures used already for the preparations of 
other artificial nucleosides.42,93,141-146 
First the nucleosides (28b and 29b) were protected at the O5´ with the stericly bulky 
DMTr group. The nucleosides were dissolved in pyridine and after the addition of 
DMTr-Cl and a catalytical amount of DMAP the solutions were stirred for three or 
four hours, respectively. After the work up yields of 63% were obtained for both, the 
1-deazapurine-N9-β-[2´-deoxy-5´-O-(4,4´-dimethoxytrityl)-ribonucleoside] (31) and 
the 1-deazapurine-N7-β-[2´-deoxy-5´-O-(4,4´-dimethoxytrityl)-ribonucleoside] (32). It 
is important to avoid any acidification of the solution, because otherwise the DMTr 
protecting group comes off again rapidly. The pyridine, which builds pyridinium 
chloride with the HCl that is formed during the reaction, is supported by the DMAP, 
which prevents the solution to become acidic and helps the pyridine to build 
pyridinium chloride more rapidly. The reaction was done under exclusion of water, 
which would hydrolyse the DMTr-Cl and dissolve produced HCl, which could again 
destroy the nucleosides.  
For the 1-deazapurine-N9-β-[2´-deoxy-5´-O-(4,4´-dimethoxytrityl)-ribonucleoside] 
(31) an interesting observation was made during 1H NMR measurements in CDCl3, 
where an anomerisation was observed. This anomerisation could be stopped by the 
addition of a catalytical amount of Et3N. The CDCl3 seemed to have catalysed the 
isomerisation, probably because some DCl has been built. However, for the natural 
nucleobases the isomerisation in the same way did not work. 
The introduction of the phosphoramidite protecting group was also done following 
standard procedures.42,93,141-146 The addition of (i-Pr)2EtN and chloro-(2-
cyanoethoxy)-(diisopropylamino)-phosphane to the 1-deazapurine-N9- or 1-
deazapurine N7-β-[2´-deoxy-5´-O-(4,4´-dimethoxytrityl)-ribonucleoside] (31 and 32) 
dissolved in dry CH2Cl2 and stirring for an hour at r.t. gave the two building blocks 
needed for the automated DNA-synthesizer, the 1-deazapurine-N9-β-[2´-deoxy-3´-O-
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(2-cyanoethyl)-N,N-diisopropyl-phosphoramidite-5´-O-(4,4´-dimethoxytrityl)-
ribonucleoside] (33) and the 1-deazapurine-N7-β-[2´-deoxy-3´-O-(2-cyanoethyl)-N,N-
diisopropyl-phosphoramidite-5´-O-(4,4´-dimethoxytrityl)-ribonucleoside] (34). The 
reaction was also done under exclusion of water. No further work ups were done for 
two reasons; firstly, since the side product (hydrolysed chloro-(2-cyanoethoxy)-
(diisopropyl-amino)-phosphane) was not visible on the TLC plates, therefore it was 
difficult to separate the side product from the product without a great loss of product 
and secondly, since the side product should not interfere with the reactions inside 
the DNA-synthesizers. Therefore the yield was calculated through the ratio of 
product to side product and the mean molar mass. Then excellent yields were 
obtained. 
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Figure 52: Schematic diagram of the synthesis of the 1-deazapurine-N9- and N7- 
building blocks (33 and 34) for the DNA-synthesizer. 
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The 1-deazapurine-N9- and 1-deazapurine-N7-β-[2´-deoxy-3´-O-(2-cyanoethyl)-N,N-
diisopropyl-phosphoramidite-5´-O-(4,4´-dimethoxytrityl)-ribonucleoside] (33 and 34) 
could then be introduced to the automated DNA-synthesizer. 
The following oligonucleotide strands were synthesised with the 1-deazapurine-N7-
β-2´-deoxyribonucleoside as the artificial nucleobase (X): 
 
(a) 5´-d(AAA AAA AXX XTT TTT TT) ‹ 1% yield 
(b) 5´-d(AAA AAA AXX XXT TTT TTT) 
(c) 5´-d(AAA AAA AXA AAA AAA) 
(d) 5´-d(TTT TTT TXT TTT TTT) 
 
The first strand (a) was synthesised in DMTr-off mode, deprotected, purified over an 
ion-exchange column (HPLC), desalted, lyophilised and the concentration was 
determined with the help of the Lambert-Beer Law and finally the yield was 
calculated. The second strand (b) was not purified, because the expected yield was 
very low and the results from measurements with the first one (a) were no 
motivation for a further engagement.  
The strands (c) and (d) were synthesised in DMTr-on mode, deprotected, purified 
over a reversed-phase column (HPLC), deprotected with acetic acid (80%), purified 
again over a reversed-phase column (HPLC), lyophilised and the concentration was 
determined with the help of the Lambert-Beer Law. MALDI-TOF spectra though did 
not show any sign of the wanted oligonucleotides (c) and (d). Probably the acetic acid 
in the deprotection step has destroyed the oligonucleotides, since the glycosidic 
bonds of the used artificial nucleobases are by far not as stable as for natural 
nucleobases, for which these procedures have been developed for. The purification 
took place more than two weeks after the synthesis on the automated DNA-
synthesiser Therefore another explanation could be that the purification has to be 
done immediately after the synthesis otherwise the oligonucleotide depurinates over 
time. 
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The following oligonucleotide strands were synthesised with the 1-deazapurine-N9-
β-2´-deoxyribonucleoside as the artificial nucleobase (Y): 
 
(e) 5´-d(CYY YYG)    ‹ 1% yield 
(f) 5´-d(CGC GYA TYC GCG)   ‹ 9% 
(g) 5´-d(AAA AAA AYA AAA AAA)  ‹ 6% 
(h) 5´-d(TTT TTT TYT TTT TTT)  ‹ 17% 
(i) 5´-d(YYY YYY YYY YYY YYY YA) ‹ 1% 
 
All strands with Y were synthesised in the DMTr-off mode, deprotected, purified 
over an ion-exchange column (HPLC), desalted, lyophilised and the concentration 
was determined with the help of the Lambert-Beer Law and finally the yield was 
calculated. The differences in the yields and the repeatedly low yields can have many 
possible factors. The trifluoroacetic acid (3% in CH2Cl2) used to take off the DMTr 
protecting groups in the automated DNA-synthesizer could depurinate or denature 
the oligonucleotide or single artificial nucleobases. The more artificial nucleosides 
were introduced the lower the yield, the broader the peaks in the HPLC 
chromatogram and therefore the more difficult to select. An especially visible effect 
of loss in yield was seen at changes from natural nucleobases to artificial ones. In the 
HPLC chromatograms for (g) and (h) peaks for three products are seen.  The fact that 
the adenine rich strand has a lower yield than the thymine rich one has been 
observed many times and is comparable with the synthesis of natural nucleobases. 
Another obvious factor is the length of the oligonucleotides; the longer the strand, 
the lower the yield generally.  
After the synthesis the oligonucleotide is still on a solid support. The oligonucleotide 
gets taken off with the help of AMA (5min / 65°C). If this step is insufficient, since 
the time is not long enough and only a few percent of product are taken off the solid 
support, one would also get generally low yields.  
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3.5 Melting Curves 
 
To be able to discuss melting curves the used terminology has to be explained first. 
In the melting curves the absorbance at 260nm (usually used for natural nucleobases) 
is observed upon the change in temperature. With changing temperature the 
conformation of two single strands can vary between a double helix structure at 
lower temperatures and two single strands at higher temperatures, since the double 
helix structure is only stable up to a certain temperature. Above the temperature the 
amount of single strand goes up and the amount of double helix goes down. At a 
certain temperature only single strands are present in the solution, Ts. Then the 
absorbance is the highest and vice versa for only double helix being present. The 
temperature range between only single strand and only double helix being present, 
Ts-Td, lies usually around 10-15°C. One then speaks of cooperative melting. If this 
temperature range is larger, non-cooperative melting is present.  
The melting temperature, Tm, that is always stated, has the temperature value for 
50% single strand and 50% double helix being present. The size of the change in 
absorbance upon a change in temperature differs from system to system and is 
quantified in percentage by the hypochromicity. At maximal absorbance only single 
strands are present. When a double helix is present, this value is lower. The size in 
hypochromicity upon the for-
mation of a double helix gives 
an idea about the strength of 
the helix.  
The oligonucleotides are 
always written from the 5´-end 
(left) to the 3´-end (right), if 
not stated otherwise.  
 
 
 
Graph 7: Example of a melting curve. 
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(a) 5´-d(AAA AAA AXX XTT TTT TT) 
This strand was meant to be self complementary. The melting curves were all done at 
the same conditions: 5mM MOPS (pH 6.8), 150mM NaClO4 and a strand concen-
tration of 1µM. As metal ions Fe3+, Cu2+ and Hg2+ were used. Without metal ions the 
strand (a) has a Tm of around 44°C, which is around 8°C higher than in the com-
parable A15-T15 system. This could be due to (a) forming a duplex and the X not inter-
fering, but adding to the stability by π-stacking interactions. Another explanation 
could be that the strand (a) forms a hairpin, which is known to have high melting 
points, although it has only seven base pairs. This could be distinguished by mea-
suring the Tm of different concentrations. If the Tm is concentration dependent, a du-
plex is likely to be present, if it is not concentration dependent, a hairpin is formed. It 
was refrained from concentration dependent measurements, due to the low yield 
that was obtained. A hairpin structure is probably preferred, since in a similar strand, 
where X equaled a triazole nucleoside, a hairpin structure was found.147 It was 
preferred to measure the change in Tm upon the addition of different metal ions, but 
with other metal ions (Fe3+, Cu2+ and Hg2+) no increase in Tm was observed.  
 
(e) 5´-d(CYY YYG) 
The strand (e) was primarily synthesised to test the ability of introducing Y into an 
oligonucleotide. The melting behaviour was observed with 5´-d(CTT TTG) as possible 
complementtary strand (each 1µM). As metal ions Hg2+ at pH 5 and pH 7 and Ag+ at 
pH 5 were used. No melting behaviour at all was found, without or with metal ions. 
The reason for this could be the length of the oligonucleotide (e). The metal ions must 
be strongly stabilising for the Y-T pairs in the 6-mer to get a melting behaviour. There 
is also a possibility of having Y-Y pairs in the 6-mer, but those do not seem to be 
more stable, as we did not observe any melting behaviour at all. 
 
(f) 5´-d(CGC GYA TYC GCG) 
This strand (f) was meant to be self complementary, as the Dickerson Drew strand. 
As buffer 5mM MOPS (pH 6.8) was used. But (f) did not show any melting 
behaviour, without or with Hg2+, nor at different salt concentrations between 100mM 
and 1M NaClO4. One reason for this could be the protecting groups on the C and G 
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nucleobases, which eventually have not been deprotected fully. The protecting 
groups are more robust in comparison with the protecting groups of the A and T 
bases that can easily be deprotected using AMA for five minutes at 65°C. The 
protecting groups on the nucleobases do not allow the strand (f) to self assembly. The 
nucleobases are too large and the H-bonding sites are mostly blocked. Also a reason 
could be the two artificial Y nucleobases, strongly destabilising the helix formation.  
 
(g) 5´-d(AAA AAA AYA AAA AAA)    (h) 5´-d(TTT TTT TYT TTT TTT) 
It was expected that these two strands, (g) and (h), could build a double helix to-
gether, so that a possible binding of a metal ion in the inside of this helix at the arti-
ficial Y nucleobases could be observed. Next to the possibility to examine the beha-
viour of a Y-Y pair with a metal ion, it was also possible to have a look into the beha-
viour of Y-A, Y-C, Y-G and Y-T pairs. For this purpose the needed oligonucleotides, 
containing only natural nucleobases were bought. The melting curves were all done 
at the same conditions: 5mM MOPS (pH 6.8), 150mM NaClO4 and each strand 1µM. 
These conditions are roughly standard conditions as used by other research groups, 
too. Sometimes higher salt or strand concentrations are used. Though, the addition of 
metal ions is on occasions done in an excess and not in an equimolar amount com-
pared to the strand concentrations.51,52,56,60,62,63,65-67 The melting curves were measured 
on a UV spectrometer without metal ion, with one equivalent of metal ion and with 
three equivalents of metal ion. The metal ion Ag+ was used, as it, as stated before, has 
the tendency to build linear complexes. It was refrained from further use of Hg2+, 
since it showed the tendency to bind to thymine.148 It is expected that all the strands 
form a double helix with each other, since 14 of the 15 base pairs possible to form are 
natural A-T base pairs. The length of the oligonucleotides and the amount of A-T 
base pairs should bring the Tm in a measurable range. At temperatures less than 5°C 
the measurements become inaccurate due to the condensation of humidity. Some-
times this happens at even higher temperatures. For the measurements 10°C were the 
lower limit. Since the range of melting usually lies around 10-15°C, in which also the 
Tm lies, one is only able to measure Tm values down to around 18°C without getting 
values with high errors. On the other side measurements up to 90°C are possible. The 
two 15-mers in a double helix structure should melt far below this temperature.  
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 T7-T-T7 T7-G-T7 T7-C-T7 T7-A-T7 T7-Y-T7 
A7-A-A7 36.1°C 27.6°C 24.8°C 24.1°C 24.2°C 
A7-C-A7 26.0°C 36.9°C 20 and 33°Ca 24.1°C 20.8°C 
A7-G-A7 26.1°C 26.4°C 35.0°C 25.4°C 20.9°C 
A7-T-A7 26.3°C 28.1°C 23.6°C 32.9°C 22.0°C 
A7-Y-A7 24.2°C 18.9°C 16°Ca 19.1°C 21.5°C 
 
Table 8: Tm without any metal ions; a no cooperative melting has been observed. 
 
Looking at Table 8 some interesting observations can be made: 
• The natural base pairs A-T, T-A, C-G and G-C give the most stable duplexes, 
as one would expect, with Tm between 32.9 and 36.9°C. Though, it should be 
noticed that interestingly the A7-A-A7/T7-T-T7 duplex is about 3.2°C more 
stable than the A7-T-A7/T7-A-T7. This could be due to less efficiency in the π-
stacking, because of the change between the pyrimidine and purine bases.  
• This effect is also visible in A7-A-A7/T7-Y-T7 (24.2°C) and A7-Y-A7/T7-A-T7 
(19.1°C), since no difference should be between the actual A-Y or Y-A, unless 
the structure forces the potential base pair in a more or less favoured position. 
• One general point that needs mentioning is the destabilising effect of Y. 
Without a metal ion the Tm values are the lowest, when a Y nucleobase is 
present in the oligonucleotide. The destabilisation is greater than observed for 
mismatches of natural nucleobases, where the Tm drops roughly by 7-12°C. 
• All strands showed self assembling properties except for the T7-C-T7 strand 
with A7-C-A7 or A7-Y-A7, where no cooperative melting could be observed. 
The Tm values can therefore not be taken as accurate and are only written for a 
rough orientation. 
The effect upon the addition of one equivalent Ag+ on the 25 different systems can be 
seen in Table 9. One equivalent equals a 1µM concentration in solution compared to a 
concentration of 1µM for each strand to build a 2:1 complex. After the addition of 
metal ions the solution has to be heated up, so that only single strands are present. 
Upon slow cooling, the double helices can form with or without the metal ion inside.  
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 T7-T-T7 T7-G-T7 T7-C-T7 T7-A-T7 T7-Y-T7 
A7-A-A7 0.6°C 3.6°C 5.7°C 0°C 1.9°C 
A7-C-A7 4.6°C 1.3°C a) 7.7°C 9.2°C 
A7-G-A7 0.6°C 0.9°C 1.6°C 4.1°C 8.9°C 
A7-T-A7 0.2°C 0.1°C 2.8°C 0.1°C 2.0°C 
A7-Y-A7 2.5°C 11.3°C b) 3.2°C 5.5°C 
 
Table 9: The increase of the Tmwith one equivalent of Ag+, ΔTm;  
a) Tm = 32.2°C and b) Tm = 28.3°C. 
 
• The natural base pairs A-T, T-A, C-G and G-C have negligible increases in Tm 
upon the addition of Ag+.  
• This is the same for the mismatching base pairs with only a few exceptions. 
One of those is the G-A or A-G base pair that gets slightly stabilised. Other 
exceptions are the base pairs with cytosine. With thymine the increase is small 
with 2.8 and 4.8°C; with adenine it is larger with 5.7 and 7.7°C. For the C-C 
base pair it is difficult to state a value, because of the non distinct melting 
without Ag+. But it can be said that the melting curve with Ag+ shows a 
distinct melting.  
• For the artificial nucleobase Y only a small increase between 1.9 and 3.2°C can 
be observed with adenine or thymine. The artificial base pair Y-Y shows a 
larger increase of 5.5°C. Really large stabilisation effects are observed with 
cytosine with an increase of 9.2°C and guanine with increases of 8.9 and 
11.3°C.  
• The C-Y base pair that showed no distinct melting without Ag+, has a nice 
distinct melting curve, now. 
 
After the addition of further two equivalents of Ag+ the Tm was not raised by a 
significant amount for any of the different base pairs. The differences were between 0 
and 3.4°C, whereby the higher values were for the systems that had a large increase 
in Tm after the addition of one equivalent Ag+.  
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Looking at Graph 8, one can gain more information of the melting curves than only 
the Tm. The size of the hypochromicity change in the A7-C-A7/T7-Y-T7 system is at a 
usual value of around 22% and no change is observed upon the addition of Ag+. The 
Tm, however, changes significantly by + 9.2°C, if one equivalent of Ag+ is added. But 
the addition of more equivalents does not raise the Tm much further, showing the 
specificity in this system and that the metal ion is probably binding inside the double 
helix. The temperature range Td-Ts is around 20-25°C, if no metal ions are present, 
but decreases upon the addition of metal ion. This shows an increase in cooperativity 
in the system due to the addition of Ag+. Though, one can not state anything about 
the selectivity of the Ag+ in this system. For this data of other metal ions are 
necessary for obvious comparison reasons. 
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Graph 8: Melting curves of A7-C-A7 and T7-Y-T7 with different equivalents of Ag+. 
 
From these data it is not possible to give any structural information on the systems, 
neither of the oligonucleotides and their conformations, nor on the actual base pairs 
inside. But one can assume that the oligonucleotides build anti-parallel double 
helices with Watson-Crick binding between the 14 A-T base pairs. Though, it is very 
challenging to give a definite structure for the base pairs in the middle of the double 
helices from the collected data. 
One can, however, put forward possible structures of the metal-mediated base pairs, 
for example, with Y binding over the Hoogsteen side, the only possible side for Y. 
Results and Discussion        Chapter II 
 
78 
N
N
sugar
N
N
N
N
sugar
N
O
O
H
H
T
A
N
N
sugar
N
O
C
H
H
N
N
N
N
sugar
O
G
N
H
H
N
N
N
sugar
Y
N
N
N
sugar
Y
N
N
N
sugar
Y
N
N
N
sugar
Y
H
H
H
H
H
H
H
H
H
N
N
N
sugar
N
N
N
sugar
Y
H
HH
H
Y
= Ag+
= possible H-bond
 
 
Figure 53: Schematic diagram of possible metal ion binding between the different 
nucleobases. 
 
Without the metal ion present the G-Y base pair could build one or two H-bonds, but 
the formation of such a base pair might interrupt the π-stacking leading to the lower 
Tm. But in this case the A-Y base should have a lower Tm, which it has not. The addi-
tion of a metal ion stabilises then greatly through the formation of covalent metal 
ligand bond. But for the A-Y base pair no stabilising effect is observed. Looking at 
the T-Y base pair without a metal ion one could assume the formation of three H-
bonds, at the most, but only one H-bond for the C-Y base pair. A possible inter-
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ruption of π-stacking interactions and the difference in H-bonds present could ex-
plain why the C-Y base pair greatly destabilises the double helix. With the metal ion 
the C-Y base pair stabilises the double helix more than a T-Y base pair. For the Y-Y 
base pair there are also many binding possibilities, but probably only the N7-position 
is able to bind a metal ion. There are many factors influencing the bonding sides and 
modes of the nucleobases. The π-stacking interactions through the whole double 
helix and its possible disturbance through the Y nucleobase, the distances bet-ween 
the sugar phosphate backbones and H-bonding are the most important factors. 
 
(i) 5´-d(YYY YYY YYY YYY YYY YA) 
Initially the strand was thought to be able to bind to a 5´-d(TTT TTT TTT TTT TTT 
TT) (j) with the help of Hg2+. Coordination behaviour of Hg2+ with nucleic acids has 
been studied97,99,100 and it is thought that Hg2+ can insert into base pairs by substi-
tution of an imino proton.149,150 As has been shown recently in the literature, the Hg2+ 
can bind selectively to thymines inside a double helix containg only thymine.148,151 
Many metal ions have been tested and only Hg2+ showed notable effects on the 
duplex stability. Ag+ was also tested, but no effect on the duplex stability of the used 
oligonucleotides was found, although Ag+ can bind linearly, too. However, for 
5´-d(TTT TTT TTT TTT TTT TT) (j) self assembling in the presence of Ag+ was 
observed, as shown in Graph 9. Therefore (j) will not necessarily bind to (i) with Ag+. 
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Graph 9: Melting curves of 5´-d(TTT TTT TTT TTT TTT TT) (j) with different 
equivalents of Ag+ (Tmh = melting temperature of the hairpin). 
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One equivalent of Ag+ equals the amount needed to form a double helix that has one 
Ag+ present in each base pair. The melting curves were measured at 5mM MOPS (pH 
6.8) and 150mM NaClO4 and 1µM strand concentration. The 5´-d(TTT TTT TTT TTT 
TTT TT) (j) shows no melting without Ag+, as one would expect; only single strand 
is present. But upon the addition of different equivalents Ag+ two Tm values can be 
observed, Tmh and Tm. One could be a hairpin (Tmh) and the other a duplex (Tm) that 
is favoured the more Ag+ is added. 
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Figure 54: Possible equilibrium between hairpin and double helix structure. 
 
Interesting was also that the cooling temperature (Tc) was always closer to the lower 
Tmh. The fact that two species are built and that even after addition of ten equivalents 
Ag+ the Tm still rises shows that the melting behaviour is not very specific. When 
measuring at higher NaClO4 concentrations the hairpin is only present until the 
addition of two equivalents of Ag+, showing that the species of the higher Tm, 
probably a double helix, is greatly favoured. The specificity, though, has not changed 
and is still low. The change in hypochromicity is astonishingly large with a value of 
nearly 50%. Comparing the obtained data with the data in the literature it has to be 
said that next to the Hg2+, the Ag+ is also in favour of being a highly selective 
thymine nucleobase binding partner. 
Due to the ability of 5´-d(TTT TTT TTT TTT TTT TT) (j) to bind Ag+, the possibility 
of concurrent reactions can not be excluded. In Figure 55 a T-T base pair with an Ag+ 
can be seen, as it would be expected from the data obtained by A. Ono and H. 
Togashi.148 
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Figure 55: A T-T base pair with no H-bonds, a), and a T-T metal-mediated base pair 
with Ag+, b). 
 
Then the 5´-d(YYY YYY YYY YYY YYY YA) (i) was measured at 5mM MOPS (pH 
6.8) and 150mM NaClO4 and 3µM strand concentration. The strand (i) is stabilised by 
around 17°C upon the addition of Ag+ taking a Tm of around 28°C for the strand 
itself without Ag+ for the non-cooperative melting. The melting behaviour becomes 
cooperative upon the addition of Ag+. Surprisingly, the absorbance values at 80°C 
are not the same, as expected for only single strand being present (Graph 10). 
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Graph 10: Melting curves of 5´-d(YYY YYY YYY YYY YYY YA) (i) with different 
equivalents of Ag+. 
Results and Discussion        Chapter II 
 
82 
The melting curves were measured three times to obtain repeatable results. In Graph 
11 the change in Tm with different equivalents Ag+ is shown. An increase in Tm was 
observed up to an addition of roughly 0.5 equivalents Ag+. Considering that one 
equivalent equals eight Ag+ per strand, so that two strands have 16 Ag+, 0.5 
equivalents mean that 16 Ag+ are used for four strands or eight for two. Additional 
equivalents of Ag+ do not seem to have a further stabilising effect, which shows that 
the metal ions must have some specific purpose. The reason for only eight Ag+ inside 
a double helix could be the Ag+ not wanting to be to close to one another, because of 
its size or charge. Also the positions of the artificial nucleobases in such a double 
helix might not always be close enough for the binding of a metal ion.  
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Graph 11: Change in Tm upon the addition of different equivalents of Ag+ to (i). 
 
Normally one would not expect any Tm for (i), but the CD-spectra showed that some 
kind of structure is present in the solution at 10°C and that this structure does not 
change upon the addition of Ag+. So there should be some kind of structure present 
that shows a non-cooperative melting behaviour. One possibility would be the 
presence of double helices with different chain length. These would melt at different 
temperatures and after the melting process the single strands could again form 
longer double helices. Though, it can not be stated, whether these would be parallel 
or anti-parallel.   
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Figure 56: Possible double helix formations of (i). 
 
Looking at Graph 12 it can be seen that the change in hypochromicity without metal 
ions is quite small. A hypochromicity effect seems to be present; hence, the 
hypochromicity rises upon the addition of Ag+. The change from non-cooperative to 
cooperative melting upon the addition of Ag+ can also be seen. The difference 
between Ts and Td decreases from around 30°C to 10-15°C. This indicates certain 
specificity in the binding of the Ag+. 
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Graph 12: Melting curves of 5´-d(YYY YYY YYY YYY YYY YA) (i) with different 
equivalents of Ag+. 
 
There is an increase in Tm, a switch from non-cooperative to cooperative melting, a 
hypochromicity effect and an indication for specific binding of the Ag+. But from 
these data one can not derive any structural knowledge of the possible double helix 
or eventually of the metal-mediated base pair.  
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3.6 CD-Spectra 
 
The information from circular dichroism (CD) measurements is complementary to 
that from absorption spectra, in fact, it is even greater. The CD spectra above 210nm 
are influenced by the overall structure and by the nearest neighbours of the nucleic 
acids. This method is based on DNA and other molecules interacting differently with 
right and left circularly polarised light. This light is chiral and needs a chiral 
molecule to discriminate between its two chiral forms. One measures the change in 
ellipticity with the change in wavelength. The ellipticity is then converted to molar 
ellipticity.152,153 
 
Since it was not possible to derive any structural knowledge from the melting curves 
of 5´-d(YYY YYY YYY YYY YYY YA) (i), CD-spectra were measured. The buffer and 
salt concentrations (5mM MOPS and 150mM NaClO4) were kept equal and the 
strand concentration was 13.5µM. At 10°C the strand was expected to be found in 
solution as single strand and upon the addition of Ag+ a change in structure should 
be seen, if the binding of metal ions leads to a structural conformation of the 
oligonucleotide (i). 
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Graph 13: Δε x 10-5 at different wavelengths at 10°C for (i) upon the addition of Ag+. 
Results and Discussion        Chapter II 
 
85 
Surprisingly, no change in structure was observed, which can have two reasons. The 
addition of Ag+ does not lead to defined rigid structural conformation or there could 
be some kind of structure present in solution at 10°C without metal ions being 
present. This is the case, if the CD-spectrum of the 1-deazapurine-N9-β nucleoside 
(28b) (measured under the same conditions and at the same concentration) differs 
significantly from the CD-spectrum of the oligonucleotide (i). The 1-deazapurine-N9-
β nucleoside (28b) has a random order in solution and if the CD-spectra are similar, 
the oligonucleotide (i) does not possess a defined structural conformation.  
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Graph 14: Δε x 10-5 at different wavelengths at r.t. of 1-deazapurine-N9-β nucleoside 
(28b). 
 
Only looking at the size of Δε in Graph 14 one can easily see that it is much smaller 
than the Δε for the oligonucleotide in Graph 13. The spectrum of the 1-deazapurine-
N9-β nucleoside (28b) shows no significant change above 270nm, a minimum at 
255nm and a broad maximum from 210nm to 240nm. For the spectrum of the 
oligonucleotide (i) (Graph 13) two minima (225nm and 275nm) and three maxima 
(210nm, 245nm and 290nm) are observed. Therefore the oligonucleotide (i) has a 
structural conformation even without metal ions being present and the conformation 
does not change upon the addition of Ag+. The Ag+, however, stabilises the structure 
by a great amount, which can be seen in the melting curves that have been shown 
before and the significant change in melting behaviour. If the structure is now melted 
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by heating up the solution to 80°C the CD-spectrum of the single strand should be 
seen and it should differ from the spectrum of the possible helix. 
200 220 240 260 280 300 320 340
-3,0
-2,5
-2,0
-1,5
-1,0
-0,5
0,0
0,5
1,0
1,5
Δε
 x
 1
0-
5  /
 d
eg
 c
m
2  d
m
ol
-1
Wavelength / nm
  10°C (1/3 equivalent Ag+)
  80°C (1/3 equivalent Ag+)
 
Graph 15: Δε x 10-5 at different wavelengths at 10°C and 80°C for (i) upon the 
addition of Ag+. 
 
A structural difference can clearly be seen, but it is only shown in the amount of ε 
and only at the already known wavelengths. So the absorption minima and maxima 
do not change. The changes between 10°C and 80°C are the same for the 
measurements with different equivalents Ag+ and without Ag+. This has already 
been observed for the unstacking of single stranded DNA. Upon an increase in 
temperature the near-UV CD bands decrease and the absorption at 260nm increases 
by around 15%. The decrease in the near-UV bands is a measure of a decrease in 
interaction between the neighbouring bases.152,153 This all can be observed for (i), too. 
Even the crossover points at 265nm and 280nm do not change, which is also typical, 
however, these do not lie near the base line as usually. And one could say that in 
Graph 15 the bands of the spectrum at 80°C are slightly moved to higher wavelength. 
Interesting is also the unequally sized decrease in the bands upon a change in 
temperature, which is also unusual. In the case of some interstrand interactions it is 
difficult to visualise their presence in the CD spectra. The spectra of poly[A] and 
poly[T] strands binding are roughly the average of the single stranded poly[A] and 
poly[T] spectra.152,153 At 10°C this could also be the case for (i), since the average of 
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two (i) equals (i). This is in accord with the observation of the absorption spectra 
having nearly exactly the same bands at the same wavelength. This leaves the 
questions why the Ag+ binds so specifically. Eight Ag+ (half an equivalent) inside 
two single strands maybe building a helix. If the metal ions would bind at the 
backbone, the binding would be much less specific and probably more than eight 
ions would stabilise the structure. One could propose that the structure of the strands 
without metal ions can stack and therefore has some kind of stability. If now a single 
strand can stack in such a fashion that the Y lies opposite another Y of another 
strand, these could bind with a metal ion stabilising the structure without any great 
change in structure. It would still not be possible to describe the orientation of the 
two strands to each other. For double helices of poly[A] with poly[T] no great 
structural difference was found between a parallel and an anti-parallel orientation. 
The position of the adenine base (A) in the oligonucleotide (i) is also important, but 
the possible positions (Figure 57) can not be distinguished with the help of the data 
obtained from the different measurements. 
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Figure 57: Possible double helix formations of 5´-d(YYY YYY YYY YYY YYY YA) (i) 
with Ag+. 
 
So there seems to be a structure of the strand (i) present in solution that shows 
specific binding upon the addition of eight Ag+ (half an equivalent) for two strands, a 
stabilisation and a hyperchromicity effect. All suggestions about the overall structure 
and the eventual artificial Y-Y base pairs can only be of speculative and hypothetical 
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nature, due to the lack of reliable information. Two possible Y-Y base pairs with Ag+ 
are shown in Figure 58.  
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Figure 58: Schematic diagram of possible structures of an Ag+-mediated Y-Y base 
pair. 
 
Possible NMR measurements are difficult, because of the probable high symmetry, 
which makes the identification nearly impossible. Crystallography could be a good 
method to gather further information about the structure, but the amount of strand 
(i) needed for the crystallisation procedures with the generally available 
crystallisation kits is compared to the yields obtained much higher (factor of a 
thousand). A new way of actually observing the formation of a double or triple helix 
was recently published, using a conjugated polymer complex that wraps around a 
double or triple helix, since it contains positive charges that go to the negative 
charges of a double helix backbone. Due to the different charge balance upon single 
strand, double or triple helix, different colours are observed, giving raise to the actual 
structure.154  
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4 1-Deazaadenine 
 
For the introduction of 1-deazaadenine in an oligonucleotide, one has to synthesise 
the nucleoside first and characterise it. This is then followed by the preparation of the 
nucleoside with protecting groups for the automated DNA-synthesizer and the work 
up for the oligonucleotides.  
 
4.1 Synthesis of the Nucleoside  
 
The synthesis of the 1-deaza-6-aminopurine-N9-β-2´-deoxyribonucleoside (1-
deazaadenine nucleoside) was started at the already known 1-deazapurine (21), 
which was oxidised using H2O2 and refluxing for two days, giving, after the work 
up, 1-deaza-N3-oxidepurine (35) in high yields.155  
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Figure 59: Schematic diagram of the synthesis of 1-deaza-N3-oxidepurine (35).155 
 
A crystal structure could be obtained, which includes two water molecules bonding 
along the N-O axis of the molecule, but the resolution was not very good and the 
crystal data were not useable for publishing. The difficulties are due to the crystals 
that are thin needles and therefore difficult to be measured. Though, it can be seen 
that the aromatic rings show the expected planarity. The two water molecules (not 
shown in Figure 60) are connected via an H-bond to each other and to the O3, too. 
The length of the H-bonds are 2.858(1)Å and 2.850(1)Å, respectively, with bond 
angles of 170.63(1)° and 171.67(1)°. There is a third H-bond with a length of 2.879(1)Å 
and an angle of 146.22(1)° between the N7-H7·· O3 of two different molecules. Due to 
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this H-bond the molecules build one dimensional chains in the unit cell. The one 
dimensional chains are not connected to each other and the water molecules are in 
the holes in-between these chains. In the unit cell two molecules stack on top of each 
other with the N3-O3 bonds in opposite direction and the six membered ring slightly 
moved on top of the five membered ring. Looking along the plane of the molecules 
and along the chain direction one can see that the chains are orientated like steps, one 
horizontally, another diagonally and so on. 
 
Figure 60: Crystal structure of 1-deaza-N3-oxidepurine (35). 
 
Next, the 1-deaza-N3-oxidepurine (35) was dissolved in trifluoroacetic acid at 0°C 
and fuming HNO3 (100%) was added drop wise. Important to notice here is that the 
reaction only worked with fuming HNO3 (100%) and not with usual HNO3 (90%), as 
described in the literature.106,155 This could be reasoned in them using 1-deaza-N3-
oxidepurine and not 1-deaza-N3-oxidepurine 2H2O (35). The reaction was then 
heated for four instead of three hours under reflux and neutralised using NH3. It was 
essential to keep the solution underneath 30°C and to permanently stir the solution, 
to obtain some product at all. Further standard work up gave then 1-deaza-N3-oxide-
6-nitropurine (36) as a yellow solid in quantitative yield. 
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Figure 61: Schematic diagram of the synthesis of 1-deaza-N3-oxide-6-nitropurine 
(36). 
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To reduce the 1-deaza-N3-oxide-6-nitropurine (36) to 1-deaza-6-nitropurine (37) PCl3 
was used, but only half of the yield in the literature could be obtained.156 This could 
be due to chlorination at the C4 or C5 position, as has been described in the literature 
for reactions with 1-deaza-N3-oxidepurines.108 
 
3N
NH
N
NO2
O
N N
NH
NO2
3
6 7
9
6 7
9
36 37
fresh PCl3
CH3CN
 
 
Figure 62: Schematic diagram of the synthesis of 1-deaza-6-nitropurine (37). 
 
Though, red crystals were obtained that turned out to be suitable for X-ray 
crystallography and the crystal structure is shown in Figure 63. 
 
 
 
Figure 63: Crystal structure of 1-deaza-6-nitropurine (37). 
 
The aromatic system is planar with the NO2 group coming out slightly of the ring 
plane (7.18(17)°). The bond lengths and the angles of all bonds are in the expected 
ranges. In the solid state the H atom is observed at the N7 position, as it has been 
observed for purine, too.157 This could be assigned by looking at the difference in the 
angles between C8-N9-C4 and C8-N7-C5 (103.7(2)° and 106.4(2)°, respectively). This 
difference is around 3° and the larger angle normally contains the protonated N 
atom. Also it can be said that the larger bond length of C8-N7 compared to C8-N9 
Results and Discussion        Chapter II 
 
92 
(1.352(3) and 1.303(3)Å, respectively) shows nicely that the C8-N9 must contain of a 
double bond and vice versa. This fits well into the chemical scheme shown in Figure 
61. The molecules in the crystal structure form a one dimensional chain over an H-
bond N7-H7··· N9 of the next molecule (H7··· N9 = 1.88(3)Å), as can be seen in 
Figure 64. 
 
 
Figure 64: Unit cell of 6-nitro-1-deazapurine 
 
Theoretical calculations with the ADF program show that in the gas phase the N7 
tautomer is more stable by 14.1kJ/mol compared to the N9 tautomer. In solution 
there is a solvent-dependent equilibrium between the two tautomers present.158 
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Figure 65: Schematic diagram of the tautomer forms of 1-deaza-6-nitropurine (37). 
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Then 1-deaza-6-nitropurine (37) was deprotonated with NaH and Hoffer´s 
chlorosugar (25)122-124 was added to give 1-deaza-6-nitropurine-N9-β(α)-[2´-deoxy-
3´,5´-di-O-(p-toluoyl)-ribonucleoside (38b and 38a).159  
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Figure 66: Schematic diagram of the synthesis of 1-deaza-6-nitropurine-N9-β(α)-[2´-
deoxy-3´,5´-di-O-(p-toluoyl)-ribonucleoside] (38b and 38a). 
 
The appearance of both, the N9 and N7 product (no N3) has not been observed. 
There must be a reason that only the N9 product was formed. It is thought to be due 
to one of the tautomeric structures of 37 being more stable than the other. The pre-
ferred tautomeric structure in the equilibrium of 1-deaza-6-nitropurine (37), where 
the nitro group stabilises one form, is shown in Figure 65 (right side) and Figure 66 
(bottom left). No preferred tautomeric structure was found in the equilibrium of the 
1-deazapurine (21).113 The low reaction temperature of 0°C could also be a reason for 
the presence of only N9 product, as already described for the 1-deazapurine. T. 
Wenzel and F. Seela,113 though they synthesised the two products using five equi-
valents of powdered KOH and TDA-1 as catalyst, instead of NaH had roughly the 
same yield as Cristalli et. al.159 Another glycosylation reaction was done using SnCl2 
as catalyst, getting, as is proposed, N9- and N3-isomers, but similar yields.160 Further 
it is proposed that the yield of the reaction using NaH and Hoffer´s chlorosugar can 
be raised by longer reaction times. This could not be observed in the synthesis here. 
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There are other reaction routes to the 1-deazaadenine nucleoside and its derivatives 
found in the literature, though looking at the reaction conditions and the yield, they 
do not appear to be more successful than the one used.161 However, the formation of 
alpha- and beta-anomers was not observed, previously. Therefore purification of the 
product and separation from its alpha-anomer with flash chromatography had to be 
developed. After separation of the alpha-anomer the yield was only slightly lower 
than in the described literature.113,159 The reaction solvent could also be a reason for 
the formation of only N9-isomer, as has been described in the literature.109 
The two anomers of the 1-deaza-6-nitropurine-N9-β(α)-[2´-deoxy-3´,5´-di-O-(p-
toluoyl)-ribonucleoside] (38b and 38a) can be distinguished by 1H, 1H NOESY, by 
looking at the coupling constants or by looking at the protecting groups. As already 
described for the 1-deazapurine nucleosides, most rapidly the anomers can be 
distinguished by looking in the 1H NMR spectrum at the p-Tol protecting group 
signals of the alpha-anomer. The protecting group of the beta-anomer shows 
chemical shifts in only two regions of the aromatic region (2 multiplets), in the alpha-
anomer a third in-between the other two is observed. This is probably due to two 
protons on the protecting group on the O3´, which observe a high field shift, 
probably, because these protons experience the ring current of the heterocyclic 
aromatic ring of 1-deaza-6-nitropurine in the alpha-anomer (38a). 
 For the 1-deaza-6-nitropurine-N9-β-[2´-deoxy-3´,5´-di-O-(p-toluoyl)-ribonucleoside] 
(38b) the coupling constants H1´/ H2´ and H1´/ H2´´ are almost identical (4.1 and 
5.9Hz), which often gives raise to a pseudo-triplet in the 1H NMR spectrum, whereas 
for the alpha-anomer the coupling constants are quite different (4.8 and 8.2Hz), 
leading more likely to a doublet of doublets. Using 1H, 1H NOESY experiments both 
anomers can easily be distinguished. The H1´ of 1-deaza-6-nitropurine-N9-β-[2´-
deoxy-3´,5´-di-O-(p-toluoyl)-ribonucleoside] (38b) displays a strong cross-peak to 
H2´´, but only a week to the H2´. This is the opposite trend for the alpha-anomer. The 
stereospecific assignement of H2´and H2´´ can be facilitated by comparing the 
intensities of their cross-peaks to the H3´, which are strong and weak, respectively.  
 
The 1-deaza-6-nitropurine-N9-β-[2´-deoxy-3´,5´-di-O-(p-toluoyl)-ribonucleoside] 
(38b) was then deprotected using saturated NH3/CH3OH solution to give 1-deaza-6-
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nitropurine-N9-β-2´-deoxyribonucleoside (39). The reaction was monitored using 
TLC and the reaction time was much shorter than described by Cristalli et. al.,159. The 
yield, however, was found to be higher.  
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Figure 67: Schematic diagram of the synthesis of 1-deaza-6-nitropurine nucleoside 
(39). 
 
Also a side product was found in small yields, the 1-deaza-6-methoxypurine-N9-β-
[2´-deoxy-3´,5´-di-O-(p-toluoyl)-ribonucleoside]. The shorter the reaction time is, the 
lower the yield of the side product and the higher the yield of the product. The 
CH3OH can get deprotonated and attack the slightly positively charged C6 and 
therefore substitute the NO2 group. It was possible to keep the amount of side 
product formed during the reaction small. 
It has to be mentioned that 1-deaza-6-nitropurine-N9-β-2´-deoxyribonucleoside (39) 
could also be a possible artificial nucleobase building metal-mediated base pairs in 
oligonucleotides. A possible base pair with cytosine is shown in Figure 68. 
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Figure 68: Possible metal-mediated base pair formation of 1-deaza-6-nitropurine 
nucleoside (39) with a cytosine. 
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One could already observe the 1-deazapurine building block Y in two strands, g (5´-
d(AAA AAA AYA AAA AAA)) and h (5´-d(TTT TTT TYT TTT TTT)), building a base 
pair with cytosine in the opposite position of another strand upon the addition of a 
metal ion (see Section 3.5). Without the metal ion the melting behaviour was poor 
and no melting point could be obtained. Maybe the possible H-bond formation of 
this 1-deaza-6-nitropurine building block with cytosine could stabilise the double 
helix formation without a metal ion. Then, upon the addition of a metal ion a large 
increase in Tm would be expected. Also this base pair could be compared with the 1-
deazadenine thymine base pair, since both would have three stabilising interactions 
present, the π-stacking, the H-bonding and the metal-ligand interactions.  
 
Reduction of 1-deaza-6-nitropurine-N9-β-2´-deoxyribonucleoside (39) using Raney-
Nickel and hydrazine hydrate gave 1-deaza-6-aminopurine-N9-β-2´-
deoxyribonucleoside (40), also called 1-deazadenine-N9-β-2´-deoxyribonucleoside or 
1-deazaadenine nucleoside. The yield was lower than described in the literature,162 
but still reasonably good. This method was used, since it is less dangerous and more 
easily handable than the method described in the literature, which uses H2 in 
combination with pressure.163 Crystals of the 1-deazaadenine nucleoside (40) could 
be obtained easily as needles or blocks. The unit cells and the space groups were 
nearly identical to the crystal structures published by F. Seela et al.164 The solvent 
used for crystallisation was water instead of iso-propanol.   
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Figure 69: Schematic diagram of the synthesis of 1-deazaadenine nucleoside (40). 
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4.2 Characterisation 
 
As done before with the ligand 1-deaza-9-methylpurine (22) of the model structure, 
[Hg(9-MeDP)2](NO3)2 · H2O (24) and the 1-deazapurine nucleosides (28b and 29b), it 
is important to look at the protonation reaction of the 1-deazaadenine nucleoside 
(40), to rule out an interference with the wanted metalation reaction. Therefore the 
pKa values for the 1-deazaadenine nucleoside (40) needed to be determined. pD-
dependent 1H chemical shifts of the aromatic protons of the nucleoside have been 
measured trying to confirm the pKa value of 4.6,93 in comparison to the value of 4.7111 
for the 1-deazaadenenine ribonucleoside (2´-OH group present), that were obtained 
by UV spectroscopy. This value, however, could not be confirmed, since lowering the 
pD value underneath 5, lead to a fast depurination of the 1-deazaadenine nucleoside 
(40). Above a pD value of 5 no protonation reaction was observed, hence above that 
value we would not expect the protonation reaction to disturb the metalation 
reaction. Although it has been reported that the pKa value of the nucleoside in an 
oligonucleotide is about 0.6 units higher than the one from the monomer,93 working 
at pH 7 should rule out any competition reaction between protonation and 
metalation. In comparison with the 1-deazapurine nucleosides (28b and 29b) this 
means that the additional NH2 group has a destabilising effect on the glycosidic 
bond. Attempts were also undertaken to quantify the half-life of the depurination of 
the 1-deazaadenine nucleoside (40) using 1H NMR spectroscopy, but the calculated 
data were too far away from the actually observed experimental data. Though the 
fact that the 1-deazaadenine nucleoside turned out to be very labile and easily 
depurinated at pH values lower than 5 is of great importance. Especially for the 
further synthesis this has to be considered. 
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But as can be seen in Graph 16, the pKa value for 1-deazaadenine (41) could be 
measured.   
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Graph 16: Chemical shift (δH/ppm) of the aromatic protons against pD-value for 1-
deazaadenine (41). 
 
The same was done for the reaction intermediates, 1-deazapurine (21), 1-deaza-N3-
oxidepurine (35), 1-deaza-N3-oxide-6-nitropurine (36) and 1-deaza-6-nitropurine 
(37). In Table 10 the different pKa values that have been found can be seen. 
 
Purine derivatives pKa value I pKa value II 
1-Deazapurine (21) 4.01 ± 0.03 10.87 ± 0.05 
1-Deaza-N3-oxidepurine (35) 1.02 ± 0.01 8.73 ± 0.01 
1-Deaza-N3-oxide-6-nitropurine (36) ‹ 0 7.19 ± 0.02 
1-Deaza-6-nitropurine (37) 1.39 ± 0.02 ---a 
1-Deaza-6-aminopurine (41) -0.53 ± 0.03 7.94 ± 0.04 
 
Table 10: The pKa values calculated (weighted mean of the values for the different 
aromatic protons) for the intermediates of the synthesis of the 1-deazaadenine 
nucleoside (40); a = pD values over 7 have not been determined. 
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The pKa value I of 1-deazapurine (21) of 4.01 fits nicely to the found value of 4.1 in 
the literature.139 The pKa values I drop upon the oxidation of the N3 position and the 
addition of a NO2 group (electron withdrawing) at the C6 position. A dramatic 
change is observed upon the addition of a NH2 group at the C6 position. These 
changes are also visible in the pKa values II, but the effects are much smaller.  
 
Since the wanted 1-deazaadenine-thymine base pair (Z-T) needs to be planar inside 
the oligonucleotide for binding, DFT calculations165 have been made to calculate the 
structure in the gas phase. For simplification the sugar has been replaced by a methyl 
group and as metal ion Hg2+ has been used.  
 
Figure 70: Calculated structure of a 1-deazaadenine-Hg2+-thymine base pair (C, H, N: 
B3LYP/6-31 G*, metal ions: B3LYP/LanL2DZ). 
 
A glycosidic bond distance of 11.3Å has been observed, which is slightly larger but 
comparable with the glycosidic bond distances observed between natural 
nucleobases inside DNA (in B-DNA 10.85Å).4-6 The bases in the calculated structure 
are not planar, since a propeller twist of 27.2° has been found. This, however, is not 
unusual and can also be found in natural DNA. 
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4.3 Synthesis of Oligonucleotides 
 
For the automated DNA-synthesizer protecting groups have to be introduced at the 
O5´-position and the O3´-position of the 1-deazaadenine nucleoside (40). 
Additionally the NH2 group needs protection. At first the NH2 group was protected 
with benzoyl chloride, followed by the standard procedures for the O5´-position and 
the O3´-position used already for the preparations of other nucleotides.93,146,162,166,167 
Reaction of the 1-deazaadenine nucleoside (40) with benzoyl chloride gave the 1-
deaza-(6-benzoylamino)-purine-N9-β-2´-deoxyribonucleoside (42) as colourless 
crystals. The yield was slightly higher than found in the literature.93,146 The crystals 
turned out to be suitable for X-ray crystallography and two different crystal 
structures (42I and 42II) were obtained out of two different solvents.  
 
Figure 71: Crystal structure of 1-deaza-(6-benzoylamino)-purine-N9-β-2´-
deoxyribonucleoside · H2O (42I). 
 
In Figure 71 one can easily recognise the C2´-endo (2E) S-type conformation. The C5´-
O5´ points towards the ring and can be found in the +gauche or +sc conformation 
and the base is in the syn position. Three intramolecular H-bonds can be found in 
42I, O5´-H5´···N3, Ow-Hw1···N7 and N6-H6···Ow. The first two H-bonds have usual 
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lengths of 2.715(4)Å and 2.791(4)Å with bond angles of 170(3)° and 157(4)°, 
respectively. The third is a bit longer with 3.116(5)Å, but with an angle of 173(3)° it 
can still be regarded as H-bond. 
 
Figure 72: Crystal structure of 1-deaza-(6-benzoylamino)-purine-N9-β-2´-
deoxyribonucleoside · CH3OH (42II). 
 
The second crystal structure has identical conformations, as one would expect, since 
only one water molecule is substituted by one methanol. Also the same 
intramolecular H-bonds can be found, except that the O atom now belongs to the 
methanol. The O5´-H5´···N3 has a length of 2.771(5)Å with an angle of 177.5(2)° and 
the second H-bond, Om-Hm···N7, a length of 2.789(5)Å, with an angle of 155.5(2)°. 
Again, the third H-bond, N6-H6···Om, is a little bit longer with 3.034(5)Å and the 
angle is 164.9(3)°.  
Interestingly, a different packing pattern of 42I and 42II was found. Both have 
alternating stacking between one 1-deazapurine ring and the phenyl e ring of 
another molecule. Though, for 42I the 1-deazapurine ring and the phenyl ring of one 
molecule stack with a phenyl ring and a 1-deazapurine ring of another molecule. For 
42II the 1-deazapurine ring stacks with the phenyl ring of one molecule, and the 
phenyl ring with the 1-deazapurine of a third molecule. This leads to a zick zack of 
the stacking channels. The different channels build a zick zack chain and the different 
chains are connected through an H-bond of the O3´-H3´ with the O5´ atom of another 
molecule. The O3´-H3´···O5´ has a length of 2.786(5)Å and an angle of 158.1(3)°. For 
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42I also an H-bond between O3´-H3´and O5´ with a length of 2.818(4)Å and an angle 
of 178(3)° can be found. Therefore, one finds two stacking channels that are linked to 
other two stacking channels via the H-bonds from the sugars that are present to the 
left and to the right. There is connection through another H-bond, Ow-Hw2···O4´, 
with a bonding length of 3.042(4) and an angle of 175(5)° that links the water 
molecule with a neighbouring sugar ring of a neighbouring stacking channel. 
 
 42I 42II 
ν0 - 15.6(4)° - 19.4(5)° 
ν1 +30.4(4)° +34.2(5)° 
ν2 - 33.2(4)° - 35.7(5)° 
ν3 +24.4(4)° +25.1(5)° 
ν4 - 5.7(4)° - 4.0(5)° 
P 171° +167° 
 2E (S) 2E (S) 
νm 34° 37° 
γ +44.4(5)° +44.3(6)° 
 +sc, +gauche +sc, +gauche 
χ +57.5(5)° +53.7(6)° 
 syn syn 
 
Table 11: The endocyclic torsion angles (ν0-4) in the sugar ring to calculate the phase 
angle of pseudorotation (P) and the puckering amplitude (νm), the torsion angle (γ) 
for the conformation of C5´-O5´ compared to the sugar ring and the glycosidic bond 
angle (χ) are shown. 
 
42I and 42II have a conformation of the base in the crystal structures (N3 pointing 
toward the O5´ and N6 and N7 (the Hoogsteen side) pointing towards the possible 
base pairing partner) that is assumed to be formed in solution by 1-deazaadenine 
nucleoside (40). However, in the corresponding crystal structures of 40 this 
conformation could not be observed.146,164 Also, one has to mention that the bases 
stand in the right position for binding over the Hoogsteen side with the water and 
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the methanol molecules in the position, where one wants to find a metal ion, when 
the 1-deazaadenine nucleoside has been introduced into an oligonucleotide. 
Now the 1-deaza-(6-benzoylamino)-purine-N9-β-2´-deoxyribonucleoside (42) was 
protected at the O5´-position with the stericly bulky DMTr group. The obtained yield 
for the 1-deaza-(6-benzoylamino)-purine-N9-β-[2´-deoxy-5´-O-(4,4´-dimethoxytrityl)-
ribonucleoside] (43) was with 56% much lower than the 76% in the literature.93,146 The 
introduction of the phosphoramidite protecting group was, as mentioned already, 
done following a standard procedure. The addition of (i-Pr)2EtN and chloro-(2-
cyanoethoxy)-(diisopropylamino)-phosphane to the 1-deaza-(6-benzoylamino)-
purine-N9-β-[2´-deoxy-5´-O-(4,4´-dimethoxytrityl)-ribonucleoside] (43) dissolved in 
dry CH2Cl2 and stirring for an hour at r.t. gave the building block for the automated 
DNA-synthesizer, the 1-deaza-(6-benzoylamino)-purine-N9-β-[2´-deoxy-3´-O-(2-cy-
anoethyl)-N,N-diisopropylphosphoramidite-5´-O-(4,4´-dimethoxytrityl)-ribonucleo-
side] (44).93,146 
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Figure 73: Schematic diagram of the synthesis of the N6, O5´ and O3´-protected 
1-deazaadenine nucleotide (44). 
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No further work up was done for the same two reasons that were already mentioned 
for the 1-deazapurine nucleotides (33 and 34). Therefore the yield was calculated 
through the ratio of product to side product and the mean molar mass.  
The 1-deaza-(6-benzoylamino)-purine-N9-β-[2´-deoxy-3´-O-(2-cyanoethyl)-N,N-
diisopropylphosphoramidite-5´-O-(4,4´-dimethoxytrityl)-ribonucleoside] (44) could 
then be introduced to the automated DNA-synthesizer. The following 
oligonucleotide strand was synthesised with the 1-deazaadenine nucleoside as the 
artificial nucleobase (Z): 
 
(k) 5´-d(AZZ ZZZ ZZZ A) 
 
The strand (k) was synthesised in the DMTr-off mode, deprotected, purified over a 
reversed phase column (no collectable peak found in the ion-exchange column) 
(HPLC), desalted, lyophilised and the concentrations were calculated with the help 
of the Lambert-Beer Law. The very low absorptions in the UV-spectra that were 
hardly much higher than the absorption from the salt (from the column), lead to the 
assumption that the synthesis has not been successful. The MALDI-TOF spectra did 
not show a trace of oligonucleotide. Thinking about a reason for the unsuccessful 
synthesis one has to look at the stability of the intermediates with the protecting 
groups, but especially at the stability of the 1-deaza-(6-benzoylamino)-purine-N9-β-
2´-deoxyribonucleoside (42). It turned out to be depurinated upon the addition of 
trichloroacetic acid, which is used to deprotect the DMTr group during the 
automated DNA-synthesis. The depurination must have taken place in the matter of 
seconds, since in the 1H NMR spectra and in the observations with TLC the 1-deaza-
(6-benzoylamino)-purine-N9-β-2´-deoxyribonucleoside (42) in all cases was already 
depurinated. The known instability of the 1-deaza-(6-benzoylamino)-purine-N9-β-2´-
deoxyribo-nucleoside (42) is a strong reason for the unsuccessful DNA-synthesis.  
A new protecting group for the NH2 group was necessary. One that protects it and 
does not destabilise the glycosidic bond had been found with the methoxyacetyl 
residue.93,167,168 The reaction of the 1-deazaadenine nucleoside (40) with 
methoxyacetyl chloride afforded via peracylation, which was followed by selective 
deprotection of the sugar-protecting groups, the 1-deaza-(6-methoxyacetylamino)-
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purine-N9-β-2´-deoxyribo-nucleoside (45). Although the purification by flash 
chromatography was done differently, the yield was the same as in the literature.93,146 
The 1-deaza-(6-methoxyacetylamino)-purine-N9-β-2´-deoxyribonucleoside (45) is 
stable in trichloroacetic acid for at least an hour. This could be observed by taking 1H 
NMR spectra and doing TLC. Since the DNA-synthesiser uses the trichloroacetic acid 
for around two minutes to take off the DMTr protecting group, the methoxyacetyl 
protecting group should be suitable for our purposes.  
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Figure 74: Schematic diagram of the synthesis of the N6, O5´ and O3´-protected 
1-deazaadenine nucleotide (47). 
 
Then the 1-deaza-(6-methoxyacetylamino)-purine-N9-β-2´-deoxyribonucleoside (45) 
was protected at the O5´-position with the stericly bulky DMTr group. The obtained 
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yield for the 1-deaza-(6-methoxyacetylamino)-purine-N9-β-[2´-deoxy-5´-O-(4,4´-
dimethoxytrityl)-ribo-nucleoside] (46) was with 65% much lower than the 84% 
described in the literature, as it was found already for the 1-deaza-(6-benzoylamino)-
purine-N9-β-2´-deoxyribo-nucleoside (42).146 The introduction of the 
phosphoramidite protecting group was done following standard procedures.146 The 
addition of (i-Pr)2EtN and chloro-(2-cyanoethoxy)-(diisopropylamino)-phosphane to 
the 1-deaza-(6-methoxy-acetylamino)-purine-N9-β-[2´-deoxy-5´-O-(4,4´-dimethoxy-
trityl)-ribonucleoside] (46) dissolved in dry CH2Cl2 and stirring for an hour at r.t. 
gave the building block for the automated DNA-synthesizer, 1-deaza-(6-
methoxyacetylamino)-purine-N9-β-[2´-deoxy-3´-O-(2-cyanoethyl)-N,N-diisopropyl-
phosphoramidite-5´-O-(4,4´-dimethoxytrityl)-ribonucleoside] (47). No further work 
up was done for the same two reasons that were already mentioned for the 1-
deazapurine nucleotides (33 and 34). Therefore the yield was calculated through the 
ratio of product to side product and the mean molar mass. 
 
The 1-deaza-(6-methoxyacetylamino)-purine-N9-β-[2´-deoxy-3´-O-(2-cyanoethyl)-
N,N-diisopropylphosphoramidite-5´-O-(4,4´-dimethoxytrityl)-ribonucleoside] (47) 
could then be introduced to the automated DNA-synthesizer. 
The following oligonucleotide strands were synthesised with the 1-deazaadenine 
nucleoside as the artificial nucleobase (Z): 
 
(l) 5´-d(AZA ZAZ AZA)     ‹ 1% yield 
(m) 5´-d(ZZZ ZZZ ZZZ ZZZ ZZZ ZZZ ZA)  ‹ 1%  
 
Both strands (l and m) were synthesised in the DMTr-off mode, deprotected, purified 
over an ion-exchange column (HPLC), desalted, lyophilised and the concentration 
was determined with the help of the Lambert-Beer Law and finally the yield was 
calculated.  
The low yields can have many possible factors. The acid used to take off the DMTr 
protecting groups in the automated DNA-synthesizer could depurinate or denature 
the oligonucleotide or single artificial nucleobases, although one has tried to avoid 
this. The more artificial nucleosides were introduced the lower the yield, the broader 
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the peaks in the HPLC chromatogram and therefore the more difficult to distinguish 
between product and side product and to collect the product. An especially visible 
effect of loss in yield was observed at changes from natural nucleobases to artificial 
ones, as in 5´-d(AZA ZAZ AZA) (l). Another obvious factor is the length of the 
oligonucleotides; the longer the strand, the lower the yield. 
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4.4 Melting Curves 
(l) 5´-d(AZA ZAZ AZA) 
The strand (l) was primarily synthesised to test the ability of introducing Z into an 
oligonucleotide using the methoxyacetyl as protecting group for the NH2 group. The 
melting behaviour was observed with 5´-d(TTT TTT TTT TTT TTT) as possible 
complementary strand. The melting curves were done at the same buffer and strand 
conditions: 5mM MOPS (pH 6.8) and each strand 1µM. 150mM and 1M NaClO4 salt 
concentrations and as metal ion Ag+ was used. No melting behaviour at all was 
found, without or with Ag+. The reason for this could be the base Z that needs to 
bind over the Hoogsteen side, but due to the alternating adenine and 1-deazaadenine 
nucleobases (A and Z) it is very unlike to turn to that way. Another reason for this 
could be the length of the oligonucleotide. The metal ions must be strongly 
stabilising for the Z-T pairs in the 9-mer to get a melting behaviour in the detectable 
temperature range. The Tm for a thymine 15-mer with an adenine 15-mer is only 
36.1°C and considering the loss of six base pairs and a destabilising effect of the Z, 
due to the loss of a H-bond, the two strands are not necessarily expected to bind.  
 
(m) 5´-d(ZZZ ZZZ ZZZ ZZZ ZZZ ZZZ ZA) 
(m) should build out Z-T base pairs with a thymine 20-mer (n), as shown in Figure 75  
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Figure 75: Hoogsteen, a), and reverse Hoogsteen, b), binding of a Z-T base pair.93,146 
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and in the literature.93,146,167 Due to the missing N1 in Z, binding over the Hoogsteen 
side was expected to be favoured. But under the standard conditions we used (5mM 
MOPS (pH6.8), 1M NaClO4 and each strand 1µM) and even at high salt 
concentrations, the two strands did not show a cooperative melting behaviour.  
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Graph 17: Cooling and melting curves for 5´-d(ZZZ ZZZ ZZZ ZZZ ZZZ ZZZ ZA) 
(m) and 5´-d(TTT TTT TTT TTT TTT TTT TT) (n). 
 
However, the conditions chosen were comparable to the ones in the literature, except 
that a 5µM strand concentration was used.93 The lower strand concentrations could 
be a reason for not observing a cooperative melting behaviour, since the Tm for a 
double helix is concentration dependent. Though, these conditions are roughly 
standard conditions. Sometimes lower salt (1M is on the upper limit) or higher strand 
concentrations, as just mentioned, are used. The two strands (m) and (n) are probably 
building out double helices of different lengths upon cooling, since the self 
assembling for Hoogsteen base pairs is not as pronounced (smaller hypochromicity) 
as for the formation of Watson-Crick base pairs (larger hypochromicity). Upon the 
temperature rising slowly, the shorter double helices melt earlier than the longer 
ones, giving rise to single strands being present in the solution at lower temperature. 
These single strands can then, again, build longer double helices, leading overall to a 
non-cooperative melting behaviour. But upon the addition of Ag+, a cooperative 
melting behaviour starts to develop. This could be due to the Ag+ being able to 
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strengthen self assembling of (m) and (n). This increase in cooperativity of the 
melting behaviour can be seen nicely in Graph 18.  
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Graph 18: Melting curves of 5´-d(ZZZ ZZZ ZZZ ZZZ ZZZ ZZZ ZA) (m) and 5´-
d(TTT TTT TTT TTT TTT TTT TT) (n) with different equivalents of Ag+. 
 
Upon the addition of one equivalent Ag+ a hypochromicity effect can be observed; 
the hypochromocity roughly doubles. A Tm can be measured, when only half an 
equivalent of metal ion is present. Looking at Graph 19 it can be seen that the Tm 
does not rise further after the addition of one equivalent of Ag+ showing specificity 
(Z-Ag+-T) and that the Ag+ does not bind randomly (permanent increase in Tm). 
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Graph 19: Change of Tm/°C upon the addition of different equivalents of Ag+. 
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To gain information, whether other metal ions can also support the binding and 
therefore about the selectivity of Ag+, further melting curves with different metal 
ions would have to be measured. The two different possibilities of binding over the 
Hoogsteen side, which can not be distinguished with the data present, can be seen in 
Figure 76. 
 
N
N
N
N
N
sugar
N
O
O
H
H
T
Z
sugar
N
N
N
N
N
sugar
N
O
O
H
H
T
Z
sugar
a)
b)
1
3
3 7
9
6
4
1
3
3
7
9
6
4
2
2
= Ag+  
 
Figure 76: Hoogsteen, a), and reverse Hoogsteen, b), binding of a Z-T base pair with 
Ag+. 
 
To gather information about the structure and the actual binding more melting 
curves have to be taken, to exclude, for example, a self pairing of the 5´-d(ZZZ ZZZ 
ZZZ ZZZ ZZZ ZZZ ZA) (m)12,146,169 or 5´-d(TTT TTT TTT TTT TTT TTT TT) (n) 
with Ag+, as it has been observed before for 5´-d(TTT TTT TTT TTT TTT TT) (j). A 
measurement of 5´-d(TTT TTT TTT TTT TTT TTT TT) (n) with 5´-d(AAA AAA AAA 
AAA AAA AAA AA) with and without Ag+ would show how the Tm of a system with 
apparent Hoogsteen base pairs compares with a system of Watson-Crick base pairs. 
This could show whether one apparent H-bond and a metal-ligand bond can 
compete with two H-bonds in a natural duplex. A rough estimation for a comparison 
of the two systems could be: A double helix with 15 A-T base pairs has a Tm of 
around 36°C. These are around 2.4°C for one A-T base pair or two H-bonds with π-
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stacking interactions. A Tm of around 48°C has been found for a system with 5´-d(ZZZ 
ZZZ ZZZ ZZZ ZZZ ZZZ ZA) (m), 5´-d(TTT TTT TTT TTT TTT TTT TT) (n) and 
one equivalent Ag+. These are also around 2.4°C for one Z-T base pair. However, the 
two Tm values have a quite important difference. The first was obtained through a 
measurement at a low salt concentration (150mM) and the second at a high salt 
concentration (1M). Therefore one would expect the Watson-Crick base pairs to be 
more stable.  
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Figure 77: Possible double helix formation of 5´-d(ZZZ ZZZ ZZZ ZZZ ZZZ ZZZ ZA) 
(m) and 5´-d(TTT TTT TTT TTT TTT TTT TT) (n) without and with Ag+. 
 
With the data present one can not distinguish between parallel or anti-parallel 
binding. The one A-T base pair in the double helix is thought to bind over the 
Hoogsteen side, too. However, one can neither be certain of this, nor, whether a 
Results and Discussion        Chapter II 
 
113 
metal ion will also bind in-between this A-T base pair, or not. If one could increase 
the cooperativity of the melting behaviour of m with n without metal ions, it would 
lead to an increase in hyperchromicity and here-with to an existing Tm. One then 
would expect a double helix formation as shown above in Figure 77. 
For a better structural knowledge more data of this system have to be collected. CD-
spectra could give more information about a possible change in structure upon the 
addition of Ag+ or about the presence of a double helix without metal ions.  
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5 Summary and Discussion 
 
Synthesis of the nucleosides and their introduction into oligonucleotides: 
The synthesis of the two 1-deazapurine nucleosides (28 and 29 / Figure 78), starting 
off with the synthesis of 1-deazapurine (21) and followed by the reaction with 
Hoffer´s chlorosugar (25), was achieved in good yields. The appearance of alpha- and 
beta-anomers, could be solved partially by separating them using flash chromato-
graphy. The appearance of unwanted alpha-anomer, though, could not be hindered 
or even stopped. The deprotection steps to obtain the nucleosides, and the syntheses 
of the protected nucleotides (33 and 34) for the automated DNA-synthesizer were 
performed smoothly.   
The synthesis of the 1-deazaadenine nucleoside (40 / Figure 
78) was more challenging. The oxidation of 1-deazapurine 
(21) to the N3-oxide (35), the nitration and the reduction 
reaction gave the precursor 1-deaza-6-nitropurine (37). The 
ways of synthesising these products had to be altered and 
always to be done with great care to gain substantially good 
yields. Connecting the 1-deaza-6-nitropurine (37) to the 
Hoffer´s chlorosugar (N9-position) gave again the alpha-
anomer as side product (38a), which was separated, but no 
N7 side product was observed. Deprotection and amination 
reactions to obtain the 1-deazaadenine nucleoside (40) could 
be done with reasonable yields. With the 1-deaza-6-nitro-
purine nucleoside (39 / Figure 78) another potential artificial 
nucleobase was found. The protection of the NH2 group was 
done using benzoyl chloride at first, but the protecting group, 
unlike the description in the literature, was not found to be 
useable for the introduction of 1-deazaadenine nucleoside 
into an oligonucleotide. Surprisingly, it led to depurination 
with trichloroacetic acid in the DNA-synthesizer.          Figure 78: 28, 29, 39 
      and 40. 
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Therefore methoxy acetyl chloride was used. The next two protecting steps (DMTr / 
phosphoramidite) were done without any further surprises to obtain the protected 
nucleotide (47). 
All three nucleosides (28, 29 and 40), and their derivatives showed a high acid lability 
or the tendency under catalytical conditions to form the alpha-anomer. 
In no cases the phosphoramidites (33, 34 and 47) were purified by flash 
chromatography due to the lack of visibility of the side product. This could be one 
reason for the low yields that are obtained throughout the synthesis of the 
oligonucleotides. Finding new ways of purifying the phosphoramidites could give 
higher yields. Clearing the synthesised oligonucleotides off the solid phase 
(5min/r.t.) and deprotecting them (5min/65°C), was done with AMA. Using AMA 
twice to get the oligonucleotides off the solid phase improved the yield slightly. But, 
as experience has shown, the deprotection step has to be done over a longer period of 
time to really get all protecting groups off, especially for the cytosine and guanine. 
That is one reason probably that the modified Dickerson Drew strand (f) does not 
show any melting behaviour.  
All successfully purified oligonucleotides (a), (e)-(i), (l) and (m) were synthesised in 
the DMTr-off mode and were purified over an ion-exchange column. The problem 
herewith is the high salt concentration that has to be used and the broad peaks in the 
chromatograms that make it difficult to collect the product peak. The high salt 
concentrations damage the ion-exchange column, even with a protection column in 
front, quite rapidly, which leads to high purchasing costs. This could be avoided 
synthesising the oligonucleotides in the DMTr-on mode and purifying them over a 
reversed phase column. Attempts to synthesise in the DMTr-on mode and to use a 
reversed phase column were not successful. This is probably due to the 1-
deazaadenine nucleoside (Z) depurinating at the deprotection step with acetic acid. 
Though, for the 1-deazapurines (33 and 34) attempts should be made to test their 
stability in acetic acid, since the reversed phase column is much easier to work with 
and the life of the column much longer. Another factor for the low yields could be 
the HPLC itself. It is difficult to know, when exactly the collection of a product 
should take place, since the length of the way from the UV-detector to the collection 
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point and the time taken by an oligonucleotide for this way is yet unknown. Test 
runs with coloured substances could give a time value for the collection.  
 
Characterisation of the nucleosides, melting behaviour and structural knowledge: 
For all three nucleosides it could be shown that no competition between protonation 
and metallation reaction is expected. pKa values of 2.84 (28) and 3.26 (29) were found. 
Whereas the 1-deazapurine nucleosides (28 and 29) are stable at low pD values, the 
1-deazaadenine nucleoside (40) undergoes depurination at pD values lower than 5. 
The methyl derivatives of 1-deazapurine have higher pKa values than the α-anomers 
that themselves have higher values than the β-anomers. 
For the 1-deazapurine nucleosides (28 and 29) crystal structures were obtained and 
compared with each other and with the crystal structures of 1,3-deazapurine 
nucleoside (30), another potential artificial nucleobase that could also be crystallised. 
Although all had quite different sugar conformations, it should be mentioned that 
the bases were always found in the syn position.   
For the 1-deazapurine nucleoside (29) with the N7-glycosidic bond the titrations with 
different metal ions (Ni2+, Hg2+ and Cu2+) on the UV-spectrometer showed some 
changes in the absorbance, but the actual changes were quite small, so that it was 
difficult to say, whether bonding takes place. With Fe3+ a change in absorbance 
maxima and value was observed. Additionally the Job-Plot with Fe3+ shows the 
formation of a 2:1 complex giving rise to a possible X-Fe-X base pair (Figure 79). All 
other metal ions only formed a 1:1 complex. The synthesised strand, 5´-d(AAA AAA 
AXX XTT TTT TT) (a), had a melting behaviour, but upon the addition of metal 
ions, the Tm did not change. The actual Tm of 44°C though was larger than for an 
A15/T15 duplex with around 36°C. Therefore the formation of a double helix or a 
hairpin structure is possible, but with these data 
alone it can not be distinguished between the 
two. A study of the change of Tm upon the change 
in strand concentration would give a hint, since 
the Tm of a double helix is concentration 
dependent.                Figure 79: Possible binding of 29 
 with a metal ion. 
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For the 1-deazapurine nucleoside with the N9-glycosidic bond (28) the model struc-
ture [Hg(9-MeDP)2](NO3)2 · H2O (24) already showed the formation of a 2:1 complex. 
This was shown with the help of a crystal structure. A Job-Plot and a titration with 
Hg2+ and 1-deazapurine-N9-nucleoside (28) confirmed this nicely. Also the stability 
constants for the 1:1 and the 2:1 complex were calculated and were found to be in a 
suitable range compared to imidazole and triazole. The strands 5´-d(AAA AAA AYA 
AAA AAA) (g) and 5´-d(TTT TTT TYT TTT TTT) (h) were synthesised. The melting 
behaviour was observed having, next to the 14 A-T base pairs, different binding 
possibilities in the middle of the strand, such as A-Y, C-Y, G-Y and T-Y. Not 
amazingly suprising, the Tm dropped sometimes even dramatically, when a mispair 
was positioned in the middle base pair, so that one could not speak of a distinct 
melting behaviour. Upon the addition of one equivalent of Ag+ for cytosine, as one of 
the bases in a base pair, an increase in Tm was observed. For a Y-Y base pair a large 
increase was observed, but this increase was found to be even larger with guanine or 
cytosine as base pairing partner. All other nucleobases did not show a stabilising 
effect upon the addition of Ag+. Further addition of Ag+ raised the Tm of the systems 
only marginally. This was a first indication of Y being able to build metal-mediated 
base pairs (Figure 80). However, it is not possible from these data to relate neither to 
the conformation of the helices nor to the bonding between the nucleobases. Further 
research on the melting behaviour with other metal ions or with different artificial 
nucleobases, such as the X (29) or an imidazole nucleoside must be undertaken to get 
more information about possible artificial or natural base pairing partners and the 
specificity of certain metal ions for possible artificial or natural nucleobases. Taking 
the double helices with a large increase in Tm upon the addition of Ag+ and 
measuring CD-spectra of them would give additional structural knowledge about 
the individual systems. One would expect the A-T base pairs to bond over the 
Watson-Crick side and that 
the strands are antiparallel, 
as it is common for A-T rich 
double helices under the 
used conditions.       Figure 80: An example of an artificial Ag+-mediated G-Y 
       base pair in a 15-mer with 14 natural A-T base pairs. 
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Furthermore, with the 1-deazapurine-N9-nucleoside the strand 5´-d(YYY YYY YYY 
YYY YYY YA) (i) was synthesised. Primarily, it was prepared to observe the beha-
viour of the strand with a thymine strand of equal length (j). This was then meant to 
be compared with the 1-deazaadenine nucleoside (40) in a 20-mer (m) and its melting 
behaviour with a thymine 20-mer (n). Due to the ability of 5´-d(TTT TTT TTT TTT 
TTT TT) (j) to bind Ag+, the possibility of a competitive reaction could not be exclu-
ded. Therefore the self assembling of the strand 5´-d(YYY YYY YYY YYY YYY YA) 
(i) was studied, but, as expected, in the absence of metal ions it showed no coopera-
tive melting. Then it was looked at the melting behaviour of the strand (i) with Ag+. 
An increase in hypochromicity, cooperativity of the melting and a Tm were found up-
on the addition of Ag+. The increase in Tm of around 17°C was observed at roughly 
0.5 equivalents of Ag+ added. Addition of more equivalents did not show a further 
increase, which shows a certain specificity. 16 Ag+ for four strands or 8 Ag+ for two 
strands are needed to saturate the system and employ melting behaviour (Figure 81).  
In the CD-spectra it was shown that there is no structural difference without and 
with Ag+, showing some kind of organisation even without metal ion being present. 
A structural difference between the melted strands and the organised strands can be 
seen, but it is not a large effect. A possible explanation for all these effects is the 
formation of a double helix that is formed by π-stacking interactions and that is 
barely stable. The added Ag+ can then bind in the middle between two Ys and 
stabilise the double helix. Due to possible repulsion between two Ag+ not all base 
pairs have a metal ion, but every second.  
The high symmetry of the system rules out possible NMR measurements, but 
crystallography could be a good method to gather further information about the 
structure, the base pairing and the position of the Ag+ in the base pair. The limitation 
at this point is the low yield of this strand synthesised. The difference in melting 
behaviour upon the 
addition of different 
metal ions would be 
another interesting point.  
Figure 81: An example of a possible double helix with an  
       artificial Ag+-mediated Y-Y base pair in a 17-mer. 
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The 5´-d(ZZZ ZZZ ZZZ ZZZ ZZZ ZZZ ZA) (m) was synthesised in the hope to form 
a double helix with 5´-d(TTT TTT TTT TTT TTT TTT TT) (n). The 1-deazaadenine 
(Z) as nucleobase should bind over the Hoogsteen side to a thymine. The melting be-
haviour was measured, but no cooperative melting behaviour was observed without 
metal ion. Upon the addition of one equivalent Ag+ a cooperative melting behaviour, 
a Tm and a hypochromicity effect could be observed. After the addition of one equi-
valent Ag+ no further change in melting behaviour was observed, which shows some 
kind of specificity (Figure 82). Under the conditions measured the H-bonds do not 
seem to be strong enough to give cooperative melting, which could explain the small 
linear increase in the melting curve without metal ion. The two strands bind partially 
(a few base pairs) or fully and a slow increase in temperature breaks some of the base 
pairs of the partially bound strands. The single strands at lower temperatures can re-
organise and form again partially or fully binding helices with more base pairs pre-
sent. Hence no cooperative melting is observed. For 
further information about the structure (double helix, 
parallel or anti parallel), and the actual binding of the 
nucleobases (Hoogsteen or reverse Hoogsteen) other 
measurements are necessary. CD-spectra could give 
information about a possible change in structure upon the 
addition of metal ions. The two strands have to be tested 
each separately and together on their melting behaviour 
with metal ions. Assumable the thymine seems to bind to 
the Ag+ only, if no stronger binding possibilities are 
present. This would mean that possibly the 5´-d(YYY YYY 
YYY YYY YYY YA) (i) would show a melting behaviour 
with 5´-d(TTT TTT TTT TTT TTT TT) (j) upon the 
addition of Ag+ or even Hg2+ and this should be looked at. 
The idea of introducing metal ions into the inside of a 
double helix, however, has been strengthened trough the 
results obtained.  
Figure 82: A possibly formed double helix  
through artificial Ag+-mediated Z-T base pairs. 
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D Experimental Section 
 
1 Instrumentation and Methods 
 
Starting materials 
 
The chemicals used were purchased from Sigma-Aldrich, ABCR, Fluka or Acros or 
were present in the laboratory facilities of the University of Dortmund, if not stated 
otherwise. 
Following oligonucleotides, containing only natural nucleobases, were purchased 
from EuroGenTec:  
5´-d(AAA AAA ATA AAA AAA) 
5´-d(AAA AAA ACA AAA AAA) 
5´-d(AAA AAA AGA AAA AAA) 
5´-d(CTT TTG) 
5´-d(TTT TTT TAT TTT TTT) 
5´-d(TTT TTT TCT TTT TTT) 
5´-d(TTT TTT TGT TTT TTT) 
5´-d(TTT TTT TTT TTT TTT TT) 
5´-d(TTT TTT TTT TTT TTT TTT TT) 
 
Solvents 
 
Pyridine was dried over molecular sieves. CH3CN, CH2Cl2 and CHCl3 were freshly 
distilled over CaH2. CH3OH was freshly distilled over Mg. Et2O was dried over Na. 
All other solvents were used as purchased by Roth, Sigma-Aldrich, ABCR, Fluka or 
Acros. 
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Flash Column Chromatography and TLC 
 
TLC analyses were carried out with the use of pre-coated TLC plates 60 F254 
purchased from Fluka and were visualized in UV light (254nm) and sometimes 
additionally a colourising agent was used (2.5g molybdophosphoric acid, 1g cerium 
sulphate, 6ml conc. H2SO4 and 94ml H2O). The silica gel (0.040-0.063mm) used for 
column chromatography was purchased from Merck. The solvents for the column 
chromatography were used as purchased. 
 
Elemental Analyses 
 
Microanalyses were measured on a Leco CHNS 932 instrument. 
 
NMR-Spectroscopy 
 
1H and 13C NMR spectra were recorded on Varian Mercury 200 (200.13MHz) and 
Bruker DRX 400 (400.13MHz) spectrometers. 31P spectra were recorded on a Varian 
Mercury 200 (80.98MHz) instrument and 195Pt NMR and 199Hg NMR spectra were 
recorded on a Bruker DPX 300 instrument (64.4MHz and 53.51MHz, respectively). 
Chemical shifts (δ in ppm) were referenced to internal sodium 3-(trimethylsilyl)-
propanesulfonate (1H, D2O, δ = 0 ppm), tetramethylsilane (1H, MeOD and CDCl3, δ = 
0 ppm), external dimethylmercury (199Hg, D2O, δ = 0 ppm) or to external K2PtCl6 
(195Pt, δ = 0 ppm). Spectra in DMSO-d6 were referenced to residual DMSO-d5 at 
2.5ppm. All deuterated solvents were purchased from Deutero. 
NOESY-spectra were recorded on Bruker DRX 400 (400.13MHZ) at 300.1K with 
mixing times between 0.5 and 1.5 seconds. 
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MS-Measurement 
 
For the MS measurements a JOEL JMS_SX 102A was used. As matrix for the FAB 
measurements 3-nitrobenzylalcohol was used. 
 
pH / pD Measurements 
 
The pH-values of aqueous solutions were measured with a Model inoLab Level 1 
made by Wissenschaftliche Technische Werkstätten (WTW) with a glas electrode 
Model pH Electrode SemTix 81 pH 0…14/0-100°C/3 mol/L KCl of the 
Wissenschaftliche Technische Werkstätten (WTW). 
pD-values of D2O solutions were obtained by adding 0.4 to the pH meter reading.170 
The pKa values in H2O were calculated from the pKa* values according to 
pKa* = 1.015pKa + 0.45.171 
For the adjustment of the pD value DNO3 or NaOD solutions in different 
concentrations were added. 
 
Job-Plots with Hg2+ 
 
For the Job-Plots the method of continuous variation was used.134-137 The change in 
chemical shift (Δδppm) was observed with the help of 1H NMR at different mole 
fractions (χ) of ligand (nucleoside) and Mn+.  
The nucleoside solution was prepared by dissolving 6.0mg (25.5µmol)                        
1-deazapurine-N9-β-2´-deoxyribonucleoside in 600µl buffer solution (pD 5, 100mM 
sodium acetate/acetic acid in D2O/TSP) to give a 42.5mM solution. The metal ion 
solution was done by dissolving 25.4mg (59.5µmol) Hg(CF3COO)2 in 1400µl of the 
same buffer solution (pD 5, 100mM sodium acetate/acetic acid in D2O/TSP) to give 
an equally molar solution. 
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For 1-deazapurine-N7-β-2´-deoxyribonucleoside 3.1mg (13.0µmol) were dissolved in 
600µl buffer solution (pD 7, 60µl 1M triethylammonium acetate/540µl D2O/TSP) to 
give a 21.7mM solution. For the metal ion solution 14.3mg (33.5µmol) Hg(CF3COO)2 
were dissolved in 1528µl of the same buffer solution (pD 7, 153µl 1M 
triethylammonium acetate/1375µl D2O/TSP) to give an equally molar solution. 
 
1H NMR χnucleoside χmetal ion solutionnucleoside solutionmetal ion 
1 1 / 600µl / 
2 0.9 0.1 - 60µl + 60µl 
3 0.8 0.2 - 67µl + 67µl 
4 0.7 0.3 - 75µl + 75µl 
5 0.6 0.4 - 86µl + 86µl 
6 0.5 0.5 - 100µl + 100µl 
7 0.4 0.6 - 120µl + 120µl 
8 0.3 0.7 - 150µl + 150µl 
9 0.2 0.8 - 200µl + 200µl 
10 0.1 0.9 -300µl + 300µl 
Job-Plot method 
 
Titrations with Mn+ 
 
The titrations with Mn+ were done with the help of 1H NMR (400MHz) or UV 
spectroscopy. The changes in chemical shift (Δδppm) or in absorbance (range of 
wavelength: 190-350nm) were observed upon the addition of different equivalents 
Mn+ to a fixed amount of ligand (nucleoside).  
For the titration with the help of 1H NMR spectroscopy, the nucleoside solution was 
prepared by dissolving 4.2mg (18µmol) 1-deazapurine-N9-β-2´-deoxyribonucleoside 
in 600µl buffer solution (pD 5.0, 100mM sodium acetate/acetic acid in D2O/TSP) to 
give a 30.0mM solution.  
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For the measurement at pD 7.0, the nucleoside solution was prepared by dissolving 
5.5mg (23µmol) 1-deazapurine-N9-β-2´-deoxyribonucleoside in 600µl buffer solution 
(100mM triethylammonium acetate in D2O/TSP) to give a 39mM solution. 
The metal ion solutions were prepared, so that 5µl equaled 0.05 equivalents. As metal 
salt Hg(CF3COO)2 was used.  
For the measurements on the UV spectrometer, the nucleoside solution was prepared 
by dissolving 2.1mg (8.93µmol) 1-deazapurine-N7-β-2´-deoxyribonucleoside in 
1000µl CH3OH and diluting the solution by a factor of 100 gave an 89.3µM solution. 
The metal ion solutions were prepared, so that 20µl equaled one equivalent. 
Following metal salts were used: CuCl2•2H2O, FeCl3•6H2O, HgCl2, NiCl2•6H2O and 
ZnCl2. 
 
Stability Constants 
 
The stability constants were calculated with the help of the EQNMR programme.138 
The data used, were the chemical shifts (δppm), the concentration of the metal ion 
([Mn+]) and the concentration of the ligand (nucleoside/[L]). 
 
X-ray Crystallography 
 
Crystal data were collected at 150K or at 293K on an Enraf-Nonius-KappaCCD 
diffractometer using graphite-monochromated MoKα radiation (λ = 0.71069Å). For 
data reduction and cell refinement, a Bruker-Nonius HKL 2000 Suite and the DENZO 
and SCALE-PACK172 was used. The measurements for 28b, 29b, 30, 37, 42I and 42II 
were done by Dipl.-Chem. E. Gil Bardaji, for 7, 10, 11 and 35 by Dr. Eva Freisinger 
and for 24 by Dr. M. Roitzsch. All structures were solved by standard Patterson 
methods or by direct methods and were refined by full-matrix least squares methods 
based on F2 using the SHELXTL PLUS,173 SHELXL-97174 and WinGX175 programs. In 
the refinement process of the X-ray data, if not specified, all non-hydrogen atoms of 
the crystals were refined anisotropically. 
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DNA-Synthesizer 
 
For the syntheses of the modified DNA strands a synthesizer from Beckman, Model 
OLIGO 1000M, was used. The reagents used were purchased from Glen Research. 
Columns for a 1000nM synthesis from Beckman were used and the synthesizer 
worked with the phosphoramidite method. The synthesizer always started 
synthesizing at the solid support end at the 3´-position, where a natural nucleobase 
sits.  
The syntheses were performed in the DMTr-off mode, except for the strands 5´-d(AAA 
AAA AXA AAA AAA) and 5´-d(TTT TTT TXT TTT TTT) where the DMTr-on mode 
was used. After the synthesis the oligonucleotides were cleaved off the solid support 
and deprotected using 1ml of AMA (≤10% NH4OH and ≥90% CH3NH2) for 5min at 
r.t. and for 5min at 65°C. Afterwards the AMA could be removed under vacuum.  
 
High-Pressure (Performance)-Liquid-Chromatography (HPLC) 
 
Two high-pressure-pumps (model 1525) and a UV-detector (model 2487) from 
Waters were used, as well as the software Breeze (Version 3.20). A column 
thermostat (Jet stream 2 Plus) from Knauer was used and it was worked with 
temperatures between 25°C (r.t.) and 60°C. 
The ion-exchange column used was purchased from Macherey-Nagel (Model EC 
125/4 Nucleogen 60-7) and a precursor column (Model CC 30/4 Nucleogen) was 
used to protect the ion-exchange column. The flow rate used was at 1 to 1.5ml/min 
and the UV-detection was done at 260nm. For the ion-exchange column the solvent A 
was prepared by adding 1.31g (0.02mol) of sodium acetate to 800ml of H2O, bringing 
the pH down to 6 using acetic acid and adding 200ml of HPLC grade CH3CN. 
Solvent A with 84.78g (2mol) of LiCl gave solvent B.  
The reversed phase column used was purchased from Waters (Model Symmetry® C18 
5μm 4.6 x 150mm) and no precursor column was used. The flow rate was between 0.7 
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and 1.5ml/min and the UV-detection was done at 260nm. Solvent A was Et3NHOAc 
(0.05M) at pH 7 in H2O and solvent B was HPLC grade CH3CN. 
All solvents were filtered and degassed prior to use. 
 
Desalting 
 
To desalt the DNA solutions after HPLC treatment, a NAPTM 5 or NAPTM 10 column 
(SephadexTM G-25 DNA Grade contains 0.15% Kathon® CG as preservative) 
purchased from Amersham Biosciences or a Waters OASIS® Sample Extraction 
Products column purchased from Waters was used.  
 
UV/Vis-Spectroscopy 
 
UV-spectra were recorded on a Cary 100 spectrophotometer. 
To determine the concentrations of the DNA solutions, the absorption at 260 nm was 
used in the Lambert-Beer law (E260nm = ε c d, where distance d = 1cm). The extinction 
coefficient ε of the DNA strand equals the sum of the individual extinction 
coefficients multiplied with the correction factor, f, for the stacking interactions (0.9 
for a single stranded DNA strand).  
ε = f * Σniεi 
 
The ε values for the natural nucleobases are known, but for the synthesised 
nucleobases this value can be calculated by measuring the absorption of a known 
concentration of the nucleoside. 
ε = E260nm/c 
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 ε-values 
Adenine (A) 15.4cm2/μmol 
Cytosine (C) 7.3cm2/μmol 
Guanine (G) 11.7cm2/μmol 
Thymine (T) 8.8cm2/μmol 
1-Deazapurine-N7 (X) 3.3cm2/μmol 
1-Deazapurine-N9 (Y) 3.3cm2/μmol 
1-Deazaadenine (Z) 11.5cm2/μmol 
ε-values for the nucleosides 
 
Thermal Denaturation 
 
The melting studies were carried out in 1cm path length quartz cells from Varian 
(CELL STOP SMICRO/total volume 1ml; 0.9ml sample volume) on a Cary 100 
spectrophotometer equipped with a thermo-programmer. Melting curves were 
monitored at 260nm with a heating rate of 1°C/min. Melting temperatures were 
calculated as the first derivatives of the heating curves. 
 
MALDI-TOF 
 
The MALDI-TOF spectra were measured at a Voyager-DETM Pro Biospectrometry 
Workstation Spectrometer from the Perseptive Biosystems Company. As matrix 3-
hydroxypicolinic acid (5mg, 100µl H2O, 100µl CH3CN, 12.5µl ammonium citrate 
solution (50mg/ml)) was used. 
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2 General Work Description 
If methods from the literature are slightly modified, it will be stated. If the methods 
differ from methods in the literature, the yield is stated for comparison. 
2.1 Chapter I  
 
1-Methyltetrazole and 2-Methyltetrazole (2 and 3) 
N N
NN
1
2
5
   
N N
NN
1
2
5
 
This is a slightly modified version of the synthesis in the literature.72 
Deprotonation with NaH: 
Under argon 5.27g (75.2mmol) tetrazole are dissolved in 100ml CH3CN at 35°C. The 
solution is stirred and carefully 3.61g (75.2mmol) NaH (60% in oil) are added. The 
reaction mixture is stirred for two hours at r.t. and then evaporated to dryness to give 
a white solid, that is washed with 15ml n-hexane (3x). The solid is dried over night at 
40°C to give 6.92g (75.2mmol) sodium tetrazolate. 
1H-NMR (200MHz, DMSO-d6, δ in ppm): δ 8.01 (s, 1H, H5). 
 
Methylation of sodium tetrazolate with CH3I: 
To a suspension of 6.92g (75.2mmol) sodium tetrazolate in 40.0ml CH3CN, 4.66ml 
(75.2mmol) CH3I are added dropwise at -15°C. The suspension is heated up to 100°C 
and stirred for one hour. Then the solvent is evaporated and the residue extracted 
with 50ml CH2Cl2 (3x). The solution is evaporated to dryness to give yellowish 
brown oil, which is purified with the help of a Kugelrohr (ball-tube) distillation 
under reduced pressure (oil pump). At 20-50°C a fraction of clean 2-methyltetrazole 
is obtained and between 50°C and 75°C a mixture of 1-methyltetrazole (2) and 2-
methyltetrazole (3) is found. At temperatures higher then 75°C, 1.09g (13.0mmol) 1-
methyltetrazole (2) are obtained (17%, ref.: 58%)72; 2 : 1H-NMR (200MHz, DMSO-d6, δ 
in ppm): 9.32 (s, 1H, H5), 4.10 (s, 3H, CH3); 3: 8.94 (s, 1H, H5), 4.38 (s, 3H, CH3). 
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 [(trpy)PdCl]Cl•2H2O (4) 
N
N
N
PdIICl
+
1
2
3
4
6
5
1´
2´ 3´
4´
5´6´1´´
2´´
3´´
4´´
5´´
6´´
 
A suspension of 114mg (0.400mmol) [(COD)PdCl2] in 10ml H2O is stirred at r.t. and 
94.0mg (0.403mmol) 2,2´:6´,2´´-terpyridine are added. After roughly 15min stirring 
not reacted [(COD)PdCl2] and Pd0 are filtered off and the solution is evaporated to 
dryness. The yellow brown solid is washed with 20ml Et2O (3x) to give 174mg 
(0.386mmol) [(trpy)PdCl]Cl•2H2O (98%); 1H-NMR (200MHz, DMSO-d6, δ in ppm): 
8.73 (dd, 2H, H6, H6´´), 8.69-8.61 (m, 5H, H3, H3´, H3´´, H4´ and H5´), 8.47 (dt, 2H, 
H4, H4´´), 7.89 (dd, 2H, H5, H5´´); elemental analysis calc. (%) for 
C15H11N3Cl2Pd•2H2O (M = 450.92g/mol): C 40.3, H 3.4, N 9.4; found: C 40.0, H 3.1, N 
9.1. 
 
[(trpy)PtCl]Cl•2H2O (5) 
N
N
N
PtIICl
+
1
2
3
4
6
5
1´
2´ 3´
4´
5´6´1´´
2´´
3´´
4´´
5´´
6´´
 
This is a slightly modified version of the synthesis in the literature.73 
A suspension of 150mg (0.400mmol) [(COD)PtCl2] in 10ml H2O is stirred at 40-50°C 
and 93.6mg (0.399mmol) 2,2´:6´,2´´-terpyridine are added. After roughly 15min 
stirring excess [(COD)PtCl2] is filtered off and the yellow red solution is evaporated 
to dryness. The residue is washed with 20ml Et2O (3x) to give 155mg (0.287mmol) 
[(trpy)PtCl]Cl•2H2O as a red solid (73%, ref.: 98%)73; 1H-NMR (200MHz, DMSO-d6, δ 
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in ppm): 8.91 (dd, 2H, 2 x H6), 8.69-8.62 (m, 5H, H3, H3´, H3´´, H4´ and H5´), 8.47 (dt, 
2H, H4, H4´´), 7.95 (ddd, 2H, H5, H5´´); elemental analysis calc. (%) for 
C15H11N3Cl2Pt•2H2O (M = 539.58g/mol): C 33.7, H 2.8, N 7.9; found: C 34.1, H 2.7, N 
7.8. 
 
[(trpy)2Pd2(1-mtetate)](ClO4)3 (6) 
 
To a solution of 46.1mg (0.548mmol) 1-methyltetrazole and 33.1mg (0.195mmol) 
AgNO3 in 5ml H2O a suspension of 47.0mg (0.105mmol) [(trpy)PdCl]Cl•2H2O in 5ml 
H2O is added at r.t. The solution is then stirred in the dark for one day at 40°C. The 
resulting yellow suspension is filtered over celite and the pH-value of the solution is 
changed from 4.5 to 9.0 using a NaOH solution (0.1M). Then 5ml NaClO4 solution 
(0.25M) are added to the yellow solution. Up to a few millilitres the solution is 
evaporated, whereby a slight yellow solid precipitates. For complete precipitation the 
solution is stored at 4°C for three days. The solid is filtered off and re-crystallised 
from H2O to yield 15mg of [(trpy)2Pd2(1-mtetate)](ClO4)3 (27%). 1H-NMR (200MHz, 
DMSO-d6, δ in ppm): 8.64 (m, 6H, 2 x H3´, 2 x H4´, 2 x H5´), 8.61 (dt, 4H, 2 x H3 and 2 
x H3´´), 8.44-8.39 (m, 4H, 2 x H4 and 2 x H4´´), 8.18 (m, 4H, 2 x H6 and 2 x H6´´), 7.66-
7.56 (m, 4H, 2 x H5 and 2 x H5´´), 4.51 (s, 3H, CH3). 
 
[(trpy)Pt(1-mtetate)](ClO4) (7) 
N
N
N
PtII
2+
N
N
N
N
1
5
 
A solution containing of 18.2mg (0.216mmol) 1-methyltetrazole and 67.5mg 
(0.397mmol) AgNO3 in 5ml H2O is stirred at 60°C in the dark. To this solution a 
suspension of 108.3mg (0.202mmol) [(trpy)PtCl]Cl•2H2O in 5ml H2O is added. The 
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solution is then stirred in the dark for three days at 60°C. The pH-value of the red 
suspension is then changed from 2.8 to 9.0 using NaOH solution (0.1M) and the 
suspenion is stirred in the dark for three days at 60°C. Now, the suspension is filtred 
over celite and 5ml NaClO4 solution (0.25M) are added to the yellow solution. For 
precipitation of the product the solution is stored at 4°C for three days. The yellow 
solid, that precipitates, is filtered off and re-crystallised from H2O to yield 10.3mg of 
[(trpy)Pt(1-mtetate)](ClO4) (8%). 1H-NMR (200MHz, DMSO-d6, δ in ppm): 8.77-8.73 
(m, 5H, H3, H3´, H3´´, H4´, H5´), 8.51 (dt, 2H, H4, H4´´), 8.17 (dd, 2H, H6, H6´´), 7.78 
(ddd, 2H, H5, H5´´), 4.15 (s, 3H, CH3); 195Pt NMR (DMSO-d6, δ in ppm): -2760; 
elemental analysis calc. (%) for C17H14N7O4ClPt (M = 610.89g/mol): C 33.4, H 2.3, N 
16.1; found: C 32.5, H 2.1, N 16.0. 
 
 [(trpy)Pd(2-mtet)](ClO4)2 (8) 
 
To a solution of 16.9mg (0.2mmol) 2-methyltetrazole and 66.0mg (0.4mmol) AgNO3 
in 5ml H2O a suspension of 90.1mg (0.2mmol) [(trpy)PdCl]Cl•2H2O in 5ml H2O is 
added at r.t. The solution is then stirred in the dark for one day at 40°C. The resulting 
yellow suspension is filtered over celite and the pH-value of the solution is changed 
from 4.5 to 9.0 using NaOH solution (0.1M), whereby the yellow colour becomes 
more intensive. Then 5ml NaClO4 solution (0.25M) are added to the yellow solution. 
Up to a few millilitres the solution is evaporated and for complete precipitation the 
solution is stored at 4°C for one day. The solid is filtered off and dried over night at 
40°C. The 1H-NMR shows only the starting complex, [(trpy)PdCl]Cl•2H2O, and no 
product at all. 
 
[(trpy)Pt(2-mtet)](ClO4)2 (9) 
 
A solution containing of 17.4mg (0.2mmol) 2-methyltetrazole and 67.1mg (0.4mmol) 
AgNO3 in 5ml H2O is stirred at 60°C in the dark. To this solution a suspension of 
107.7mg (0.2mmol) [(trpy)PtCl]Cl•2H2O in 5ml H2O is added. The solution is then 
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stirred in the dark for three days at 60°C. The pH-value of the red suspension is then 
changed from 2.7 to 8.9 using NaOH solution (0.1M) and the suspension is stirred in 
the dark for a further three days at 60°C. Now, the suspension is filtered over celite 
and 5ml NaClO4 solution (0.25M) are added to the solution, whereby a solid precipi-
tates. For complete precipitation of the product the solution is stored at 4°C for three 
days. The orange red solid is filtered off and dried over night at 40°C. The 1H-NMR 
shows only the starting complex, [(trpy)PtCl]Cl•2H2O, and no product at all. 
 
[(trpy)Pd(1-mimi)](ClO4)2 (10) 
N
N
N
PdII
2+
N
N
1
3
 
To a solution of 15.9μl (0.200mmol) 1-methylimidazole and 67.5mg (0.397mmol) 
AgNO3 in 5ml H2O a suspension of 89.0mg (0.200mmol) [(trpy)PdCl]Cl•2H2O in 8ml 
H2O is added at r.t. The solution is then stirred in the dark for one day at 40°C. The 
resulting orange suspension is filtered over celite and the pH-value of the solution is 
changed from 8.3 to 9.0 using NaOH solution (0.1M). The solution is evaporated to 
half its volume and 5ml NaClO4 solution (0.5M) are added, whereby immediately a 
solid precipitates. For complete precipitation the solution is stored at 4°C for a couple 
of days. The solid is filtered off and re-crystallised in H2O to give 57.2mg 
(0.092mmol) [(trpy)Pd(1-mimi)](ClO4)2 as compact orange cubes (46%); 1H-NMR 
(200MHz, DMSO-d6, δ in ppm): 8.73-8.71 (m, 6H, H3, H3´, H3´´, H4´, H5´) 8.64 (s, 1H, 
H2(1-mimi)), 8.52 (dt, 2H, H4, H4´´), 7.83-7.81 (m, 4H, H5, H5´´, H6, H6´´), 7.76 (d, 1H, 
H5(1-mimi)), 7.59 (d, 1H, H4(1-mimi)), 3.91 (s, 3H, CH3); elemental analysis calc. (%) for 
C19H17N5O8Cl2Pd (M = 620.69g/mol): C 36.8, H 2.8, N 11.3; found: C 36.8, H 2.6, N 
11.4. 
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[(trpy)Pt(1-mimi)](ClO4)2 (11) 
N
N
N
PtII
2+
N
N
1
3
 
A solution containing of 7.90μl (0.100mmol) 1-methylimidazole and 33.7mg 
(0.198mmol) AgNO3 in 5ml H2O is stirred. To this solution a suspension of 53.5mg 
(0.100mmol) [(trpy)PtCl]Cl•2H2O in 5ml H2O is added. The solution is then stirred in 
the dark for three days at 60°C. The pH-value of the suspension is then changed from 
8.0 to 9.0 using NaOH solution (0.1M) and the suspension is stirred in the dark for a 
further three days at 60°C. Now, the suspension is filtered over celite and 5ml 
NaClO4 solution (0.5M) are added, whereafter a yellow precipitates starts to form. 
For complete precipitation of the product the solution is stored at 4°C for one day. 
The yellow solid is filtered off and re-crystallised in H2O. After a few days 23.3mg 
(32.8µmol) [(trpy)Pt(1-mimi)](ClO4)2 fall out in form of yellow sticks (33%); 1H-NMR 
(400MHz, DMSO-d6, δ in ppm):  8.76-8.69 (m, 6H, H3, H3´, H3´´, H4´, H5´ and H2(1-
mimi)), 8.57 (dt, 2H, H4, H4´´), 8.02 (dd, 2H, H6, H6´´), 7.89 (ddd, 2H, H5, H5´´), 7.84 (d, 
1H, H5(1-mimi)), 7.63 (d, 1H, H4(1-mimi)), 3.94 (s, 3H, CH3); 195Pt NMR (DMSO-d6, δ in 
ppm): -2858; elemental analysis calc. (%) for C19H17N5O8Cl2Pt (M = 709.35g/mol): C 
32.2, H 2.4, N 9.9; found: C 32.2, H 2.4, N 10.0. 
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Dimethyl 3-methylpentanedioate (13) 
O
O
O
O
1 2 3 4 5  
This is a slightly modified version of the synthesis in the literature.78 
A mixture of 250mg (1.30mmol) p-TsOH, 25.0g (170mmol) of 3-methylpentanedioic 
acid, 8.50ml (210mmol) CH3OH and 34.5g (340mmol) 2,2-dimethoxypropane is 
heated to 45°C and stirred for twelve hours. Then the solvents are evaporated and 
the residue is distilled under vacuum (Tm = 113°C/water pump) to give 25.7g 
(147mmol) dimethyl 3-methylpentanedioate as a light yellow oil (87%, ref.: 81%)78; 
1H- NMR (200MHz, CDCl3/TMS, δ in ppm): 3.61 (s, 2 x 3H, 2 x OCH3), 2.50-2.10 (m, 
5H, CH2CHCH2), 0.96 (d, 3H, CH3); 13C-NMR (200MHz, CDCl3/TMS): 172.7 (Cq), 50.5 
(OCH3), 40.6 (CH2), 27.4 (CH), 19.9 (CH3). 
 
1,5-Bis(2-pyridyl)-3-methylpentane-1,5-dione (14) 
OO
1 2 3 4 5
N N
 
This is a slightly modified version of the synthesis in the literature.78 
In a 500ml round bottom flask 300ml dry THF are cooled down to -78°C under an 
argon atmosphere. Now 20.5ml (137mmol) TMEDA are added and then 85.5ml 
(137mmol) n-BuLi (1.6M in hexane) are added drop wise. After further drop wise 
addition of 13.0ml (137mmol) 2-bromopyridine the temperature is raised to -55°C 
and the mixture is stirred for 30min, whereas it becomes yellow. The temperature is 
dropped to -78°C again and 10.0g (57.0mmol) dimethyl 3-methylpentanedioate are 
added and the mixture becomes red. After stirring the mixture for one hour, it is 
hydrolysed with 100ml H2O and the orange mixture is evaporated to dryness. The 
residue is dissolved in 100ml HCl solution (20%) and washed with 100ml CH2Cl2. 
The H2O phase is neutralised with 125ml NaOH solution (20%), whereby the product 
falls out as dark red oil. Then the product gets extracted with 100ml CH2Cl2 (4x) and 
the organic phase is dried over Na2SO4, filtered and evaporated to dryness. After 
flash chromatography over silica gel (12 x 7cm, CH2Cl2 (9) : EtOAc (1)) 4.17g 
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(15.5mmol) of brown 1,5-bis(2-pyridyl)-3-methylpentane-1,5-dione are obtained 
(27%, ref. 41%)78; 1H-NMR (200MHz, CDCl3 / TMS, δ in ppm): 8.63 (m, 2H, H6 and 
H6´´), 8.02 (td, 2H, H3 and H3´), 7.81 (dt, 2H, H4 and H4´), 7.44 (ddd, 2H, H5 and 
H5´), 3.29 (m, 4H, CH2CHCH2), 2.92 (septet, 1H, CH2CHCH2), 1.10 (d, 3H, CH3). 
 
4´-Methyl-2,2´:6´,2´´-terpyridine (15) 
N
N N
4´
2
6´2´
1
2´´
1´´  
This is a slightly modified version of the synthesis in the literature.78 
In a 500ml round bottom flask 4.17g (15.5mmol) 1,5-bis(2-pyridyl)-3-methylpentane-
1,5-dione are dissolved in 215ml acetic acid (98-100%) and 10.4g (135mmol) 
ammonium acetate are added. The mixture is heated under reflux (120°C) for two 
hours, whereby the colour changes from orange over green to dark red. Then the 
mixture is evaporated to dryness and the residue is dissolved in 200ml NaOH 
solution (10%). The H2O phase gets extracted with 150ml CH2Cl2 (3x) and the organic 
phase is dried over Na2SO4, filtered and evaporated to dryness. To the residue 50ml 
n-heptane are added and the round bottom flask is put into the ultrasonic apparatus 
for 10min at 40°C. Then the mixture is left in the refrigerator (-18°C) for 10min. The 
yellow n-heptane is decanted and evaporated. The work up procedure with the n-
heptane is done six times in total and 3.51g (14.2mmol) slightly yellow 4´-methyl-
2,2´:6´,2´´-terpyridine are obtained (91%, ref.: 76%)78; 1H-NMR (200MHz, 
CDCl3/TMS, δ in ppm): 8.71 (qd, 2H, H6 and H6´´), 8.63 (td, 2H, H3 and H3´´), 8.31 
(d, 2H, H3´ and H5´), 7.87 (dt, 2H, H4 and H4´´), 7.34 (ddd, 2H, H5 and H5´´), 2.54 (s, 
3H, CH3); elemental analysis calc. (%) for C16H13N3 (M =247.30g/mol): C 77.7, H 5.3, 
N 17.0; found: C 76.3, H 5.5, N 16.3. 
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4´-(Carboxaldehyde)-2,2´:6´,2´´-terpyridine (17) 
N
N N
4´
2
6´2´
1
2´´
1´´
O
 
This is a slightly modified version of the synthesis in the literature.79 
In a 500ml round bottom flask 2.17g (8.78mmol) 4´-methyl-2,2´:6´,2´´-terpyridine are 
dissolved in 220ml acetic acid (98-100%), 2.01g (18.1mmol) SeO2 are added and the 
mixture is refluxed (120°C) for 43h. Then a tip of chelating resin is added, the mixture 
is filtered to remove the gray selenium metal and the solution is evaporated to 
dryness. The residue is neutralised with 100ml NaOH solution (20%). The aqueous 
phase is extracted three times with 150ml CHCl3, the organic phase is dried over 
Na2SO4 and then evaporated. Then 2.50g of a dark green product are obtained (4´-
methyl-2,2´:6´,2´´-terpyridine (4) : 4´-carboxyaldehyde-2,2´:6´,2´´-terpyridine (1)) and 
used without further workup for the preparation of 18. 1H-NMR (200MHz, 
CDCl3/TMS, δ in ppm): 8.90 (d, 2H, H3´ and H5´), 8.76 (qd, 2H, H6 and H6´´), 8.64 
(td, 2H, H3 and H3´´), 7.91 (dt, 2H, H4 and H4´´), 7.40 (ddd, 2H, H5 and H5´´), δ 5.31 
(s, 1H, CH). 
 
4´-(Hydroxymethyl)-2,2´:6´,2´´-terpyridine (18) 
N
N N
4´
2
6´2´
1
2´´
1´´
HO
 
In a 250ml round bottom flask 2.50 g of a mixture of 4´-methyl-2,2´:6´,2´´-terpyridine 
(2.0g, 8.09mmol) and 4´-carboxyaldehyde-2,2´:6´,2´´-terpyridine (0.50g, 1.91mmol) 
and 240mg (6.36mmol) NaBH4 are dissolved in 120ml dry THF under argon and stir-
red at 0°C for one hour. The solvent is evaporated and the resulting yellow solid is 
dissolved in 200ml EtOAc using an ultrasonic apparatus. The organic phase gets 
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washed with 50ml saturated NaCl solution (3x) and the aqueous phase is then 
washed with 100ml EtOAc. The combined organic phases are evaporated. To the 
residue 100ml n-heptane are added and the round bottom flask is put into the ultra-
sonic apparatus for 10min at 40°C. Then the suspension is left in the refrigerator (-
18°C) for 10min. The n-heptane is decanted (product still in the round bottom flask) 
and evaporated to give 4´-methyl-2,2´:6´,2´´-terpyridine. To the residual solid 100ml 
CH2Cl2 are added and the suspension is centrifuged. The solution is decanted (pro-
duct) and the solid is again extracted with 100ml CH2Cl2. The CH2Cl2 phases are 
combined and evaporated. To the residue 50ml n-heptane are added again and the 
round bottom flask is put into the ultrasonic apparatus for 10min at 40°C. Then the 
suspension is left in the refrigerator (-18°C) for 10min. The n-heptane is decanted 
(product still in the round bottom flask) and evaporated to give 4´-methyl-2,2´:6´,2´´-
terpyridine. This extraction with n-heptane is done four times, whereby the last two 
times the n-heptane is not decanted, but filtered off. The n-heptane is evaporated to 
give 4´-methyl-2,2´:6´,2´´-terpyridine. The remaining orange solid is 175mg (665µmol) 
clean 4´-hydroxymethyl-2,2´:6´,2´´-terpyridine (35%, ref.: 85%)83. 1H-NMR (200MHz, 
CDCl3/TMS, δ in ppm): 8.74 (d, 2H, H3´ and H5´), 8.76 (qd, 2H, H6 and H6´´), 8.64 
(td, 2H, H3 and H3´´), 7.91 (dt, 2H, H4 and H4´´), 7.40 (ddd, 2H, H5 and H5´´), 4.93 (s, 
2H, CH2). 
 
4´-(Bromomethyl)-2,2´:6´,2´´-terpyridine (19) 
N
N N
4´
2
6´2´
1
2´´
1´´
Br
 
In a 50ml round bottom flask 138mg (520µmol) 4´-hydroxymethyl-2,2´:6´,2´´-
terpyridine are dissolved in 4.0ml CH2Cl2 and to the solution 347mg (1.05mmol) CBr4 
are added. The solution is cooled to 0°C and 151mg (580µmol) triphenylphosphane 
are added in several portions over 15min. Then the solution is stirred for 30min at 
0°C and for 30min at r.t. The solution is directly poured onto a silica gel column (6 x 
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2.5cm) and eluted off the column with CH2Cl2 and EtOAc (250ml CH2Cl2 / 300ml 
EtOAc/ flashed with CH3OH). First the 4´-bromomethyl-2,2´:6´,2´´-terpyridine is 
eluted, then the triphenylphosphaneoxide. Mixed fractions are further purified with 
flash chromatography over silica gel (2cm x 2.5cm / 200ml fractions of only CH2Cl2 / 
CH2Cl2 (5) : EtOAc (1) in full steps down to 2 : 1). From the 4´-bromomethyl-
2,2´:6´,2´´-terpyridine 63.2mg (190µmol) are obtained (37%, ref.: 40%)83. 1H-NMR 
(200MHz, CDCl3/TMS, δ in ppm): 8.71 (qd, 2H, H6 and H6´´), 8.62 (td, 2H, H3 and 
H3´´), 8.49 (s, 2H, H3´ and H5´), 7.87 (dt, 2H, H4 and H4´´), 7.35 (ddd, 2H, H5 and 
H5´´), 4.57 (s, 2H, CH2Br); 13C-NMR (200MHz, CDCl3 / TMS, δ in ppm): 149.0 (C6 
and C6´´), 137.1 (C4 and C4´´), 124.1 (C3 and C3´´), 121.4 (C5 and C5´´), 120.9 (C3´ 
and C5´), 30.9 (CH2Br); elemental analysis calc. (%) for C16H12N3Br (M = 
326.20g/mol): C 58.9, H 3.7, N 12.9; found: C 57.2, H 3.6, N 12.5. 
 
DMTr-(S)-glycidol (20) 
O
O
O
O
 
In a 50ml round bottom flask a mixture of 12.5ml dry CH2Cl2 and 2.0ml of Et3N is 
stirred and 356μl (5.10mmol) (R)-glycidol are added. Additionally 2.11g (6.20mmol) 
DMTr-Cl are added. The mixture is stirred for 40min at r.t., whereby the colour of the 
solution changes from orange to green. Then the suspension is filtered and the 
solution is washed with 10ml H2O. The organic phase is dried over Na2SO4, filtered 
off and evaporated. Chromatographic purification over silica gel (16 x 2.5cm / n-
hexane (18) : EtOAc (1) : Et3N (1)) gives 333mg (880µmol) DMTr-(S)-glycidol (17%, 
ref.: 65%). 1H-NMR (200MHz, DMSO-d6): 6.9 and 7.3 (m, 13H, aryl), 3.7 (s, 2 x 3H, 2 x 
OCH3), 3.3 and 3.4 (2 x d, 2H, CH2ODMTr), 3.1 (m, 1H, CH), 2.7 and 2.9 (2 x m, 2H, 
CH2 (endocyclic)); elemental analysis calc. (%) for C24H24O4 (M = 376.452g/mol): C 
76.6, H 6.4; found: C 75.0, H 6.5; FAB-MS calc. (M/Z): 377.175; found: 376.432. 
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2.2 Chapter II 
 
1-Deazapurine (21) 
N NH
N1
2
3
6 7
8
9  
This is a slightly modified version of the synthesis in the literature.106 
A mixture of 5.0g (46mmol) 2,3-diaminopyridine and 100ml freshly distilled triethyl 
orthoformate is stirred at reflux (128-130°C) for three hours. The solution is 
evaporated to dryness in vacuo (60°C) and the residue is stirred at reflux (ca. 50°C) 
for one hour after having been dissolved in 50ml of concentrated HCl. After letting 
the mixture cool down to r.t., it is carefully neutralized with solid Na2CO3•10H2O 
(vigorous reaction!). Using a liquid-liquid extractor, the mixture is extracted with 
EtOAc over night. The organic phase gets dried over Na2SO4, filtered and evaporated 
to dryness. The residue is dissolved in 50 ml absolute CH3CH2OH, treated with 
charcoal, and heated at reflux (ca. 80°C) over night. The charcoal is filtered off and 
the solvent evaporated until needles start to fall out of the solution. Now the solution 
is stored over night at 4°C and at the next morning the slight yellow needles are 
filtered off and dried at 40°C to give 3.8g (32mmol) 1-deazapurine (70%, ref.: 73%)106; 
1H-NMR (200MHz, DMSO-d6, δ in ppm): 12.94 (br, 1H, N7/9H), 8.44 (s, 1H, H8), 8.35 
(dd, 1H, H2), 8.02 (dd, 1H, H6), 7.23 (dd, 1H, H1); elemental analysis calc. (%) for 
C6H5N3 (M = 119.12g/mol): C 60.5, H 4.2, N 35.3; found: C 60.2, H 3.9, N 35.0. 
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1-Deaza-9-methylpurine and 1-Deaza-7-methylpurine (22 and 23)  
N N
N
9
   
7
N N
N
 
In 30ml dry DMF 1.04g (8.69mmol) 1-deazapurine and 207mg (8.63mmol) NaH 
(emulsion in mineral oil, washed with dry diethyl ether) are dissolved and the clear 
solution is cooled to 0°C and stirred for 90min. After addition of 639µl (10.1mmol) 
CH3I, the reaction is allowed to proceed until the ice bath reaches ambient 
temperature (ca. two and a half hours). The DMF is then removed by vacuum 
distillation (oil pump) at 35 °C, and the crude product is purified by flash 
chromatography over silica gel (19 x 4cm, EtOH) to give 345mg (2.59 mmol) 1-deaza-
9-methylpurine (30%) and 212mg (1.59 mmol) 1-deaza-7-methylpurine (18%). Re-
crystallization from CHCl3 gives hygroscopic white foams. 1-deaza-9-methylpurine: 
1H-NMR (200MHz, D2O, pD 6.6, δ in ppm):  8.14 (d, 1H, H2), 8.10 (s, 1H, H8), 7.88 (d, 
1H, H6), 7.20 (dd, 1H, H1), 3.71 (s, 3H, CH3); elemental analysis calc. (%) for 
C7H7N3•0.83H2O (M = 148.11g/mol): C 56.7, H 5.9, N 28.4; found: C 56.7, H 5.9, N 
28.4; 1-deaza-7-methylpurine: 1H-NMR (200MHz, D2O, pD 5.6, δ in ppm): 8.32 (d, 1H, 
H2), 8.19 (s, 1H, H8), 7.83 (d, 1H, H6), 7.27 (dd, 1H, H1), 3.79 (s, 3H, CH3); elemental 
analysis calc. (%) for C7H7N3•4.1H2O (M = 207.03g/mol): C 40.6, H 7.4, N 20.3; found: 
C 40.6, H 6.4, N 20.0. 
 
[Hg(1-deaza-9-methylpurine)2](NO3)2•H2O (24) 
N
N
N
N
N
N HgII
2+
9
9
7
7
 
To a solution of 45.0mg (0.37mmol) 9-methyl-1-deazapurine in 1ml H2O 250µl of a 
0.74mM solution of Hg(CF3COO)2 in H2O (0.19mmol) and 200µl of a 2.2mM solution 
of NaNO3 in H2O (0.44mmol) are added. After one day, colourless crystals of [Hg(1-
deaza-9-methylpurine)2](NO3)2•H2O are found. Upon drying at 40 °C overnight, 
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[Hg(1-deaza-9-methyl-purine)2](NO3)2•H2O looses its water of crystallization to give 
54.0mg (91.0µmol) [Hg(1-deaza-9-methylpurine)2](NO3)2 (50%). 1H NMR (200MHz, 
D2O, pD 4.0, δ in ppm): 9.16 (s, 1H, H8), 8.72 (d, 1H, H2), 8.59 (d, 1H, H6), 7.73 (dd, 
1H, H1), 4.18 (s, 3H, CH3); 199Hg NMR (53.51MHz, D2O, pD 4.0, δ in ppm): -1948; 
elemental analysis calc. (%) for C14H14HgN8O6 (M = 484.91g/mol): C 28.5, H 2.4, N 
19.0; found: C 28.3, H 2.6, N 19.0. 
 
1-Deazapurine-N9(N7)-β(α)-[2´-deoxy-3´,5´-di-O-(p-toluoyl)-
ribonucleoside] (26 and 27) 
O
O
N
N
N
9
α/β
O
O
O
5´
3´
O
O
N
N
N
7
α/β
O
O
O
5´
3´
 
In a 250ml round bottom flask 1.97g (16.6mmol) 1-deazapurine are added to 211ml 
dry CH3CN and stirred at r.t. To the yellow suspension 857mg (21.4mmol) NaH (60% 
in oil) are added and the reaction mixture is stirred for 30min at r.t. Now the cloudy 
white/yellow suspension is cooled down to 0°C and 8.25g (21.2mmol) Hoffer´s 
chlorosugar are added in portions within one hour. The suspension is stirred for 
three hours at 0°C and then the solvent is evaporated. The oily suspension is purified 
by flash chromatography over silica gel (25 x 2.5cm, EtOAc (20) : CH3OH (1) : CHCl3 
(3)) to give 4.10g (8.70mmol) 1-deazapurine-N9-β(α)-[2´-deoxy-3´,5´-di-O-(p-toluoyl)-
ribonucleoside] (53%, ref.: 48%)113 and 2.00g (4.24mmol) 1-deazapurine-N7-β(α)-[2´-
deoxy-3´,5´-di-O(p-toluoyl)-ribonucleoside] (26%, ref.: 29%)113(overall yield: 79%, ref.: 
77%)113; 1H-NMR (200MHz, CDCl3/TMS, δ in ppm) 1-deazapurine-N9-β(α)-[2´-
deoxy-3´,5´-di-O-(p-toluoyl)-ribonucleoside]: 8.46 (s, 1H (only alpha), H8), 8.40 (8.40) 
(dd, 1H, H2), 8.25 (s, 1H (only beta), H8), 8.08 (8.11) (dd, 1H, H6), 8.02-7.89 (8.02-7.89) 
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(m, 4H (alpha 3H), p-Tol), 7.61 (m, 1H (only alpha), p-Tol), 7.34-7.24 (7.34-7.24) (m, 
4H, p-Tol), 7.21 (7.21) (dd, 1H, H1), 6.69 (6.78) (pt, 1H, H1´), 5.83 (5.73) (m, 1H, H3´), 
(4.93) (m, 1H (only alpha), H4´), 4.75-4.62 (4.75-4.62) (m, 1H (only beta), H4´; 2H, H5 
and H5´), 3.2-2.8 (3.2-2.8) (m, 2H, H2´ and H2´´), 2.46 and 2.43 (2.44 and 2.41) (2 x s, 2 
x 3H, 2 x p-Tol CH3); 1H-NMR (200MHz, CDCl3/TMS, δ in ppm) 1-deazapurine-N7-
β(α)-[2´-deoxy-3´,5´-di-O-(p-toluoyl)-ribonucleoside]:  8.56 (8.61) (dd, 1H, H2), 8.46 (s, 
1H (only alpha), H8), 8.32 (s, 1H (only beta), H8), 8.04-7.91 (8.04-7.91) (m, 1H, H6), 
8.00-7.84 (8.00-7.84) (m, 4H (alpha 3H), p-Tol), (7.74) (m, 1H (only alpha), p-Tol), 7.33-
7.19 (7.33-7.19) (m, 4H, p-Tol), 7.06 (7.21) (dd, 1H, H1), 6.38 (6.47) (pt, 1H, H1´), 5.74 
(5.74) (m, 1H, H3´), 4.80-4.60 (4.80-4.60) (m, 1H, H4´; 2H, H5 and H5´), 3.2-2.7 (3.2-2.7) 
(m, 2H, H2´ and H2´´), 2.45 and 2.42 (2.43 and 2.40) (2 x s, 2 x 3H, 2 x p-Tol CH3); 
elemental analysis calc. (%) for C27H25N3O5 (α and β) (M = 471.50g/mol); C 68.8, H 
5.4, N 8.9; found: C 68.1, H 6.1, N 8.1.  
 
1-Deazapurine-N9-β(α)-2´-deoxyribonucleoside (28b and 28a) 
O
HO
N
N
N
9β
HO  
O
HO
HO
9
N
N
N
α
 
In a 250ml round bottom flask 4.1g (8.7mmol) 1-deazapurine-N9-β(α)-[2´-deoxy-3´,5´-
di-O-(p-toluoyl)-ribonucleoside] are dissolved in 10ml CH3OH and under stirring 
and at r.t. 65ml of a saturated NH3/CH3OH solution are added. The yellow solution 
is stirred and the reaction is monitored by TLC. After 92h and 15min the solvent is 
evaporated off. The oily suspension is purified by flash chromatography over silica 
gel (40 x 7cm, CH2Cl2 (9) : CH3OH (1)) to give 920mg (3.9mmol) 1-deazapurine-N9-β-
2´-deoxyribonucleoside (45%, ref.: 90%)113 and 240mg (1.0mmol) α/β (12%) and 
560mg (2.4mmol) 1-deazapurine-N9-α-2´-deoxyribonucleoside (27%) (overall yield: 
84%); 1H-NMR (200MHz, D2O/TSP, pD 5.8, δ in ppm) 1-deazapurine-N9-β-2´-
deoxyribonucleoside:  8.54 (s, 1H, H8), 8.36 (d, 1H, H2), 8.14 (d, 1H, H6), 7.41 (dd, 1H, 
H1), 6.59 (pt, 1H, H1´), 4.67 (m, 1H, H3´), 4.21 (m, 1H, H4´), 3.82 (m, 2H, H5´ and 
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H5´´), 2.97-2.51 (m, 2H, H2´ and H2´´); 1H-NMR (200MHz, D2O/TSP, pD 6.5, δ in 
ppm) 1-deazapurine-N9-α-2´-deoxyribonucleoside: 8.63 (s, 1H, H8), 8.40 (d, 1H, H2), 
8.18 (d, 1H, H6), 7.44 (dd, 1H, H1), 6.60 (pt, 1H, H1´), 4.56 (m, 1H, H3´), 4.39 (m, 1H, 
H4´), 3.73 (m, 2H, H5´ and H5´´), 2.98 and 2.62 (m, 2H, H2´ and H2´´); elemental 
analysis calc. (%) for C11H13N3O3 (β) (M = 235.24g/mol): C 56.2, H 5.6, N 17.9; found: 
C 56.3, H, 5.5; N, 18.2; FAB-MS calc. value (M/Z): 236.1035; found for β: 236.1056. 
 
1-Deazapurine-N7-β(α)-2´-deoxyribonucleoside (29b and 29a) 
O
HO
N
N
N
7β
HO   
O
HO
HO
7
N
N
N
α
 
In a 100ml round bottom flask 2.0g (4.2mmol) 1-deazapurine-N7-β(α)-[2´-deoxy-3´,5´-
di-O-(p-toluoyl)-ribonucleoside] are dissolved in 25ml CH3OH and while stirring 
55ml of a saturated NH3/CH3OH solution are added. The reaction is monitored by 
TLC (CH2Cl2 (9) : CH3OH (1)). The yellow solution is stirred for 88h 35min and 
evaporated to dryness. The yellowish foam gets purified by flash chromatography 
over silica gel (20 x 2.5cm, CH2Cl2 (8) : CH3OH (2) : Et3N (1)) to give 419mg 
(1.78mmol) 1-deazapurine-N7-β-2´-deoxyribonucleoside (42%) and 315mg 
(1.34mmol) 1-deazapurine-N7-α-2´-deoxyribonucleoside (32%) (overall yield: 74%, 
ref.: 72%); 1H-NMR (200MHz, D2O/TSP, pD 5.0, δ in ppm) 1-deazapurine-N7-β(α)-
2´-deoxyribonucleoside: 8.65 (8.60) (s, 1H, H8), 8.43 (8.43) (dd, 1H, H2), 8.16 (8.12) (m, 
1H, H6), 7.39 (7.39) (dd, 1H, H1), 6.47 (6.47) (pt, 1H, H1´), 4.57 (4.65) (dt, 1H, H3´), 
4.32 (4.15) (dt, 1H, H4´), 3.79 (3.79) (ddd, 2H, H5 and H5´), 2.90-2.54 (3.00-2.64) (m, 
2H, H2´ and H2´´); FAB-MS calc. (M/Z): 236.1035; found for α and β: 236.1053. 
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1-Deazapurine-N9-β-[2´-deoxy-5´-O-(4,4´-dimethoxytrityl)-
ribonucleoside]•0.5H2O (31) 
O
O
N
N
N
HO
O
O
5´
 
In a 50ml round bottom flask 499mg (2.12mmol) 1-deazapurine-N9-β-2´-
deoxyribonucleoside are dissolved in 27.5ml dry pyridine under argon atmosphere. 
To the slightly yellow solution 1.37g (4.04mmol) of DMTr-Cl and a catalytical 
amount of DMAP are added and the orange solution is stirred for four hours at r.t. 
under argon atmosphere. Over the time a little bit of solid (pyridinium chloride) falls 
out. Then the reaction mixture is quenched by adding 41.0ml NaHCO3 solution (5%) 
and the resulting orange solution with a white solid is extracted three times with 
CH2Cl2. The organic phase is dried over Na2SO4 for two hours, filtered and 
evaporated. The yellowish foam is purified by flash chromatography over silica gel 
(33 x 2.5cm, CH2Cl2 (95) : CH3OH (5)) to give 729mg (1.36mmol) 1-deazapurine-N9-β-
[2´-deoxy-5´-O-(4,4´-dimethoxytrityl)-ribonucleoside] as a white solid (63%); 1H-
NMR (200MHz, CDCl3/TSP, δ in ppm): 8.39 (dd, 1H, H2), 8.36 (s, 1H, H8), 8.17 (dd, 
1H, H6), 7.34 (dd, 1H, H1), 7.31-7.25 (m, 5H, (CH3O)2Tr), 7.21-7.14 (m, 4H, 
(CH3O)2Tr), 6.87-6.79 (m, 4H, (CH3O)2Tr), 6.46 (dd, 1H, H1´), 4.84 (m, 1H, H3´), 4.25 
(dt, 1H, H4´), 3.80 (2 x s, 2 x 3H, Tr-(OCH3)2), 3.81-4.01 (m, 2H, H5´ and H5´´), 3.25-
3.11 and 2.43-2.32 (m, 2H, H2´ and H2´´); elemental analysis calc. (%) for 
C32H31N3O5•0.5H2O (M = 547.70g/mol): C 70.3, H 5.9, N, 7.7; found: C 70.4, H 5.6, N 
7.6; FAB-MS calc. (M/Z): 538.2342; found: 538.2370. 
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1-Deazapurine-N7-β-[2´-deoxy-5´-O-(4,4´-dimethoxytrityl)-
ribonucleoside] (32) 
O
O
N
N
N
HO
O
O
5´
 
In a 50ml round bottom flask and under argon atmosphere 201mg (0.85mmol) 1-
deazapurine-N7-β-2´-deoxyribonucleoside are dissolved in 11.0ml dry pyridine. 
Now 576mg (1.70mmol) DMTr-Cl and a catalytical amount of DMAP are added and 
the slightly yellow solution is stirred for three hours. Then the reaction is quenched 
by 16.0ml NaHCO3 solution (5%) and the solution is stirred for a further 20min. 
Extraction with CH2Cl2 (1 x 50ml and 2 x 30ml), drying of the organic phase over 
Na2SO4 and evaporation give a yellowish foam, which gets purified by flash 
chromatography over silica gel (15 x 2.5cm, CH2Cl2 (95) : CH3OH (5)) to give  290mg 
(0.54mmol) of 1-deazapurine-N7-β-[2´-deoxy-5´-O-(4,4´-dimethoxytrityl)-ribonucleo-
side] as a white foam (63.5%). 1H-NMR (400MHz, CDCl3/TMS, δ in ppm): 8.40 (dd, 
1H, H2), 8.35 (s, 1H, H8), 7.98 (dd, 1H, H6), 7.33-7.08 (m, 9H, (CH3O)2Tr), 6.96 (dd, 
1H, H1), 6.68 (m, 4H, (CH3O)2Tr), 6.40 (pt, 1H, H1´), 4.87 (m, 1H, H3´), 4.23 (dt, 1H, 
H4´), 3.67 (2 x s, 2 x 3H, Tr-(OCH3)2), 3.35 (m, 2H, H5´ and H5´´), 2.57-2.78 (m, 2H, 
H2´ and H2´´); FAB-MS calc. (M/Z): 538.2342; found: 538.2356. 
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1-Deazapurine-N9-β-[2´-deoxy-3´-O-(2-cyanoethyl)-N,N-
diisopropylphosphoramidite-5´-O-(4,4´-dimethoxytrityl)-
ribonucleoside] (33) 
O
O
N
N
N
O
O
O
3´
P
N O N
 
In a 100ml round bottom flask 290mg (529µmol) 1-deazapurine-N9-β-[2´-deoxy-5´-O-
(4,4´-dimethoxytrityl)-ribonucleoside] are dissolved in 19.3ml dry CH2Cl2 under an 
argon atmosphere. Now, 710µl (4.08mmol) (i-Pr)2EtN and 180µl (809µmol) chloro-(2-
cyanoethoxy)-(diisopropylamino)-phosphane are added and the reaction mixture is 
stirred for one hour at r.t. The solution is quenched with 38.0ml saturated NaHCO3 
solution and extracted with CH2Cl2. The organic solvents are dried over Na2SO4 for 
one hour, filtered and evaporated. The product was not purified further and the 
yield was quantitative. Yellow syrup of 1-deazapurine-N9-β-[2´-deoxy-3´-O-(2-
cyanoethyl)-N,N-diisopropylphosphoramidite-5´-O-(4,4´-dimethoxytrityl)-ribo-
nucleoside]; 1H-NMR (200MHz, CDCl3/TMS, δ in ppm): 8.48 (s, 1H, H8), 8.26 (d, 1H, 
H2), 7.99 (d, 1H, H6), 7.37-7.14 (m, 9H, (CH3O)2Tr; 1H, H1), 6.71 (m, 4H, (CH3O)2Tr), 
6.52 (pt, 1H, H1´), 4.71 (m, 1H, H3´), 4.24 (m, 1H, H4´), 3.79-3.26 (m, 2H, H5´ and 
H5´´) 3.70 (2 x s, 2 x 3H, 2 x Tr-OCH3), 2.93-2.37 (m, 2H, H2´ and H2´´; 4H 
CH2CH2CN), 1.23-1.03 (m, 14H, 2 x (CH3)2CH); 31P-NMR (80.98MHz, CDCl3, δ in 
ppm): 149.8 and 149.7 (product), 15.3 ((2-cyanoethoxy)-(diisopropylamino)-
phosphane oxide); FAB-MS calc. (M/Z): 738.3420; found: 738.3430. 
 
Experimental Section        Chapter II 
 
147 
1-Deazapurine-N7-β-[2´-deoxy-3´-O-(2-cyanoethyl)-N,N-diisopropyl-
phosphoramidite-5´-O-(4,4´-dimethoxytrityl)-ribonucleoside] (34) 
O
O
N
N
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O
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P
N O N
 
In a 50ml round bottom flask and under argon atmosphere 180mg (340µmol)              
1-deazapurine-N7-β-[2´-deoxy-5´-O-(4,4´-dimethoxytrityl)-ribonucleoside] are dis-
solved in 12.0ml dry CH2Cl2. Now, 441μl (2.53mmol) (i-Pr)2EtN and 112μl 
(0.50mmol) chloro-(2-cyanoethoxy)-(diisopropylamino)-phosphane are added and 
the solution becomes slightly yellow. The solution is stirred for one hour and then 
diluted with 40.0ml EtOAc and quenched with 24.0ml saturated NaHCO3 solution. 
After addition of 50.0ml CH2Cl2 and 20.0ml H2O the organic phase is taken off, dried 
over Na2SO4 and evaporated. The yellow-brown oil is not worked up further. The 
yield of the product is calculated through the ratio of product to side product in the 
NMR spectra and the mean molar mass. The side product is the hydrolysed 
protecting group that does not interfere with the synthesis in the DNA-synthesizer. 
Raw mass = 290.0mg 
Ratio: product (0.59) : side product (0.41) 
Mean molar mass = molar mass (product) x 0.59 + molar mass (side product) x 0.41 
⇒ Mean molar mass = 534.80g/mol 
⇒ Medium moles = 553µmol 
Mass (product) = medium moles x molar mass (product) x ratio (product) 
⇒ Mass (product) = 241mg (326µmol) (97%) 
1H-NMR (200MHz, CDCl3/TMS, δ in ppm):  8.55 (d, 1H, H2), 8.26 (s, 1H, H8),  7.93 
(d, 1H, H6), 7.26 (m, 9H, (CH3O)2Tr), 6.99 (m, 1H, H1), 6.75 (m, 4H, (CH3O)2Tr), 6.29 
(pt, 1H, H1´), 4.73 (m, 1H, H3´), 4.29 (m, 1H, H4´), 3.80-3.30 (m, 2H, H5´ and H5´´) 
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3.77 (2 x s, 2 x 3H, Tr-OCH3), 2.80-2.50 (m, 2H, H2´ and H2´´; 4H, CH2CH2CN), 1.30-
1.08 (m, 14H, 2 x (CH3)2CH); 31P-NMR (80.98MHz, CDCl3, δ in ppm): 149.8 and 149.7 
(product), 15.3 ((2-cyanoethoxy)-(diisopropylamino)-phosphane oxide); FAB-MS 
calc. (M/Z): 738.3420; found: 738.3435. 
 
Oligonucleotides (X = 1-deazapurine-N7 nucleoside) 
 
(a) 5´-d(AAA AAA AXX XTT TTT TT) 
(b) 5´-d(AAA AAA AXX XXT TTT TTT) 
(c) 5´-d(AAA AAA AXA AAA AAA) 
(d) 5´-d(TTT TTT TXT TTT TTT) 
 
The 290.0mg (240.6mg / 0.326mmol product) 1-deazapurine-N7-β-[2´-deoxy-3´-O-(2-
cyanoethyl)-N,N-diisopropylphosphoramidite-5´-O-(4,4´-dimethoxy-trityl)-ribo-
nucleoside] are dissolved in 3.26ml dry CH3CN to give a 100mM solution that can be 
used in the oligonucleotide synthesis at the DNA-synthesizer. 
 
(a) 5´-d(AAA AAA AXX XTT TTT TT) 
 
HPLC Column: ion-exchange column 
Temperature: 50°C 
Time 
(min) 
Flow 
(ml min-1) % of solvent A % of solvent B 
0.0 1.50 100 0 
5.0 1.50 100 0 
20.0 1.50 83 17 
30.0 1.50 76 24 
40.0 1.50 0 100 
45.0 1.50 100 0 
50.0 0.01 100 0 
HPLC-method 
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One product was collected and desalted (2 x NAPTM 10 column). 
Peak 1 at T1 = 23.0-25.0min  
After the desalting the oligonucleotide (peak 1) is lyophilised, dissolved in 1000μl 
and 90µl are diluted to a volume of 900μl and the absorption spectrum is taken. 
E(260nm) = c * d * ε , where ε = f * Σniεi (for further explanation see UV-Vis 
spectroscopy) 
E(260nm) = 0.06347 
Therefore concentration c (900µl) = 0.386μmol/l   
Overall concentration c (1000µl) = 3.86µmol/l ⇒ Yield = 0.39% 
 
(b) 5´-d(AAA AAA AXX XXT TTT TTT) 
 
No further purification steps where done until now. 
 
(c) 5´-d(AAA AAA AXA AAA AAA) 
 
HPLC Column: reversed phase column 
Temperature: 50°C 
 
Time 
(min) 
Flow 
(ml min-1) % of solvent A % of solvent B 
0.0 1.50 100 0 
25.0 1.50 90 10 
30.0 1.50 50 50 
35.0 1.50 50 50 
40.0 1.50 100 0 
41.0 0.01 100 0 
HPLC-method 
 
Three products were collected. 
Peak 1 at T1 = 10.0-11.0min 
Peak 2 at T2 = 18.8-20.5min 
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Peak 3 at T3 = 28.9-30.1min 
Then, for peak 1 and 2, the DMT-protecting group at the 5´-end is taken off by 
leaving the oligonucleotides in 2ml acetic acid (80%) for half an hour each. The acetic 
acid (80%) is taken off under vacuum.  
Product 2 is purified further. 
HPLC Column: reversed phase column 
Temperature: 50°C 
 
Time 
(min) 
Flow 
(ml min-1) % of solvent A % of solvent B 
0.0 1.00 100 0 
25.0 1.00 90 10 
30.0 1.00 50 50 
31.0 1.00 50 50 
35.0 1.00 100 0 
36.0 0.01 100 0 
HPLC-method 
 
One product was collected and desalted (1 x NAPTM 10 column). 
Peak 1 at T1 = 21.2-22.3min  
After the desalting the oligonucleotide (peak 1) is lyophilised, dissolved in 1000μl 
and 100μl are diluted to a volume of 900μl and the absorption spectrum is taken. 
After calculating the concentration and measuring MALDI-TOF spectra, none of the 
peaks showed a signal for any kind of oligonucleotide. 
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(d) 5´-d(TTT TTT TXT TTT TTT) 
 
HPLC Column: reversed phase column 
Temperature: 50°C 
 
Time 
(min) 
Flow 
(ml min-1) % of solvent A % of solvent B 
0.0 1.00 100 0 
25.0 1.00 81 19 
30.0 1.00 60 40 
35.0 0.10 100 0 
36.0 0.10 100 0 
HPLC-method 
 
One product was collected. 
Peak 1 at T1 = 16.0-16.5min 
Then the DMT-protecting group at the 5´-end is taken off by leaving the 
oligonucleotide in 1ml acetic acid (80%) for half an hour. The acetic acid (80%) is 
taken off under vacuum.  
HPLC Column: reversed phase column 
Temperature: 50°C 
 
Time 
(min) 
Flow 
(ml min-1) % of solvent A % of solvent B 
0.0 1.00 100 0 
25.0 1.00 88 12 
30.0 1.00 60 40 
35.0 1.00 100 0 
36.0 0.01 100 0 
HPLC-method 
 
One product was collected and desalted (1 x NAPTM 5 column). 
Peak 1 at T1 = 23.0-23.6min  
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After the desalting the oligonucleotide (peak 1) is lyophilised, dissolved in 1000μl 
and 900μl are taken off and the absorption spectrum is measured. After calculating 
the concentration and measuring MALDI-TOF spectra, none of the peaks showed a 
signal for any kind of oligonucleotide. 
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Oligonucleotides (Y = 1-deazapurine-N9 nucleoside) 
 
(e) 5´-d(CYY YYG) 
 
The 1-deazapurine-N9-β-[2´-deoxy-3´-O-(2-cyanoethyl)-N,N-diisopropylphosphor-
amidite-5´-O-(4,4´-dimethoxy-trityl)-ribonucleoside] is purified by flash 
chromatography over aluminium oxide (25 x 2.5cm, CH2Cl2 (1) : EtOAc (1)) to give 
166mg (226µmol) clean 1-deazapurine-N9-β-[2´-deoxy-3´-O-(2-cyanoethyl)-N,N-
diisopropylphosphor-amidite-5´-O-(4,4´-dimethoxy-trityl)-ribonucleoside], which is 
dissolved in 3.32ml dry CH3CN to give a 100mM solution that can be used in the 
oligonucleotide synthesis at the DNA-synthesizer. 
 
HPLC column: ion-exchange column 
Temperature: r.t. 
 
Time 
(min) 
Flow 
(ml min-1) % of solvent A % of solvent B 
0.0 1.50 100 0 
10.0 1.50 100 0 
60.0 1.50 75 25 
65.0 1.50 0 100 
70.0 1.50 0 100 
71.0 1.50 100 0 
81.0 1.50 100 0 
81.5 0.01 100 0 
HPLC-method 
 
One product was collected and desalted twice (2 x OASIS®). 
Peak 1 at T1 = 47.0-48.0min  
After the desalting the oligonucleotide is lyophilised, dissolved in 900 μl and the 
absorption spectrum is taken. 
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E(260nm) = c * d * ε , where ε = f * Σniεi (for further explanation see UV-Vis 
spectroscopy) 
E(260nm) = 0.376 
Therefore concentration c (900μl) = 6.51μmol/l ⇒ Yield = 0.59% 
 
(f) 5´-d(CGC GYA TYC GCG) 
(g) 5´-d(AAA AAA AYA AAA AAA) 
(h) 5´-d(TTT TTT TYT TTT TTT) 
(i) 5´-d(YYY YYY YYY YYY YYY YA) 
 
441mg (390mg / 529µmol product) 1-deazapurine-N9-β-[2´-deoxy-3´-O-(2-
cyanoethyl)-N,N-diisopropylphosphoramidite-5´-O-(4,4´-dimethoxy-trityl)-ribo-
nucleoside] are dissolved in 5.29ml dry CH3CN to give a 100mM solution that can be 
used in the oligonucleotide synthesis at the DNA-synthesizer. 
 
(f) 5´-d(CGC GYA TYC GCG) 
 
HPLC Column: ion-exchange column 
Temperature: 50°C 
 
Time 
(min) 
Flow 
(ml min-1) % of solvent A % of solvent B 
0.0 1.50 100 0 
5.0 1.50 100 0 
35.0 1.50 71 29 
40.0 1.50 0 100 
46.0 1.50 100 0 
51.0 1.50 100 0 
51.5 0.01 100 0 
HPLC-method 
 
One product was collected and desalted (2 x NAPTM 10 column). 
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Peak 1 at T1 = 24.7-25.0min  
After the desalting the oligonucleotide (peak 1) is lyophilised, dissolved in 1000μl 
and 10μl are diluted to a volume of 900μl and the absorption spectrum is taken. 
E(260nm) = c * d * ε , where ε = f * Σniεi (for further explanation see UV-Vis 
spectroscopy) 
E(260nm) = 0.110 
Therefore concentration c (900μl) = 0.99μmol/l ⇒ Yield = 8.91% 
 
MALDI-TOF 
Value calc. (M/Z) for (MH)+ = 3623.7; found: 3622.6. 
Also peaks at larger (M/Z) values were found, which are probably due to an 
incomplete deprotection of the oligonucleotide. 
 
(g) 5´-d(AAA AAA AYA AAA AAA) 
 
HPLC Column: ion-exchange column 
Temperature: 50°C 
 
Time 
(min) 
Flow 
(ml min-1) % of solvent A % of solvent B 
0.0 1.50 90 10 
5.0 1.50 90 10 
20.0 1.50 75 25 
25.0 1.50 0 100 
28.0 1.50 0 100 
30.0 1.50 90 10 
35.0 1.50 90 10 
35.5 0.01 90 10 
HPLC-method 
 
One product was collected and desalted (2 x NAPTM 10 column). 
Peak 1 at T1 = 16.0-18.0min  
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After the desalting the oligonucleotide (peak 1) is lyophilised, dissolved in 1000μl 
and 10μl are diluted to a volume of 900μl and the absorption spectrum is taken. 
E(260nm) = c * d * ε , where ε = f * Σniεi (for further explanation see UV-Vis 
spectroscopy) 
E(260nm) = 0.138 
Therefore concentration c (900μl) = 0.674μmol/l ⇒ Yield = 6.07% 
 
MALDI-TOF 
Value calc. (M/Z) for (MH)+ = 4494.7; found: 4489.4. 
 
(h) 5´-d(TTT TTT TYT TTT TTT) 
 
HPLC Column: ion-exchange column 
Temperature: 50°C 
 
Time 
(min) 
Flow 
(ml min-1) % of solvent A % of solvent B 
0.0 1.50 100 0 
5.0 1.50 100 0 
35.0 1.50 50 50 
40.0 1.50 0 100 
41.0 1.50 100 0 
51.0 1.50 100 0 
51.5 0.01 100 0 
HPLC-method 
 
One product was collected and desalted (2 x NAPTM 10 column). 
Peak 1 at T1 = 16.8-17.7min  
After the desalting the oligonucleotide (peak 1) is lyophilised, dissolved in 1000μl 
and 10μl are diluted to a volume of 900μl and the absorption spectrum is taken. 
E(260nm) = c * d * ε , where ε = f * Σniεi (for further explanation see UV-Vis 
spectroscopy) 
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E(260nm) = 0.225 
Therefore concentration c (900μl) = 1.862μmol/l ⇒ Yield = 16.75% 
MALDI-TOF 
Value calc. (M/Z) for (MH)+ = 4620.9; found: 4618.7. 
 
(i) 5´-d(YYY YYY YYY YYY YYY YA) 
 
HPLC Column: ion-exchange column 
Temperature: 50°C 
 
Time 
(min) 
Flow 
(ml min-1) % of solvent A % of solvent B 
0.0 1.50 100 0 
5.0 1.50 100 0 
20.0 1.50 83 17 
45.0 1.50 66 34 
55.0 1.50 0 100 
60.0 1.50 100 0 
65.0 1.50 100 0 
66.0 0.01 100 0 
HPLC-method 
 
One product was collected and desalted (2 x NAPTM 10 column). 
Peak 1 at T1 = 34.0-36.0min  
After the desalting the oligonucleotide (peak 1) is lyophilised, dissolved in 1000μl 
and 100μl are diluted to a volume of 900μl and the absorption spectrum is taken. 
E(260nm) = c * d * ε , where ε = f * Σniεi (for further explanation see UV-Vis 
spectroscopy) 
E(260nm) = 0.185 
Therefore concentration c (900μl) = 1.028μmol/l ⇒ Yield = 0.93% 
MALDI-TOF 
Value calc. (M/Z) for (MH)+ = 5006.9; found: 5007.5. 
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1-Deaza-N3-oxidepurine•2H2O (35) 
N NH
N
O
1
2
3
6 7
8
9
  
To a mixture of 1.60g (13.4mmol) 1-deazapurine and 12.0ml acetic acid (98-100 %), 
2.45ml H2O2 (30%) are added and the solution is stirred for 24h at 80°C. The solution 
is cooled down to r.t., further 2.45ml H2O2 (30%) are added and the solution is stirred 
at 80°C for another 24h. Upon cooling down to r.t., a yellow solid precipitates. The 
solid is filtered off and dried at 40°C. On evaporation of more solvent, further solid 
precipitates, giving in total 1.77g (10.3mmol) of 1-deaza-N3-oxidepurine•2H2O  
(77%); 1H-NMR (200MHz, DMSO-d6, δ in ppm): 8.40 (s, 1H, H8), 8.18 (dd, 1H, 
H2), 7.60 (dd, 1H, H6), 7.20 (dd, 1H, H1); elemental analysis calc. (%) for 
C6H5N3O•2H2O (M = 171.15g/mol): C 42.1, H 5.3, N 24.6; found: C 42.2, H 4.9, N 24.8. 
 
1-Deaza-N3-oxide-6-nitropurine (36) 
N NH
N
NO2
O
6
 
A solution of 1.0g (5.8mmol) 1-deaza-N3-oxidepurine•2H2O in 7.8ml of 
trifluoroacetic acid is cooled to 0°C and in a dropwise fashion, 4.3ml HNO3 (100%) 
are added in the duration of an hour. The mixture is stirred at 90°C for four hours, 
cooled and poured into a round bottom flask with crushed ice. Neutralisation is done 
with concentrated NH3, while keeping the temperature below 30°C, which is 
essential for high yields. At pH 5 a yellow solid starts to precipitate. At pH 7 the solid 
is filtered off, washed with ice water and dried at 40°C to give 990mg (5.5mmol) of 1-
deaza-N3-oxide-6-nitropurine as a yellow solid (95%, ref.: 75%)106; 1H-NMR 
(200MHz, DMSO-d6, δ in ppm): 14.02 (br, 1H, N7/9H), 8.61 (s, 1H, H8), 8.33 (d, 1H, 
H1), 8.09 (d, 1H, H2); elemental analysis calc. (%) for C6H4N4O3 (180.12g/mol): C 
40.0, H 2.2, N 31.1;  found: C 35.5, H 2.3, N 28.3. 
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1-Deaza-6-nitropurine (37) 
N NH
N
NO2
 
This is a slightly modified version of the synthesis in the literature.156 
A solution of 1.3g (7.2mmol) 1-deaza-N3-oxide-6-nitropurine in 25ml dry CH3CN is 
stirred and over the duration of one hour 5.5ml fresh PCl3 are added drop wise, 
while cooling the round bottom flask with ice water. The produced suspension is 
refluxed for two hours at 80 °C and then cooled down to r.t. The round bottom flask 
is allowed to stand in the fume hood, so that the fumes can steam off. After roughly 
15min the solid is filtered off and washed with Et2O and saturated Na2CO3 solution 
(careful, vigorous reaction! do not use vast amounts, otherwise loss in yield!) and 
dried at 40°C to give 1-deaza-6-nitropurine as a yellow-brownish solid. After re-
crystallization in water 610mg yellow blocks are found (52%, ref.: 82%)156; 1H-NMR 
(200MHz, DMSO-d6, δ in ppm): 13.69 (br, 1H, N7/9H), 8.78 (s, 1H, H8), 8.70 (d, 1H, 
H1), 8.01 (d, 1H, H2); elemental analysis calc. (%) for C6H4N4O2 (M = 164.12g/mol); C 
43.9, H 2.5, N 34.1; found: C 43.6, H 2.4, N 34.8. 
 
1-Deaza-6-nitropurine-N9-β(a)-[2´-deoxy-3´,5´-di-O-(p-toluoyl)-
ribonucleoside] (38b and 38a) 
O
O
N
N
N
9
α/β
O
O
O
5´
3´
NO2
 
This is a slightly modified version of the synthesis in the literature.159 
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A suspension of 978mg (5.96mmol) 1-deaza-6-nitropurine in 20.5ml dry CH3CN is 
stirred under argon. After addition of 260mg (6.50mmol) NaH (60% in oil) the 
reaction mixture is stirred for 30min at r.t. and under argon. Then the reaction 
mixture is cooled to 0°C and over the duration of 15min 3.50g (9.00mmol) Hoffer´s 
chlorosugar are added in small portions. For further three hours the reaction mixture 
is stirred at 0°C under argon. The insoluble material is filtered off (mainly Na salt) 
and the solution evaporated. The oily residue is purified by flash chromatography 
over silica gel (25 x 2.5cm, n-hexane (100) : EtOAc (60) : CH2Cl2 (4)) to give 1.26mg 
(2.44mmol) 1-deaza-6-nitropurine-N9-β-[2´-deoxy-3´,5´-di-O-(p-toluoyl)-
ribonucleoside] (41% beta, ref.: 60% beta)159 and 227mg (0.44mmol) 1-deaza-6-
nitropurine-N9-α-[2´-deoxy-3´,5´-di-O-(p-toluoyl)-ribonucleoside] (7%) and 138.0mg 
(0.267mmol) α/β-mixture (4%) (overall yield: 52%); 1H-NMR (200MHz, CDCl3/TSP, 
δ in ppm) 1-deaza-6-nitropurine-N9-β(α)-[2´-deoxy-3´,5´-di-O-(p-toluoyl)-
ribonucleoside]: (8.69) (only alpha, s, 1H, H8), 8.56 (8.57) (d, 1H, H1), 8.50 (only beta, 
s, 1H, H8), 8.00-7.84 (8.00-7.84) (m, 4H (alpha 3H), p-Tol; d, 1H, H2), (7.58) (only 
alpha, m, 1H, p-Tol), 7.31-7.14 (7.31-7.14) (m, 4H, p-Tol), 6.69 (6.80) (dd, 1H, 
H1´), 5.84 (5.73) (m, 1H, H3´), (4.96) (only alpha, m, 1H, H4´), 4.84-4.63 (4.84-4.63)  (m, 
2H, H5´ and H5´´; only beta, m, 1H, H4´), 3.24-2.85 (3.24-2.85) (m, 2H, H2´ and H2´´), 
2.45 and 2.40 (2.43 and 2.39) (2 x s, 2 x 3H, 2 x p-Tol-CH3); elemental analysis calc. (%) 
for C27H24N4O7 (β) (M = 516.50g/mol): C 62.8, H 4.7, N 10.9; found: C 62.7, H 4.7, N 
10.6; FAB-MS calc. (M/Z): 517.1723; found for β: 517.1749. 
 
1-Deaza-6-nitropurine-N9-β-2´-deoxyribonucleoside (39) 
O
HO
N
N
N
9β
HO
NO2
 
This is a slightly modified version of the synthesis in the literature.159 
To a round bottom flask with 1.58g (3.06mmol) 1-deaza-6-nitropurine-N9-β-[2´-
deoxy-3´,5´-di-O-(p-toluoyl)-ribonucleoside] 50.0ml of a saturated NH3/CH3OH 
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solution are added. Immediately a reddish solution with an oily residue is formed. 
After 10-15min the oil is gone into the pink solution and a white solid precipitates, 
which itself dissolves within the next five minutes to then give a yellow solution. The 
reaction is monitored by TLC. After 10h the reaction is finished and therefore the 
solution is evaporated to give an orange-reddish oil. The oil is purified by flash 
chromatography over silica gel (19 x 2.5cm, CHCl3 (88) : CH3OH (10) : NH3 (2)) to 
give 534mg (1.91mmol) 1-deaza-6-nitropurine-N9-β-2´-deoxyribonucleoside (62%, 
ref.: 55%)159; 1H-NMR (200MHz, D2O/TSP, pD 7.47, δ in ppm): 8.87 (s, 1H, H8), 8.67 
(d, 1H, H1), 8.14 (d, 1H, H2), 6.69 (pt, 1H, H1´), 4.69 (m, 1H, H3´), 4.21 (m, 1H, H4´), 
3.83 (m, 2H, H5´ and H5´´), 3.02-2.58 (m, 2H, H2´ and H2´´); elemental analysis calc. 
(%) for C11H12N4O5 (280.24g/mol); C 47.1, H 4.3, N 20.0; found: C 46.8, H 4.7, N 20.2; 
FAB-MS calc. (M/Z): 281.0886; found: 281.0876. 
 
1-Deaza-6-aminopurine-N9-β-2´-deoxyribonucleoside (1-Deaza-2´-
deoxyadenosine) (40) 
O
HO
N
N
N
HO
NH26
 
This is a slightly modified version of the synthesis in the literature.167 
To a solution of 190mg (0.678mmol) 1-deaza-6-nitropurine-N9-β-2´-
deoxyribonucleoside in 47.5ml CH3OH (yellow solution), 3.57ml H2N-NH2•H2O and 
1.20g of activated Raney-Nickel are added at r.t. to give a black suspension. After the 
solution becomes colourless (ca. 90min) the solid is filtered off (Careful, Raney-
Nickel ignites immediately up on drying!) and the solution is evaporated to give a 
yellow oil. Flash chromatography over silica gel (17 x 2.5cm, CH2Cl2 (8) : CH3OH (2)) 
gives 115mg (0.460mmol) of 1-deaza-6-aminopurine-N9-β-2´-deoxyribonucleoside 
(68%, ref.: 87%)167; 1H NMR (200MHz, D2O/TSP, pD 9.52, δ in ppm): 8.13 (s, 1H, H8), 
7.79 (d, 1H, H2), 6.49 (d, 1H, H1), 6.35 (dd, 1H, H1´), 4.50 (m, 1H, H3´), 4.04 (m, 1H, 
H4´), 3.65 (m, 2H, H5´ and H5´´), 2.79-2.31 (m, 2H, H2´ and H2´´); elemental analysis 
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calc. (%) for C11H14N4O3 (M = 250.25g/mol): C 52.8, H 5.6, N 22.4; found: C 52.4, H 
5.6, N 22.7; FAB-MS calc. for (M/Z): 251.1144; found 251.1132.  
 
1-Deaza-(6-benzoylamino)-purine-N9-β-2´-deoxyribonucleoside•H2O 
(42) 
O
HO
N
N
N
HO
NH6
O
 
This is a slightly modified version of the synthesis in the literature.167 
In a round bottom flask 250mg (999µmol) 1-deaza-6-aminopurine-N9-β-2´-
deoxyribonucleoside are dried by co-evaporation with dry pyridine (2 x 6ml). The 
round bottom flask is set under argon and the 1-deaza-6-aminopurine-2´-
deoxyribonucleoside is dissolved in 15.0ml dry pyridine. To the slightly yellow 
solution 642µl (5.06mmol) Me3SiCl are added and the solution is stirred for 15min at 
r.t. Then 579µl (4.99mmol) benzoyl chloride are added to the yellow solution and the 
solution is stirred at r.t. under argon, whereby a white solid (probably pyridinium 
chloride) falls out after five minutes. After two hours the yellow solution is cooled 
down to 0°C within 15min and hydrolysed with 1.0ml H2O. Having stirred the 
solution for five minutes at 0°C, it is quenched with 2.0ml NH3 (25%), whereby a 
solid falls out (NH4Cl), and stirred for another 30min at 0°C. The solvent is 
evaporated to give a yellowish oil, which is co-evaporated with toluene and acetone. 
The oil is dissolved in CH3OH and purified by flash chromatography over silica gel 
(26 x 2.5cm, CH2Cl2 (9) : CH3OH (1)) to give 640mg of a mixture of 1-deaza-(6-
benzoylamino)-purine-N9-β-2´-deoxyribonucleoside and benzoyl hydroxide. 
Crystallisation in CH3OH gives 300mg (806µmol) 1-deaza-(6-benzoylamino)-purine-
N9-β-2´-deoxyribonucleoside as colourless crystals (81%, ref.: 77%)167; 1H-NMR 
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(200MHz, DMSO-d6, δ in ppm): 10.42 (br, 1H, C6-NH), 8.64 (s, 1H, H8), 8.32 (d, 1H, 
H2), 7.52-8.05 (m, 1H, H1; 4H, Ph), 6.51 (dd, 1H, H1´), 5.34 (t, 1H, C3´-OH), 5.18 (t, 
1H, C5´-OH), 4.45 (m, 1H, H3´), 3.91 (m, 1H, H4´), 3.71-3.48 (m, 2H, H5´ and 
H5´´), 2.88-2.27 (m, 2H, H2´ and H2´´); elemental analysis calc. (%) for 
C18H18N4O4•H2O (M = 372.38g/mol): C 58.1, H 5.4, N 15.0; found: C 57.8, H 5.5, N 
14.9.  
 
1-Deaza-(6-benzoylamino)-purine-N9-β-[2´-deoxy-5´-O-(4,4´-
dimethoxytrityl)-ribonucleoside] (43) 
O
O
N
N
N
HO
O
O
5´
NH
O
 
This is a slightly modified version of the synthesis in the literature.167 
In a 50ml round bottom flask 116mg (312µmol) 1-deaza-(6-benzoylamino)-purine-
N9-β-2´-deoxyribonucleoside are dissolved in 4.20ml dry pyridine under argon. To 
the slightly yellow solution 210mg (620µmol) DMTr-Cl are added and the solution is 
now stirred for two hours at r.t. The solution is then quenched with NaHCO3 
solution (5%) and extracted with 40ml CH2Cl2 (3x). The organic phase is dried over 
Na2SO4 and evaporated. The resulting oil is dissolved in CH2Cl2 (9) and CH3OH (1) 
and purified by flash chromatography over silica gel (33 x 2.5cm , CH2Cl2 (95) and 
CH3OH (5)) and the product fraction is dissolved in 3.0ml CH2Cl2 and poured in 
6.0ml of a n-hexane (1) / Et2O (1) mixture to give 115mg (175µmol) 1-deaza-(6-
benzoylamino)-purine-N9-β-[2´-deoxy-5´-O-(4,4´-dimethoxytrityl)-ribonucleoside] as 
a white solid (56%, ref. 76%)167. 1H-NMR (200MHz, DMSO-d6, δ in ppm): 10.39 (br, 
1H, C6-NH), 8.53 (s, 1H, H8), 8.26 (d, 1H, H2), 8.05-6.75 (m, 1H, H1, 4H, Bz; 13H, 
(CH3O)2Tr), 6.53 (pt, 1H, H1´), 5.39 (t, 1H, C5´-OH), 4.52 (m, 1H, H3´), 4.01 (m, 1H, 
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H4´), 3.71 and 3.69 (2 x s, 2 x 3H, 2 x Tr-OCH3), 3.40-3.20 (m, 2H, H5´ and H5´´), 3.03-
2.33 (m, 2H, H2´ and H2´´). 
 
1-Deaza-(6-benzoylamino)-purine-N9-β-[2´-deoxy-3´-O-(2-cyanoethyl)-
N,N-diisopropylphosphoramidite-5´-O-(4,4´-dimethoxytrityl)-ribo-
nucleoside] (44)  
O
O
N
N
N
O
O
O
3´
P
N O N
NH
O
 
This is a slightly modified version of the synthesis in the literature.167 
In a 50ml round bottom flask 135mg (206µmol) of 1-deaza-(6-benzoylamino)-purine-
N9-β-[2´-deoxy-5´-O-(4,4´-dimethoxytrityl)-ribonucleoside] are dissolved in 4.50ml 
dry pyridine under argon. To the solution 108μl (633µmol) (i-Pr)2EtN and 135μl 
(605µmol) chloro-(2-cyanoethoxy)-(diisopropylamino)-phosphane are added at r.t. 
and the solution is stirred for one hour. Then the solution gets quenched with 4.50ml 
of NaHCO3 solution (5%), extracted with 10ml CH2Cl2 (4x) and the organic phase is 
dried over Na2SO4. The CH2Cl2 is evaporated off to give 345mg of a side product to 
product mixture. The product was not purified further and the yield was 
quantitative. Yellow-brown syrup of 1-deaza-(6-benzoylamino)-purine-N9-β-[2´-
deoxy-3´-O-(2-cyanoethyl)-N,N-diisopropylphosphoramidite-5´-O-(4,4´-dimethoxy-
trityl)-ribonucleoside]; 1H-NMR (200MHz, CDCl3/TMS, δ in ppm): 9.08 (br, 1H, C6-
NH), 8.48 (s, 1H, H8), 8.09 (d, 1H, H2), 7.97-7.14 (m, 1H, H1; 4H, Bz; 13H, (CH3O)2Tr), 
6.50 (pt, 1H, H1´), 4.72 (m, 1H, H3´), 4.01 (m, 1H, H4´),  3.70 and 3.69 (2 x s, 2 x 3H, 2 x 
OCH3), 3.30-4.30 (m, 2H, H5´ and H5´´), 3.00-2.50 (m, 2H, H2´ and H2´´; 4H, 
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CH2CH2CN), 1.30-1.10 (m, 14H, 2 x (CH3)2CH); 31P-NMR (80.98MHz, CDCl3, δ in 
ppm): 149.8 and 149.7 (product), 15.3 ((2-cyanoethoxy)-(diisopropylamino)-
phosphane oxide); FAB-MS calc. (M/Z): 857.3792; found: 857.3763. 
 
Oligonucleotides (Z = 1-Deazaadenine nucleoside) 
 
(k) 5´-d(AZZ ZZZ ZZZ A). 
 
The 345mg (177mg/206µmol product) 1-deaza-(6-benzoylamino)-purine-N9-β-[2´-
deoxy-3´-O-(2-cyanoethyl)-N,N-diisopropylphosphoramidite-5´-O-(4,4´-dimethoxy-
trityl)-ribonucleoside] are dissolved in 2.0ml dry CH3CN to give a 100mM solution 
that can be used in the oligonucleotide synthesis at the DNA-synthesizer. 
 
HPLC Column: reversed phase column 
Temperature: r.t. 
 
Time 
(min) 
Flow 
(ml min-1) % of solvent A % of solvent B 
0.0 1.50 100 0 
10.0 1.50 90 10 
40.0 1.50 80 20 
43.0 1.50 50 50 
48.0 1.50 50 50 
53.0 1.50 100 0 
53.5 0.01 100 0 
HPLC-method 
 
Three products were collected at different times and desalted (desaltation column). 
Peak 1 at T1 = 9.7min (OASIS®) 
Peak 2 at T2 = 10.4min (NAPTM 5 column) 
Peak 3 at T3 = 14.5min (OASIS®) 
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After the desalting the oligonucleotides (peaks 1-3) are lyophilised, dissolved in 
900μl and 100μl are taken off and filled up to 900μl with H2O. The absorption 
spectrum is taken. After calculating the concentration and measuring MALDI-TOF 
spectra, none of the peaks showed a signal for any kind of oligonucleotide. 
 
 
1-Deaza-(6-methoxyacetylamino)-purine-N9-β-2´-deoxyribonucleo-
side•0.5H2O (45) 
O
HO
N
N
N
HO
NH6
O
O
 
This is a slightly modified version of the synthesis in the literature.167 
In a 100ml round bottom flask 305mg (1.22mmol) 1-deaza-6-aminopurine-N9-β-2´-
deoxyribonucleoside are co-evaporated twice with 15.2ml dry pyridine and then 
dissolved in 30.0ml dry pyridine under argon. To the slightly yellow solution 800μl 
(8.75mmol) methoxyacetyl chloride are added and immediately the solution becomes 
yellow and a solid precipitates. After five minutes the solution is red and nearly all 
solid has disappeared. The solution gets stirred for two hours at r.t.. Then, to destroy 
excess methoxyacetyl chloride, 1.50ml H2O are added and the solution is stirred for 
further 25min, before it gets evaporated. The red oil is then dissolved in 30ml CH2Cl2 
and washed with 20ml NaHCO3 solution (5%/3x) and 20ml H2O (1x) and dried over 
Na2SO4. The CH2Cl2 is evaporated off to give a reddish-brown oil. To this oil 20ml of 
a solution containing Et3N (1), pyridine (1) and H2O (3) are added and the resulting 
brown solution is stirred for 30min at r.t. Evaporation and co-evaporation with 50ml 
toluene (2x) and 50ml acetone (2x) gives an orange-brown oil. Flash chromatography 
over silica gel (30.5 x 2.5cm, CH2Cl2 (19) : MeOH (1)) gives 314.1mg (948µmol) of 1-
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deaza-(6-methoxyacetylamino)-purine-N9-β-2´-deoxyribonucleo-side•0.5H2O as a 
white foam (78%, ref.: 78%)167. 1H-NMR (200MHz, CH3OD/TMS, δ in ppm): 8.50 (s, 
1H, H8), 8.27 and 8.22 (2 x d, 1H, H2; 1H, H1), 6.54 (pt, 1H, H1´), 4.60 (m, 1H, H3´), 
4.16 (s, 2H, CH2OCH3), 4.01 (m, 1H, H4´), 3.90-3.64 (m, 2H, H5´ and H5´´), 3.56 (s, 3H, 
CH2OCH3), 2.95-2.37 (m, 2H, H2´ and H2´´); elemental analysis calc. (%) for 
C14H18N4O5•0.5H2O (M = 331.33g/mol): C 50.8, H 5.8, N 16.9; found: C 50.7, H 5.7, N 
16.8; FAB-MS calc. (M/Z): 323.1355; found: 323.1379.  
 
1-Deaza-(6-methoxyacetylamino)-purine-N9-β-[2´-deoxy-5´-O-(4,4´-
dimethoxytrityl)-ribonucleoside] (46) 
O
O
N
N
N
HO
O
O
5´
NH
O
O
 
This is a slightly modified version of the synthesis in the literature.146 
In a 50ml round bottom flask 305mg (921µmol) 1-deaza-(6-methoxyacetylamino)-
purine-N9-β-2´-deoxyribonucleoside•0.5H2O are co-evaporated twice with 5.0ml dry 
pyridine and then dissolved in 5.0ml dry pyridine under argon. To the light yellow 
solution 385mg (1.139mmol) DMTr-Cl are added and the solution immediately turns 
orange. The solution is stirred for three hours at r.t. under argon, whereby a solid 
precipitates (pyridinium chloride). Then 800μl CH3OH are added and the solution is 
stirred for a further 30min, whereby the solid dissolves slowly. The solution is 
evaporated to half of its volume and 32.0ml CH2Cl2 are added. The organic phase is 
washed with 16ml NaHCO3 solution (5%/2x) and 16ml saturated NaCl solution (1x) 
and dried over Na2SO4. Evaporation and co-evaporation with 30ml toluene gives an 
orange-brown oil. Flash chromatography over silica gel (10.0 x 2.5cm, CH2Cl2 (8) : 
acetone (2)) gives 372mg (596µmol) of 1-deaza-(6-methoxyacetylamino)-purine-N9-β-
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2´-deoxyribonucleoside as a white solid (65%, ref. 84%)146. 1H-NMR (200MHz, 
CDCl3/TMS, δ in ppm): 9.49 (br, 1H, H1´), 8.28 (br, 1H, H2; 1H, H8), 7.99 (s, 1H, H1), 
7.31-7.14 (m, 9H, (CH3O)2Tr), 6.90-6.80 (m, 4H, (CH3O)2Tr), 6.41 (dd, 1H, H1´), 4.83 
(m, 1H, H3´), 4.25 (m, 1H, H4´), 4.12 (s, 2H, CH2OCH3), 4.03-3.80 (m, 2H, H5´ and 
H5´´), 3.80 (2 x s, 2 x 3H, 2 x Tr-OCH3), 3.57 (s, 3H, CH2OCH3), 3.30-2.27 (m, 2H, H2´ 
and H2´´); elemental analysis calc. (%) for C35H36N4O7 (M = 624.68g/mol): C 67.3, H 
5.8, N 9.0; found: C 66.3, H 4.4, N 8.1; FAB-MS calc. for (M/Z): 625.2663; found: 
625.2692.  
 
1-Deaza-(6-methoxyacetylamino)-purine-N9-β-[2´-deoxy-3´-O-(2-cyano-
ethyl)-N,N-diisopropylphosphoramidite-5´-O-(4,4´-dimethoxytrityl)-
ribonucleoside] (47)  
O
O
N
N
N
O
O
O
P
N O N
NH
O
O
 
This is a slightly modified version of the synthesis in the literature.146 
In a 100ml round bottom flask 372mg (596µmol) 1-deaza-(6-methoxyacetylamino)-
purine-N9-β-2´-deoxyribonucleoside are dissolved in 22.0ml dry CH2Cl2 under 
argon. To the solution 199μl (1.14mmol) (i-Pr)2EtN and 199μl (0.89mmol) chloro-(2-
cyanoethoxy)-(diisopropylamino)-phosphane are added at r.t. and the solution is 
stirred for 20min under argon. Now 22.0ml CH2Cl2 are added and the light yellow 
solution is washed with 15ml NaHCO3 solution (5% / 2x) and 15ml saturated NaCl 
solution and the organic phase is dried over Na2SO4. The CH2Cl2 is evaporated off 
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and the resulting yellow oil is co-evaporated twice with dry CH2Cl2 to give 555mg of 
a side-product-product mixture. 
The yellow oil is not worked up further. The yield is calculated through the ratio of 
product to side product and the mean molar mass. 
Raw mass = 555.3mg 
Ratio: product (0.6) : side product (0.4) 
Mean molar mass = molar mass (product) x 0.6 + molar mass (side product) x 0.4 
⇒ Mean molar mass = 582.23g/mol 
⇒ Medium moles = 954µmol 
Mass (product) = medium moles x molar mass (product) x ratio (product) 
⇒ Mass (product) = 472mg (572µmol) (96%, ref. 87%)146 
1H-NMR (200MHz, CDCl3/TMS, δ in ppm): 9.41 (br, 1H, C6-NH), 8.55 (s, 1H, H8), 
8.24 (d, 1H, H2), 8.14 (d, 1H, H1), 7.42-6.76 (m, 13H, (CH3O)2Tr), 6.55 (pt, 1H, H1´), 
4.77 (m, 1H, H3´), 4.20 (m, 1H, H4´), 4.11 (s, 2H, CH2OCH3), 3.77 and 3.78 (2 x s, 2 x 
3H, 2 x OCH3), 3.56 (s, 3H, CH2OCH3), 4.30-3.30 (m, 2H, H5´ and H5´´), 3.00-2.50 (m, 
2H, H2´ and H2´´; 4H, CH2CH2CN), 1.30-1.10 (m, 14H, 2 x (CH3)2CH); 31P-NMR 
(80.98MHz, CDCl3, δ in ppm): 149.8 and 149.6 (product), 15.3 ((2-cyanoethoxy)-
(diisopropylamino)-phosphane oxide); FAB-MS calc. value (M/Z): 825.3741; found: 
825.3716. 
 
Oligonucleotides (Z = 1-Deazaadenine nucleoside) 
 
(l) 5´-d(AZA ZAZ AZA) 
 
The 178mg (104mg/126µmol product) 1-deaza-(6-methoxyacetylamino)-purine-N9-
β-[2´-deoxy-3´-O-(2-cyanoethyl)-N,N-diisopropylphosphoramidite-5´-O-(4,4´-
dimethoxytrityl)-ribonucleoside] are dissolved in 1.25ml dry CH3CN to give a 
100mM solution that can be used in the oligonucleotide synthesis at the DNA-
synthesizer. 
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HPLC Column: ion-exchange column 
Temperature: 50°C 
 
Time 
(min) 
Flow 
(ml min-1) % of solvent A % of solvent B 
0.0 1.50 100 0 
10.0 1.50 100 0 
40.0 1.50 75 25 
45.0 1.50 0 100 
48.0 1.50 0 100 
50.0 1.50 100 0 
55.0 1.50 100 0 
55.5 0.01 100 0 
HPLC-method 
 
Three products were collected at different times and desalted (desaltation column). 
Peak 1 at T1 = 15.2min (none) 
Peak 2 at T2 = 25.2min (none) 
Peak 3 at T3 = 28.2min (2 x NAPTM 10 column) 
After the desalting the oligonucleotide (peak 3) is lyophilised, dissolved in 900 μl and 
the absorption spectrum is taken. 
E(260nm) = c * d * ε , where ε = f * Σniεi (for further explanation see UV-Vis 
spectroscopy) 
E(260nm) = 0.717 
Therefore concentration c (900μl) = 6.48μmol/l ⇒ Yield = 0.58% 
 
MALDI-TOF 
Value calc. (M/Z) for (MH)+ = 2753.97; found: 2756.34. 
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(m) 5´-d(ZZZ ZZZ ZZZ ZZZ ZZZ ZZZ ZA) 
 
The 555.3mg (472.0mg/0.5722mmol product) 1-deaza-(6-methoxyacetylamino)-
purine-N9-β-[2´-deoxy-3´-O-(2-cyanoethyl)-N,N-diisopropylphosphoramidite-5´-O-
(4,4´-dimethoxytrityl)-ribonucleoside] are dissolved in 5.72ml dry CH3CN to give a 
100mM solution that can be used in the oligonucleotide synthesis at the DNA-
synthesizer. 
 
HPLC Column: ion-exchange column 
Temperature: 60°C 
 
Time 
(min) 
Flow 
(ml min-1) % of solvent A % of solvent B 
0.0 1.5 100 0 
5.0 1.5 100 0 
55.0 1.5 75 25 
60.0 1.5 75 25 
90.0 1.5 65 35 
93.0 1.5 0 100 
97.0 1.5 0 100 
100.0 1.5 100 0 
105.0 1.5 100 0 
106.0 0.01 100 0 
HPLC-method 
 
Five products were collected at different times and desalted (desaltation column). 
Peak 1 at T1 = 62.5-65.8min (1 x NAPTM 10 column) 
Peak 2 at T2 = 66.0-68.3min (2 x NAPTM 10 column) 
Peak 3 at T3 = 68.5-71.3min (2 x NAPTM 10 column) 
Peak 4 at T4 = 71.5-74.5min (2 x NAPTM 10 column) 
Peak 5 at T5 = 75-78min (2 x NAPTM 10 column) 
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After the desalting the oligonucleotides (peaks 2-4) are lyophilised, dissolved in 
900μl and 100μl are taken off and filled up to 900μl with H2O. The absorption 
spectrum is taken. After calculating the concentration and measuring a MALDI-TOF, 
none of the peaks showed a clear signal.  
The peaks 2-4 are joined and again treated with 1ml AMA. The AMA is taken off 
under vacuum. 
 
HPLC Column: reversed phase column 
Temperature: 50°C 
 
Time 
(min) 
Flow 
(ml min-1) % of solvent A % of solvent B 
0.0 1.0 100 0 
25.0 1.0 81 19 
30.0 1.0 60 40 
35.0 0.1 100 0 
36.0 0.1 100 0 
HPLC-method 
 
One product was collected and desalted (1 x NAPTM 5 column). 
Peak 2-4(II) at T1 = 19.9-20.5min  
 
After the desalting the oligonucleotide (peak 2-4(II)) is lyophilised, dissolved in 
1000μl and 900μl are taken off and the absorption spectrum is taken. After calculating 
the concentration and measuring MALDI-TOF spectra, none of the peaks showed a 
signal for any kind of oligonucleotide. 
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After the desalting the oligonucleotide (peak 5) is lyophilised, dissolved in 900μl and 
100μl are taken off and filled up to 900μl with H2O. The absorption spectrum is 
taken. 
E(260nm) = c * d * ε , where ε = f * Σniεi (for further explanation see UV-Vis 
spectroscopy) 
E(260nm) = 0.0787 
Therefore concentration c (900μl) = 0.374μmol/l ⇒ Yield = 0.30% 
 
MALDI-TOF 
Value calc. (M/Z) for (MH)+ = 6184.3; found: 6190.7.  
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E Summary  
1 English Version 
 
The generall aim of this work is the synthesis of oligonucleotides containing new 
artificial nucleobases that are able to build artificial planar metal-mediated base pairs 
without disturbing the geometry of the backbone and therefore partially or fully 
exchanging H-bonding and π-stacking interactions through covalent metal ligand 
interactions. Through the synthesis of these new systems further information about 
the structure and the bonding behaviours are studied. Four different systems with 
four different coordination modes ([3+1], [2+2], [1+1] and [1+1] + H-bond) are 
discussed in this thesis. 
Chapter I 
Model structures with 2,2´:6´,2´´-terpyridine, Pd2+ or Pt2+ and either of the two 
different monodentate ligands, 1-methylimidazole or 1-methyltetrazole, were 
synthesised and characterised. In [(trpy)Pd(1-mimi)](ClO4)2 and [(trpy)Pt(1-
mimi)](ClO4)2 the 1-methylimidazole binds over the N3 position, as expected. Crystal 
structures show clearly that there is no planarity between the 2,2´:6´,2´´-terpyridine 
and the opposite 1-methylimidazole, due to sterical hindrance of some H atoms of 
the ligands. It is shown, through a crystal structure, that the [(trpy)Pt(1-
mtetate)](ClO4) (Figure I) binds over the C5 atom and not over N3, again, having a 
sterical hindrance for planarity, this time through the methyl group. The Pd2+ 
complex probably binds similarly, except that 
it seems to have additional binding over the 
N4 or N3 to another 2,2´:6´,2´´-terpyridine-Pd 
entity. The binding of the C5 atom might be 
avoided through a change in pH and it is 
obvious that binding over N3 would open the 
possibility of H-bonding. 
     Figure I: Crystal structure of the  
     cation of [(trpy)Pt(1-mtet)](ClO4). 
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In this case the N2 and N4 positions can build H-bonds to the H6 and H6´´ positions 
of the outer 2,2´:6´,2´´-terpyridine rings giving rise to a near planar system, which has 
been shown by DFT calculations. It is expected that the 1-methyltetrazole will bind a 
metal ion over the N3 position inside an 
oligonucleotide due to sterical reasons. 
Therefore it could be shown that having 
terpyridine and tetrazole as artificial 
nucleobases in opposite positions inside two 
complementary oligonucleotide strands is very 
promising for metal-mediated base pairing. 
Figure II: A possible planar metal- 
      mediated  base pair  with a 
[3+1]-coordination. 
 
It is also shown that the 2,2´:6´,2´´-terpyridine can be a useful artificial nucleobase 
due to its high metal affinity, for example. The attempts that were undertaken to 
synthesise the 4´-methyl-2,2´:6´,2´´-terpyridine nucleoside are described. For these 
attempts a couple of precursors were synthesised such as the 4´-methyl-2,2´:6´,2´´-
terpyridine and the 4´-bromomethyl-2,2´:6´,2´´-terpyridine. These were meant to be 
linked to different protected sugar moieties.  
The C-glycosidic bond formation was not successful and reasons, such as the high 
metal affinity of the terpyridine rings, are described and discussed. A new synthetic 
route is proposed. This concludes the build up of the terpyridine ring after the C-
glycosidic bond formation.  
 
Chapter II 
The synthesis of three different artificial nucleosides with N-glycosidic bonds that are 
thought to be able to form metal-mediated base pairs is described. 1-deazapurine-N7 
nucleoside and 1-deazapurine-N9 nucleoside, as well as 1-deazaadenine nucleoside 
were synthesised and characterised. Characterisation included crystal structures of 
the nucleosides and synthesised model structures, comparisons with DFT 
calculations, pKa value determinations, Job-Plots, titrations with different metal ions 
N
N
N
N
N
N
N
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3
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CH2
R
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and determination of stabilisation constants. For all three nucleosides a competitive 
protonation to the wanted metalation could be excluded. Especially for the 1-
deazapurine-N9 nucleoside a 2:1 complex formation with Hg2+ (linear coordinating 
metal ion) could be observed and certified with a crystal structure of [Hg(9-
MeDP)2](NO3)2 · H2O. Crystal structures of the 1-deazapurine nucleosides were 
obtained and described in detail. The further synthesis to obtain the different 
nucleotides and the synthesis and 
purification of artificial oligonucleo-
tides are described and challenging 
parts, such as the high acid lability of 
the N-glycosidic bond, are discussed. 
On occasions crystal structures of 
intermediates were obtained and 
analysed. 
Figure III: Crystal structure of  
1-deazapurine-N9-β-2´-deoxyribonucleoside. 
 
Whereas the formation of metal-mediated base pairs with the synthesised 
1-deazapurine-N7 (X) containing oligonucleotides was not succesful, the 
1-deazapurine-N9 (Y) containing oligonucleotides showed some indication of the 
formation of those base pairs with Ag+ (linear coordinating metal ion).  
Y-A, Y-C, Y-G, Y-T and Y-Y base pairs inside a 15-mer with 14 A-T base pairs were 
looked at and discussed. Especially for Y-G and Y-C a metal-mediated base pair 
formation can be assumed because of a high increase in melting temperature (11.3°C 
and 9.2°C, respectively) and cooperativity of the melting.  
A A A A A A Y
GTTTTTT T T T T T T T
A A A A A A A
T
A
Y = 1-deazapurine
= sugar phosphate backbone
A = adenine
3´
5´
3´
5´
 = metal ligand bond
= Ag+
T = thymine
 
Figure IV: A possible Ag+-mediated Y-G base pair inside a 15-mer. 
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Also the increase in melting temperature is specific for one equivalent of Ag+, hence, 
a further addition does not give an increase in melting temperature, which excludes a 
possible binding at the backbone. Without Ag+ the natural base pairs (A-T and C-G) 
have higher melting temperatures than the base pairs with Y, but for the natural base 
pairs neither an increase in melting temperature nor a change in the cooperativity of 
the melting is observed upon the addition of Ag+. The results of the base pair 
formation with and without Ag+ of all base pairs are discussed and the differences 
are pointed out. 
 
The melting behaviour of an oligonucleotide, Y16A (Y = 1-deazapurine-N9 
nucleoside), containing nearly only Y and maybe self assembling upon the addition 
of Ag+ has been looked at. It has been found with the help of CD-spectra that even 
without Ag+ a defined rigid structural conformation is present. After the addition of 
only half an equivalent of Ag+, the melting temperature of around 43°C did not 
change further. Hence, the increase in melting temperature is specific for half an 
equivalent of Ag+. Also a hypochromic effect is present and the cooperativity of the 
melting is significantly increased. However, the structural conformation of the 
possible double helix does not change upon the addition of Ag+. Every second 
possible artificial base pair probably has one Ag+ bound inside (Figure V), as in the 
nearest neighbour exclusion principle. Possible structural conformations of the base 
pairs or the double helices that are not known at the moment are suggested and 
discussed.  
 
Y = 1-deazapurine = metal ligand bond
= sugar phosphate backbone= Ag+
Y Y Y Y Y Y Y
YYYYYYY Y Y Y Y Y Y Y
Y Y Y Y Y Y Y
Y
Y
Y
A
A
Y
A = adenine
5´
3´ 5´
3´
 
 
Figure V: Possible structure of a Y16A strand self assembling upon the addition of 
half an equivalent of Ag+. 
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The melting behaviour of an oligonucleotide, containing 19 1-deazaadenine 
nucleosides (Z) and one adenine nucleoside, with a thymine 20-mer was examined. 
Without Ag+ no cooperative melting has been observed. Upon the addition of Ag+ a 
melting temperature of around 48°C is found. Next to the increase in cooperativity of 
the melting, a large hypochromic effect can be seen. The increase in melting 
temperature is specific for one equivalent 
of Ag+, hence, a further addition does not 
give an increase in melting temperature, 
which excludes a possible binding of Ag+ 
at the backbone.  
Figure VI: Possible structure of an 
Ag+-mediated Z-T base pair with a 
[1+1]-coordination and an additional 
H-bond. 
 
The possible binding over the Hoogsteen 
side of Z and the introduction of Ag+ to 
form a stable double helix with possible 19 
Ag+ in a one dimensional chain inside, is 
pointed out and discussed, but up to this 
point could not be fully proven. Further 
measurements to obtain a greater know-
ledge about the structure of the possible 
double helix and the artificial metal-
mediated base pair are suggested.  
 
    Figure VII: A possibly formed double 
     helix through artificial Ag+-mediated 
   Z-T base pairs. 
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2 German Version 
 
Das Ziel dieser Arbeit ist die Synthese von Oligonucleotiden, die neuartige künst-
liche Nucleobasen enthalten, welche die Ausbildung künstlicher und planarer 
Metallionen-vermittelter Basenpaare fördern. Durch den Aufbau dieser Basenpaare 
sollen die Wasserstoffbrückenbindungen und die π-Stapelwechselwirkungen ent-
weder teilweise oder komplett durch kovalente Metall-Liganden Bindungen ersetzt 
werden ohne die Geometrie des Rückgrates zu beeinflussen. Durch die Synthese und 
Charakterisierung dieser neuartigen Systeme wurden Informationen über die 
Struktur und das Verhalten von Bindungspartnern studiert. Vier Systeme mit 
verschiedenen Koordinationsmodi ([3+1], [2+2], [1+1] und [1+1] + Wasserstoff-
brückenbindung) werden beschrieben. 
 
Kapitel I 
Modellstrukturen mit 2,2´:6´,2´´-Terpyridin, einem Pd2+- oder einem Pt2+-Metallion 
und zwei verschiedenen monodentaten Liganden, 1-Methylimidazol und 1-Methyl-
tetrazol, wurden synthetisiert und charakterisiert. In den Komplexen, die über eines 
der Metalle an das 1-Methylimidazol verknüpft sind, bindet dies, wie erwartet, über 
N3. Kristallstrukturen zeigen eindeutig, dass aus sterischen Gründen keine Planarität 
zwischen den Liganden vorhanden ist. Aus einer Kristallstruktur von [(trpy)Pt(1-
mtetate)](ClO4) geht hervor, dass das 1-Methyltetrazol nicht über N3, sondern über 
C5 an das Metall bindet. Die auch hier nicht vorhandene Planarität des Liganden 
wird diskutiert. Ein über C5 gebundenes 1-Methyl-
tetrazol wurde auch für den Pd2+ Komplex gefunden, 
allerdings bindet es auch noch zusätzlich über N4 
oder N3 an ein weiteres Pd2+. Eine Bindung über C5 
könnte möglicherweise durch einen veränderten pH 
Wert vermieden werden und offensichtlich könnte 
eine Bindung über N3 durch mögliche Wasserstoff-
brücken zu einem planaren Komplex führen.        Abbildung I: Kristallstruktur  
 von [(trpy)Pt(1-mtetate)](ClO4). 
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Die N2- und N4-Positionen könnten mit H6 und H6´´ von den äußeren Ringen des 
2,2´:6´,2´´-Terpyridin Wasserstoffbrücken ausbilden und somit ein planares System 
fördern. Dies wurde mit Hilfe von DFT Rechnungen gezeigt. Aus sterischen 
Gründen würde der Ligand eingebaut in einem Oligonucleotid wahrscheinlich über 
N3 binden. So kann man feststellen, dass Terpyridin und Tetrazol als künstliche 
Nucleobasen, eingebaut in gegenüberliegender Position in einem Oligonucleotid, ein 
sehr hoffnungsvolles System ergeben für metallmodifizierte Basenpaarungen.  
Die Versuche, die unternommen wurden, um das 4´-Methyl-2,2´:6´,2´´-terpyridin 
Nucleosid zu synthetisieren, werden beschrieben. Zu diesem Zweck wurden 
verschiedene Ausgangsverbindungen hergestellt, wie das 4´-Methyl-2,2´:6´,2´´-
terpyridin und das 4´-Bromomethyl-2,2´:6´,2´´-terpyridin. Diese Ausgangs-
verbindungen wurden dann in mehreren Versuchen mit verschieden Zuckern 
verknüpft. Die Synthese der C-glycosidischen Bindung war allerdings in keinem Fall 
erfolgreich und Gründe hierfür werden aufgezeigt und besprochen. Auch wird eine 
neue synthetische Route zum Zielmolekül 
vorgeschlagen, welche den Aufbau des 
Terpyridins an einer Zuckereinheit nach erfolg-
reicher Synthese der C-glycosidischen Bindung 
beinhaltet. 
 
Abbildung II: Ein mögliches planares  
Metall-vermitteltes Basenpaar ([3+1]). 
 
Kapitel II 
Die Synthese von drei künstlichen Nucleosiden mit N-glycosidischen Bindungen, die 
in möglichen Metallionen-vermittelten Basenpaaren nützlich sein könnten, wird 
beschrieben. Das 1-Deazapurin-N7 Nucleosid, das 1-Deazapurin-N9 Nucleosid und 
das 1-Deazaadenin Nucleosid wurden synthetisiert und charakterisiert. Die 
Charakterisierung beinhaltet Kristallstrukturen von Nucleosiden und Modell-
strukturen, Vergleiche mit DFT Rechnungen, die Bestimmung von pKs Werten und 
Stabilitätskonstanten, Job-Plots und Titrationen mit Metallionen. Für alle drei 
Nucleoside konnte eine konkurrierende Protonierung ausgeschlossen werden. 
N
N
N
N
N
N
N
1
3
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CH2
R
R = Zucker
= Mn+
2
4
6
6´´
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Speziell für das 1-Deazapurin-N9 Nucleosid wurde ein stabiler 2:1 Komplex mit Hg2+ 
(ein linear koordinierendes Metallion) gefunden und durch eine Kristallstruktur von 
[Hg(9-MeDP)2](NO3)2 · H2O bestätigt. Kristallstrukturen von den 1-Deazapurin 
Nucleosiden wurden erhalten und beschrieben. Die weiteren Synthesestufen der 
Nucleotide und der Oligonucleotide 
sowie deren Aufreinigung sind im De-
tail beschrieben und eventuelle Beson-
derheiten, wie die Säureempfindlichkeit 
der N-glycosidischen Bindung werden 
diskutiert. Kristallstrukturen von zahl-
reichen Zwischenstufen wurden erhal-
ten und analysiert. 
Abbildung III: Kristallstruktur von 
  1-Deazapurin-N9-β-2´-desoxyribonucleosid. 
 
Das Erzeugen von Metallionen-vermittelten Basenpaaren mit einem synthetisierten 
1-Deazapurin-N7 (X) enthaltenden Oligonucleotid war nicht erfolgreich. Mögliche 
Gründe werden benannt und diskutiert. Dies steht im Gegensatz zu den erhaltenen 
Daten mit einem synthetisierten 1-Deazapurin-N9 (Y) enthaltenden Oligonucleotid 
und Ag+ (ein linear koordinierendes Metallion). 
1-Deazapurin-N9 (Y) enthaltende Oligonucleotide zeigten Anzeichen für das 
Vorhandensein von Ag+-vermittelten Basenpaaren. Y-A, Y-C, Y-G, Y-T und Y-Y 
Basenpaare in einem 15-mer mit 14 A-T Basenpaaren wurden untersucht. Für die Y-
G und Y-C Basenpaare mit Ag+ zeigte eine Erhöhung der Schmelztemperatur (um 
11,3°C und 9,2°C) und die Kooperativität des Schmelzvorganges, dass 
möglicherweise ein Metallionen-vermitteltes Basenpaar erhalten werden konnte.  
A A A A A A Y
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A A A A A A A
T
A
3´
5´
3´
5´
T = Thymin
Y = 1-Deazapurin-N9
 = Metall-Liganden Bindung
= Zucker-Phosphat Rückgrat= Ag+
A = Adenin
 
Abbildung IV: Ein mögliches Ag+-vermitteltes Y-G Basenpaar in einem 15-mer. 
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Nach Zugabe von einem Äquivalent Ag+ kann eine Schmelzpunkterhöhung für die Y 
enthaltenden Basenpaare beobachtet werden. Weitere Zugaben von Ag+ erhöhen den 
Schmelzpunkt nur noch geringfügig. Dies schließt ein mögliches Binden am 
Rückgrat aus. Ohne Ag+ hatten die natürlichen Basenpaare (A-T und C-G) eine 
höhere Schmelztemperatur als die Y enthaltenden Basenpaare. Allerdings zeigten die 
natürlichen Basenpaare durch die Zugabe von Ag+ weder eine 
Schmelzpunkterhöhung, noch sonstige Änderungen im Schmelzverhalten. Die 
Ergebnisse der Schmelzkurven werden eingehend diskutiert und die Unterschiede 
analysiert.  
 
Das Schmelzverhalten eines synthetisierten Oligonucleotids, Y16A (Y = 1-
Deazapurine-N9-nucleosid), und eine mögliche Y-Y Basenpaarung mit Ag+ wurden 
untersucht. Mittels CD-Spektren wurde herausgefunden, dass der Strang auch ohne 
Ag+ eine geordnete Struktur einnimmt. Nach der Zugabe von einem halben 
Äquivalent Ag+ wurde eine Schmelztemperatur von rund 43°C gemessen, die sich 
auch nach weiterer Zugabe nicht weiter erhöhte. Dies schließt ein mögliches Binden 
des Ag+ am Rückgrat aus. Die nach Zugabe von Ag+ beobachtete Hypochromizität 
wird im Detail besprochen. Auch erhöht sich die Kooperativität des Schmelzens. 
Allerdings ändert sich die Struktur (möglicherweise eine Doppelhelix) durch die 
Zugabe von Ag+ nicht. Wahrscheinlich enthält jedes zweite Basenpaar ein Ag+ wie es 
auch in Abbildung V gezeigt ist. Strukturen der Basenpaare und einer möglichen 
Doppelhelix werden vorgeschlagen und diskutiert.  
 
Y = 1-Deazapurin-N9 = Metall-Liganden Bindung
= Zucker-Phosphat Rückgrat= Ag+
Y Y Y Y Y Y Y
YYYYYYY Y Y Y Y Y Y Y
Y Y Y Y Y Y Y
Y
Y
Y
A
A
Y
A = Adenin
5´
3´ 5´
3´
 
 
Abbildung V: Mögliche Struktur des Y16A  nach der Zugabe von Ag+. 
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Das Schmelzverhalten eines Oligonucleotids, welches 19 1-Deazaadenin Nucleoside 
(Z) und ein Adenin Nucleosid enthält, mit einem T20 unter Zugabe von Ag+ wurde 
untersucht. Ohne Ag+ wurde kein kooperatives Schmelzverhalten gefunden. Nach 
der Zugabe von einem Äquivalent Ag+ erhält man eine Schmelztemperatur von rund 
48°C. Eine weitere Zugabe an Ag+ erhöht die Schmelztemperatur nicht, was darauf 
schließen lässt, dass Ag+ an den Basen und nicht am Rückgrat bindet. Neben einem 
starken Anstieg der Kooperativität des 
Schmelzens, kann auch Hypochromizität 
beobachtet werden.   
Abbildung VI: Eine mögliche Struktur 
eines Ag+-vermittelten Z-T Basen-
paares ([1+1] + Wasserstoffbrücke). 
 
Eine mögliche Bindung über die 
Hoogsteen Seite von Z mit Thymin 
durch ein Ag+ würde zu einer stabilen 
Doppelhelix führen, in der 19 Ag+ in 
einer eindimensionalen Anordnung zu 
finden wären. Weitere Messungen, die 
eine größere Bandbreite an struk-
turellen Informationen zur Verfügung 
stellen würden, werden vorgeschlagen 
und erläutert. 
 
 
  Abbildung VII: Mögliche Struktur einer 
Doppelhelix durch künstliche  
        Ag+-modifizierte Z-T Basenpaare. 
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F Appendix 
1 Crystallographic Tables 
 
Compound [(trpy)Pt(1-mtet)](ClO4) (7) 
Empirical formula C17H14N7O4ClPt 
Molar weight (g/mol) 610.89 
Crystal colour and habit yellow stick 
Solvent H2O 
Space system triclinic 
Space group P-1 
Cell constants (Å and °) a = 8.136(2) / α = 100.57(3) 
 b = 10.592(2) / β = 91.00(3) 
 c = 10.835(2) / γ = 94.40(3) 
Cell volume (Å ) 914.7(3) 
Z 2 
ρcalc (g/cm) 2.218 
µ (MoKα) (1/mm) 7.860 
F(000) 584 
Temperature (K) 183(2) 
θ range (°) 2.98-29.12 
No. of reflections collected / observed 17970/14546 
Absorption correction numerical 
No. of parameters refined 274 
R1 (observed data) 0.0382 
wR2 (observed data) 0.0949 
GooF 1.054 
Residual ρmin, ρmax (e/ Å3) -2.007, 2.106 
Completion until θ = 29.12 (%) 92.2 
 
Crystallographic table 1: [(trpy)Pt(1-mtet)](ClO4) (7). 
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Compound [(trpy)Pd(1-mimi)](ClO4)2 (10) 
Empirical formula C19H17N5O8Cl2Pd 
Molar weight (g/mol) 620.69 
Crystal colour and habit orange cube 
Solvent H2O 
Space system monoclinic 
Space group P21/n 
Cell constants (Å and °) a = 8.477(2) 
 b = 10.529(2) / β = 92.98(3) 
 c = 26.042(5) 
Cell volume (Å ) 2321.2(8) 
Z 4 
ρcalc (g/cm) 1.776 
µ (MoKα) (1/mm) 1.086 
F(000) 1240 
Temperature (K) 183(2) 
θ range (°) 3.04-27.10 
No. of reflections collected / observed 5059/5059 
Absorption correction numerical 
No. of parameters refined 357 
R1 (observed data) 0.0590 
wR2 (observed data) 0.1364 
GooF 0.814 
Residual ρmin, ρmax (e/ Å3) -1.366, 0.769 
Completion until θ = 27.10 (%) 98.9 
 
Crystallographic table 2: [(trpy)Pd(1-mimi)](ClO4)2 (10). 
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Compound [(trpy)Pt(1-mimi)](ClO4)2 (11) 
Empirical formula C19H17N5O8Cl2Pt 
Molar weight (g/mol) 709.35 
Crystal colour and habit yellow stick 
Solvent H2O 
Space system monoclinic 
Space group P21/n 
Cell constants (Å and °) a = 8.472(2) 
 b = 10.703(2) / β = 93.53(3) 
 c = 25.740(5) 
Cell volume (Å ) 2329.6(8) 
Z 4 
ρcalc (g/cm) 2.023 
µ (MoKα) (1/mm) 6.309 
F(000) 1368 
Temperature (K) 183(2) 
θ range (°) 3.05-28.28 
No. of reflections collected / observed 5765/5765 
Absorption correction numerical 
No. of parameters refined 365 
R1 (observed data) 0.0366 
wR2 (observed data) 0.0965 
GooF 0.939 
Residual ρmin, ρmax (e/ Å3) -1.127, 1.488 
Completion until θ = 28.28 (%) 99.5 
 
Crystallographic table 3: [(trpy)Pt(1-mimi)](ClO4)2 (11). 
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Compound [Hg(9-MeDP)2](NO3)2 · H2O (24) 
Empirical formula C14H16HgN8O7 
Molar weight (g/mol) 608.94 
Crystal colour and habit colourless needles 
Solvent H2O 
Space system monoclinic 
Space group P21/c 
Cell constants (Å and °) a = 5.4015(11) 
 b = 20.467(4) / β = 97.00(3) 
 c = 17.775(4) 
Cell volume (Å ) 1950.4(7) 
Z 4 
ρcalc (g/cm3) 2.074 
µ (MoKα) (1/mm) 7.948 
F(000) 1168 
Temperature (K) 293(2) 
θ range (°) 3.20-27.5 
No. of reflections collected / observed 14611/4429 
Absorption correction SADABS 
No. of parameters refined 335 
R1 (observed data) 0.032 
wR2 (observed data) 0.042 
GooF 0.979 
Residual ρmin, ρmax (e/ Å3) -0.603, 0.618 
Completion until θ = 27.5 (%) 99.2 
 
Crystallographic table 4: [Hg(9-MeDP)2](NO3)2 · H2O (24). 
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Compound 
1-deazapurine-N9-β-2´-deoxyribonucleo-
side (28b) 
Empirical formula C11H13N3O3 
Molar weight (g/mol) 235.24 
Crystal colour and habit colourless blocks 
Solvent cyclohexane / THF 
Space system orthorhombic 
Space group P212121 
Cell constants (Å and °) a = 7.1639(11) 
 b = 14.921(3) 
 c = 20.1672(18) 
Cell volume (Å ) 2155.7(6) 
Z 8 
ρcalc (g/cm) 1.450 
µ (MoKα) (1/mm) 0.108 
F(000) 992 
Temperature (K) 150(2) 
θ range (°) 3.02-25.41 
No. of reflections collected / observed 2303/2281 
Absorption correction none 
No. of parameters refined 385 
R1 (observed data) 0.0295 
wR2 (observed data) 0.0449 
GooF 0.593 
Residual ρmin, ρmax (e/ Å3) -0.176, 0.155 
Completion until θ = 25.41 (%) 99.6 
 
Crystallographic table 5: 1-deazapurine-N9-β-2´-deoxyribonucleoside (28b). 
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Compound 
1-deazapurine-N7-β-2´-deoxyribonucleo-
side (29b) 
Empirical formula C11H13N3O3 
Molar weight (g/mol) 235.24 
Crystal colour and habit colourless blocks 
Solvent cyclohexane / THF 
Space system orthorhombic 
Space group C2221 
Cell constants (Å and °) a = 7.256(2) 
 b = 21.920(5) 
 c = 13.741(4) 
Cell volume (Å ) 2185.5(10) 
Z 8 
ρcalc (g/cm) 1.430 
µ (MoKα) (1/mm) 0.106 
F(000) 992 
Temperature (K) 298(2) 
θ range (°) 2.96-25.35 
No. of reflections collected / observed 1158/1151 
Absorption correction none 
No. of parameters refined 181 
R1 (observed data) 0.0347 
wR2 (observed data) 0.0476 
GooF 0.758 
Residual ρmin, ρmax (e/ Å3) -0.106, 0.159 
Completion until θ = 25.35 (%) 99.2 
 
Crystallographic table 6: 1-deazapurine-N7-β-2´-deoxyribonucleoside (29b). 
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Compound 
1,3-deazapurine-β-2´-deoxyribonucleo-
side (30) 
Empirical formula C12H14N2O3 
Molar weight (g/mol) 234.25 
Crystal colour and habit colourless block 
Solvent CH3OH 
Space system monoclinic 
Space group P21 
Cell constants (Å and °) a = 5.8146(5) 
 b = 7.8927(14) / β = 94.019(8) 
 c = 12.6224(18) 
Cell volume (Å ) 577.85(35) 
Z 2 
ρcalc (g/cm) 1.346 
µ (MoKα) (1/mm) 0.098 
F(000) 248 
Temperature (K) 298(2) 
θ range (°) 3.05-25.35 
No. of reflections collected / observed 1138/1134 
Absorption correction none 
No. of parameters refined 197 
R1 (observed data) 0.0274 
wR2 (observed data) 0.0538 
GooF 0.918 
Residual ρmin, ρmax (e/ Å3) -0.105, 0.111 
Completion until θ = 25.35 (%) 99.9 
 
Crystallographic table 7: 1,3-deazapurine-β-2´-deoxyribonucleoside (30). 
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Compound 1-deaza-N3-oxidepurine (35) 
Empirical formula C6H9N3O3 
Molar weight (g/mol) 171.15 
Crystal colour and habit colourless sticks 
Solvent H2O 
Space system Orthorhombic 
Space group Pbcn 
Cell constants (Å and °) a = 10.7699(19) 
 b = 6.8914(9) 
 c = 20.693(18) 
Cell volume (Å3) 1535.9(4) 
Z 8 
ρcalc (g/cm) 1.480 
µ (MoKα) (1/mm) 1.029 
F(000) 720 
Temperature (K) 183(2) 
θ range (°) 2.92-64.29 
No. of reflections collected / observed 4723/968 
Absorption correction numerical 
No. of parameters refined 121 
R1 (observed data) 0.0685 
wR2 (observed data) 0.1738 
GooF 1.082 
Residual ρmin, ρmax (e/ Å3) -0.284, 0.243 
Completion until θ = 55.94 (%) 96.8 
 
Crystallographic table 8: 1-deaza-N3-oxidepurine (35). 
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Compound 1-deaza-6-nitropurine (37) 
Empirical formula C6H4N4O2 
Molar weight (g/mol) 164.13 
Crystal colour and habit yellow blocks 
Solvent H2O 
Space system monoclinic 
Space group P21/c 
Cell constants (Å and °) a = 11.684(2) 
 b = 9.5750(19) / β = 116.53(3) 
 c = 7.2052(14) 
Cell volume (Å3) 721.2(2) 
Z 4 
ρcalc (g/cm) 1.512 
µ (MoKα) (1/mm) 0.119 
F(000) 336 
Temperature (K) 298(2) 
θ range (°) 3.58-26.51 
No. of reflections collected / observed 6047/1483 
Absorption correction none 
No. of parameters refined 125 
R1 (observed data) 0.0531 
wR2 (observed data) 0.0994 
GooF 1.011 
Residual ρmin, ρmax (e/ Å3) -0.217, 0.191 
Completion until θ = 26.51 (%) 99.3 
 
Crystallographic table 9: 1-deaza-6-nitropurine (35). 
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Compound 
1-deaza-(6-benzoylamino)-purine-N9-β-
2´-deoxyribonucleoside· H2O (42I) 
Empirical formula C18H20N4O5 
Molar weight (g/mol) 372.38 
Crystal colour and habit colourless block 
Solvent iso-propanol 
Space system orthorhombic 
Space group P212121 
Cell constants (Å and °) a = 6.9486(7) 
 b = 9.0272(12) 
 c = 27.091(3) 
Cell volume (Å ) 1699.3(3) 
Z 4 
ρcalc (g/cm3) 1.456 
µ (MoKα) (1/mm) 0.108 
F(000) 784 
Temperature (K) 150(2) 
θ range (°) 3.01-25.32 
No. of reflections collected / observed 1822/868 
Absorption correction none 
No. of parameters refined 306 
R1 (observed data) 0.0303 
wR2 (observed data) 0.0399 
GooF 0.705 
Residual ρmin, ρmax (e/ Å3) -0.162, 0.130 
Completion until θ = 25.32 (%) 99.8 
 
Crystallographic table 10: 1-deaza-(6-benzoylamino)-purine-N9-β-2´-deoxyribo-
nucleoside· H2O (42I). 
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Compound 
1-deaza-(6-benzoylamino)-purine-N9-β-
2´-deoxyribonucleoside· CH3OH (42II) 
Empirical formula C19H22N4O5 
Molar weight (g/mol) 386.41 
Crystal colour and habit colourless blocks 
Solvent CH3OH 
Space system monoclinic 
Space group P21 
Cell constants (Å and °) a = 7.860(2) 
 b = 9.194(3) / β = 105.055(16) 
 c = 13.385(3) 
Cell volume (Å ) 934.0(4) 
Z 2 
ρcalc (g/cm) 1.374 
µ (MoKα) (1/mm) 0.101 
F(000) 408 
Temperature (K) 298(2) 
θ range (°) 3.15-25.37 
No. of reflections collected / observed 1802/1797 
Absorption correction none 
No. of parameters refined 258 
R1 (observed data) 0.0276 
wR2 (observed data) 0.0385 
GooF 0.562 
Residual ρmin, ρmax (e/ Å3) -0.114, 0.097 
Completion until θ = 25.37 (%) 98.1 
 
Crystallographic table 11: 1-deaza-(6-benzoylamino)-purine-N9-β-2´-deoxyribo-
nucleoside· CH3OH (42II). 
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3 List of the Compounds Discussed in this Thesis 
 
Synthesised Compounds 
 
(1)   1-methylimidazole (1-mimi)  
(2)   1-methyltetrazole (1-mtet)  
(3)   2-methyltetrazole (2-mtet) 
(4)   [(trpy)PdCl]Cl· 2H2O 
(5)   [(trpy)PtCl]Cl· 2H2O 
(6)   [(trpy)2Pd2(1-mtetate)](ClO4)3 
(7)   [(trpy)Pt(1-mtetate)](ClO4) 
(8)   [(trpy)Pd(2-mtet)](ClO4)2 
(9)   [(trpy)Pt(2-mtet)](ClO4)2 
(10)   [(trpy)Pd(1-mimi)](ClO4)2 
(11)   [(trpy)Pt(1-mimi)](ClO4)2 
(12)   3-methylpentanedioic acid 
(13)   dimethyl 3-methylpentanedioate 
(14)   1,5-bis(2-pyridyl)-3-methylpentane-1,5-dione 
(15)   4´-methyl-2,2´:6´,2´´-terpyridine 
(16)   disiloxane-protected 2-deoxyribonolactone 
(17)   4´-carboxyaldehyde-2,2´:6´,2´´-terpyridine 
(18)   4´-hydroxymethyl-2,2´:6´,2´´-terpyridine 
(19)   4´-bromomethyl-2,2´:6´,2´´-terpyridine 
(20)   DMTr-(S)-glycidol 
(21)   1-deazapurine 
(22)   1-deaza-9-methylpurine 
(23)   1-deaza-7-methylpurine 
(24)   [Hg(1-deaza-9-methylpurine)2](NO3)2 · H2O 
(25)   Hoffer´s chlorosugar 
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(26b and 26a) 1-deazapurine-N9-β(α)-[2´-deoxy-3´,5´-di-O-(p-toluoyl)-ribo-
nucleoside 
(27b and 27a) 1-deazapurine-N7-β(α)-[2´-deoxy-3´,5´-di-O-(p-toluoyl)-ribo-
nucleoside 
(28b and 28a) 1-deazapurine-N9-β(α)-2´-deoxyribonucleoside (Y) 
(29b and 29a) 1-deazapurine-N7-β(α)-2´-deoxyribonucleoside (X) 
(30)   1,3-deazapurine-β-2´deoxyribonucleoside 
(31) 1-deazapurine N9-β-[2´-deoxy-5´-O-(4,4´-dimethoxytrityl)-ribo-
nucleoside] 
(32) 1-deazapurine N7-β-[2´-deoxy-5´-O-(4,4´-dimethoxytrityl)-ribo-
nucleoside] 
(33) 1-deazapurine-N9-β-[2´-deoxy-3´-O-(2-cyanoethyl)-N,N-diiso-
propylphosphoramidite-5´-O-(4,4´-dimethoxytrityl)-ribonucleo-
side] 
(34) 1-deazapurine-N7-β-[2´-deoxy-3´-O-(2-cyanoethyl)-N,N-diiso-
propylphosphoramidite-5´-O-(4,4´-dimethoxytrityl)-ribonucleo-
side] 
(35)   1-deaza-N3-oxidepurine· H2O 
(36)   1-deaza-N3-oxide-6-nitropurine 
(37)   1-deaza-6-nitropurine 
(38b and 38a) 1-deaza-6-nitropurine-N9-β(α)-[2´-deoxy-3´,5´-di-O-(p-toluoyl)-
ribonucleoside 
(39)   1-deaza-6-nitropurine-N9-β-2´-deoxyribonucleoside 
(40)   1-deazaadenine-N9-β-2´-deoxyribonucleoside (Z) 
(41)   1-deaza-6-aminopurine 
(42) 1-deaza-(6-benzoylamino)-purine-N9-β-[2´-deoxyribonucleoside] 
· H2O 
(43) 1-deaza-(6-benzoylamino)-purine-N9-β-[2´-deoxy-5´-O-(4,4´-
dimethoxytrityl)-ribonucleoside] 
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(44) 1-deaza-(6-benzoylamino)-purine-N9-β-[2´-deoxy-3´-O-(2-cyano-
ethyl)-N,N-diisopropylphosphoramidite-5´-O-(4,4´-dimethoxy-
trityl)-ribonucleoside] 
(45) 1-deaza-(6-methoxyacetylamino)-purine-N9-β-[2´-deoxyribo-
nucleoside]· 0.5H2O 
(46) 1-deaza-(6-methoxyacetylamino)-purine-N9-β-[2´-deoxy-5´-O-
(4,4´-dimethoxytrityl)-ribonucleoside] 
(47) 1-deaza-(6-methoxyacetylamino)-purine-N9-β-[2´-deoxy-3´-O-(2-
cyanoethyl)-N,N-diisopropylphosphoramidite-5´-O-(4,4´-
dimethoxytrityl)-ribonucleoside] 
 
Oligonucleotides 
 
(a)   5´-d(AAA AAA AXX XTT TTT TT) 
(b)   5´-d(AAA AAA AXX XXT TTT TTT) 
(c)   5´-d(AAA AAA AXA AAA AAA) 
(d)   5´-d(TTT TTT TXT TTT TTT) 
X = 1-deazapurine-N7-β(α)-2´-deoxyribonucleoside (29b and 29a) 
(e)   5´-d(CYY YYG) 
(f)   5´-d(CGC GYA TYC GCG) 
(g)   5´-d(AAA AAA AYA AAA AAA) 
(h)   5´-d(TTT TTT TYT TTT TTT) 
(i)   5´-d(YYY YYY YYY YYY YYY YA) 
(j)   5´-d(TTT TTT TTT TTT TTT TT) 
Y = 1-deazapurine-N9-β(α)-2´-deoxyribonucleoside (28b and 28a) 
(k)   5´-d(AZZ ZZZ ZZZ A) 
(l)   5´-d(AZA ZAZ AZA) 
(m)   5´-d(ZZZ ZZZ ZZZ ZZZ ZZZ ZZZ ZA) 
(n)   5´-d(TTT TTT TTT TTT TTT TTT TT) 
Z = 1-deazaadenine-N9-β-2´-deoxyribonucleoside (40) 
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